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Abstract 
Xeroderma pigmentosum (XP), a cancer model disease, is the perfect proof for the existing model of 
carcinogenesis activated by mutations. All patients share a defect in Nucleotide excision repair (NER). 
The gene, which is disease-causing for XP complementation group G (XPG) patients, encodes for the 
multifunctional endonuclease XPG. This enzyme has many binding partners like TFIIH, RPA and PCNA, 
and acts at a crucial step at the very end of NER. Several functional domains of XPG were mutated to 
investigate the behavior of the respective mutants during NER intermediates of dual incision, using 
DNA repair synthesis (UDS) and Host cell reactivation (HCR) assays. Furthermore, a new XPG patient 
with implications for the functional XPG-TFIIH interaction has been studied. 
By genotype-phenotype correlation of a XPG patient (XP172MA), this study greatly suggests to 
narrow down the functionally important XPG interaction domain between TFIIH and XPG to the XPG 
amino-acids 30-85. 
This study demonstrates that the functional PCNA-XPG interaction is more important for NER than 
the endonuclease function of XPG. The C-terminally located PIP-box of XPG is required for immediate 
UV response but not for the functionality of XPG during NER in transiently transfected primary 
fibroblasts. The N-terminal PIP-UBM ubiquitin binding domain is more important for integrity of NER 
than the C-terminal PIP-box.  
I raise the model of an NER intermediate state that involves obligatory ubiquitination during NER and 
the blocking of error-prone translesion polymerases by XPG. This study excludes XPG as the 
responsible factor for PCNA recruitment and designates XPG as the factor as restrictive element for 
UV-damage dependent activation of translesion polymerases to S-phase. 
The results obtained with the endonuclease defective E791A XPG mutant confirm the actual “cut-
patch-cat-patch” model of dual incision during NER. Moreover, this study clearly demonstrates the 
ability of endonuclease defective XPG to perform accurate NER in living cells. This accounts for the 
existence of a cellular backup mechanism for the XPG endonuclease function. 
The proposal for a nuclear backup mechanism is supported by the investigation of a physiologically 
relevant (evolutionary developed) XPG splicevariant with NER activity (IsoVI). The severely truncated 
XPG isoform is able to structurally complement a XPG defect. This complementation is dependent on 
the endonuclease function of Fen1. This suggests the existence of an evolutionary developed backup 
mechanism for XPG during NER. 
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Ultraviolet (UV) light 
 
Figure 1: Ultraviolet (UV) light 
UV light is divided into short wave UVC, middle wave UVB and long wave UVA light (Soehnge et al, 
1997). Both UVA and UVB reach the earth's surface (the eyes, the skin) in sufficient amounts to 
provoke DNA damage (see chapter 1.2.2) in living species and in turn to be carcinogenic (see chapter 
1.1). Normally, UVC is effectively blocked from reaching the earth's surface by the ozone layer of the 
atmosphere, although carries the highest energy and is used during the experiments to gain DNA 
damage.  
Introduction 
1 
1 Introduction 
All living species are constantly exposed to endogenous and environmental deoxyribonucleic acid 
(DNA) damaging agents which jeopardize integrity of nucleic acids, mainly by base modifications 
(Lindahl, 1993). Among other things, unrepaired DNA damages in coding or functional chromosomal 
areas can lead to mutations (see chapters 1.2.3, 1.3.6) in the DNA sequence content after error 
prone replication. This in turn alters the amino acid sequence and functions of its gene products 
(Jena, 2012). Moreover, malfunctions of enzymes and proteins (mutated tumor suppressors or 
activated oncogenes) can drive the cellular transformation towards cancer (Hoeijmakers, 2009).   
1.1 Multistep carcinogenesis model – malignant NER associated disorders – XP, 
CS and others 
Human cancer is, among other things, hallmarked by the accumulation of errors (Hanahan & 
Weinberg, 2000). Mutations in the genome are the first key step to the activation of oncogenes or 
the inhibition of tumor suppressor genes. This results in the loss of cell cycle control and apoptosis 
(Soehnge et al, 1997), thus in carcinogenesis.  
In squamous cell carcinomas (SCCs) and basal cell carcinomas (BCCs) the typical UVB light (see Figure 
1, Figure 2) derived CC to TT mutation pattern is found in the defective p53 tumor suppressor gene 
(Dumaz et al, 1993; Ehrhart et al, 2003). P53 is a multiplayer in the cell and fulfills a lot of functions (it 
activates cell cycle checkpoints and DNA repair pathways and initiates apoptosis), has over 100 
interaction partners and is seen as the major trigger of human cancer development in all tissues and 
is involved in the DNA damage response (Greenblatt et al, 2003) (see chapter 1.3.1). In contrast to 
other cancers, e.g. colon cancers, where p53 is affected at relatively late stages of the malign 
progression from adenoma to carcinoma (Fearon & Vogelstein, 1990), in skin cancers p53 mutations 
arise at early onset stages (Campbell et al, 1993). The oncogenic transformation is further induced by 
expression level changes due to transcription factor binding inhibition especially by the above 
mentioned two adjacent cytosine to tyrosine transitions, effecting the TATA-box consensus sequence 
and thus binding of TATA binding protein (TBP) (Tommasi et al, 1996) 
Xeroderma pigmentosum (XP), an interesting cancer model disease is the perfect proof for the 
existing model of carcinogenesis activated by mutations (Cleaver, 2000). Patients may suffer from 
mutations in different genes but share a common feature, a defect in Nucleotide excision repair 
(NER, see chapters 1.3.2, 1.3.4), this, in turn, results in the accumulation of mutations by action of 
the error prone translesion polymerases, e.g. polymerase (Pol) ζ, during replication (Gan et al, 2008). 
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1.1.1 Xeroderma Pigmentosum (XP) 
Xeroderma pigmentosum (XP, greek xeros = dry, “dry pigmented skin”) was first described by Hebra 
and Kaposi in 1874 (DiGiovanna & Kraemer, 2012). Xeroderma pigmentosum is a rare autosomal 
recessive disorder, characterized among other symptoms by extreme photosensitivity of the skin and 
eyes, pigmentary changes (freckle-like skin), premature skin aging, and rapid malignant tumor 
development (Figure 2). A defect in the removal of UV-induced (bulky) DNA lesions, induced by 
ultraviolet (UV) light (see Figure 1), is characteristic for XP and many XP-related disorders, first 
described in 1968 (Cleaver, 1968). By complementation experiments (fusion of fibroblast from 
different XP patients) the heterogeneity of the disease was demonstrated, subsequently gene 
defects in the seven major NER-genes (XPA-XPG) were identified to be responsible for the clinical 
picture and became name-givers for the proteins in the NER pathway (see chapter 1.3.2) (Arase et al, 
1979; Halley et al, 1979; Kraemer et al, 1975a; Kraemer et al, 1975b). Until today, XP patients and 
their cells in culture serve as the major model disease for NER research. 
         
Figure 2: Overview of the Xeroderma Pigmentosum (XP) symptoms 
A) XPD: severe blistering erythema of the malar area following minimal sun exposure; b) XPC: 
multiple hyper pigmented macules, a rapidly growing squamous cell carcinoma (SCC) or carcinoma 
on the upper lip and a precancerous lesion on the forehead; c) XPC: basal cell cancer on left nasal 
root and left cheek, the eyes show cornea scarring from unprotected sun exposure; d) XPA: 
numerous hyper pigmented macules on sun-exposed areas, additional neurological symptoms, 
sensorineural deafness; e) Corneal clouding, pterygium, contact lens, and loss of lashes on lower 
eyelid; f) Sharp demarcation of sun-exposed skin; g) Loss of vermillion border of the lips with 
prominent telangiectasias, scaring of the lips, and anterior tongue; h) SCC of the anterior tongue; i, j) 
short brittle hair and a smiling, outgoing personality typical for TTD-patients. (Bradford et al, 2011; 
DiGiovanna & Kraemer, 2012; Liang et al, 2005; Mahindra et al, 2008) 
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Xeroderma Pigmentosum has been diagnosed across all racial groups of all continents with its 
complementation groups XP-A to XP-G and XP variant (Schubert et al, 2013). The estimated 
prevalence of XP is 1: 1 000 000 in the USA and Europe and remarkably higher in Japan (1: 20 000), 
especially due to XPA gene defects (Hirai et al, 2006; Kleijer et al, 2008). The incidence in Northern 
Europe, North Africa and the Middle East is assumed to be also elevated, particularly in cultures with 
an increased level of consanguinity or in long term isolated populations (Kraemer KH, 2003-2014). 
Noteworthy, only about 60% of affected individuals are characterized by an excessive and prolonged 
sunburn response (Bradford et al, 2011). The statistical numbers are differing between the sources, 
but the UV-dependent development of squamous cell carcinomas (SCC) or basal cell carcinomas 
(BCC) as well as melanoma skin cancers is extraordinary enhanced,  1 000 to 10 000-fold and 1 000 to 
2 000-fold, respectively (Cohen & Ellwein, 1991). Tumors are preferentially located at sun-exposed 
areas and arise in XP patients at the mean age of six to nine years and as the case may be 22 years 
for melanomas (Bradford et al, 2011; Cleaver, 2000; DiGiovanna & Kraemer, 2012; Kraemer et al, 
1987; van Steeg & Kraemer, 1999). This is a great effect compared with normal e.g. the Caucasian 
population, wherein the first skin cancers are statistically developed about 50 years later (Bradford et 
al, 2011; Emmert & Kraemer, 2013). Furthermore, the distribution of other cancers types is nearly 
identical between XP-patients and the normal population, accounting for the influence of the 
Nucleotide excision repair (NER) on cell constitution and transformation prevention (Kraemer, 1997; 
van Steeg & Kraemer, 1999) (see chapter 1.3.2). Estimated over all complementation groups, the 
minority of XP cases shows additional neurological abnormalities, leading to phenotypes with varying 
severity (see chapters 1.1.2, 1.1.3, see Figure 2). 
1.1.2 Cockayne Syndrome (CS) and combined XP/CS  
The Cockayne Syndrome has an incidence of 1 : 2.7 million and patients exhibit XP symptoms like 
photosensitivity and freckling of sun-exposed skin, and furthermore cortically develop the 
characteristic bird-like facies with unusual deep set eyes, flat cheek bones, and neurological 
abnormalities like growth retardation (dwarfism), mental retardation, microcephaly, loss of ability to 
walk, deafness, and progressive visual loss because of pigmentary retinal degeneration (Dollfus et al, 
2003; Kleijer et al, 2008; Nance & Berry, 1992). CS arises mainly as a result of mutations in 
transcription coupled repair (TCR) - associated (see chapter 1.3.4.1.2) CSA and CSB genes (Kraemer et 
al, 2007). Interestingly, despite the fact that CSA and CSB are supposed to be involved in chromatin 
remodeling, CS patients do not exhibit an increased skin cancer risk like XP patients (Fousteri et al, 
2006; Kraemer et al, 2007).  
The combined phenotype, XP/CS-complex, arises mainly due to transcriptional missfunction and 
failures in the activation of nuclear receptors, because all three involved enzymes, XPB, XPD, and 
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XPG, are part of (XPB, XPD) or associated with (XPG) the universal transcription factor TFIIH (see 
chapters 1.3.4.31.3.4, 1.4) (Ito et al, 2007; Kraemer et al, 2007). XP/CS is phenotypically characterized 
by photosensitivity, an increased risk for the development of skin cancers and the typical CS 
symptoms like short stature, bird-like facies, mental retardation progressive neurological 
degeneration and deafness (Emmert et al, 2006; Kraemer et al, 2007).  
1.1.3 Other XP-associated syndromes 
 
 
Figure 3: Genotype-phenotype relationship of XP-associated disorders  
The violet circles depict the genotypes; the turquoise rectangles represent the several (combined) 
phenotypes. Different gene failures are able to cause manifold phenotypes and vice versa 
(DiGiovanna & Kraemer, 2012). 
 
There is a complex and yet not fully understood genotype-phenotype relationship between the 
different clinical entities of the XP-spectrum (see (DiGiovanna & Kraemer, 2012; Le May et al, 2010). 
Beside Xeroderma pigmentosum, the Cockayne Syndrome (CS) and Trichothiodystrophy (TTD) are the 
major NER-deficient disorders and exist also in a phenotypical combination with XP, depending on 
the location of the gene defect.  
Figure 3 depicts a detailed scheme. For example mutations in XPG, XPD and XPB separately provoke 
the combined XP-CS phenotypes, in case of the latter two also in combination with TTD.  
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1.2 Mutagens and DNA damage  
The amount of spontaneous mutations due to replication events is not sufficient to trigger the cancer 
development. This chapter gives a brief overview of the sources of additional DNA damage. 
1.2.1 Endogenous DNA damage sources 
Several sources of DNA damage were identified including essential substances for life like water or 
oxygen (Tice, 1985). Reactions with water by far cause the most common intercellular types of DNA 
damages. They are comprising strand breaks (hydrolysis), depurination, depyrimidination, and 
deamination, which lead to abasic sites or base modifications like formation of uracil (deamination of 
cytosine; G to A transition) or Hypoxanthine (deamination of adenine; T to C transition) (Contreras & 
Madariaga, 2003). Consequence is the formation of miss pairing base pairs and later on the 
establishment of wrong sequence context in daughter chromatids (transversions and transitions).  
Reactive oxygen species (ROS), formed by irradiation or chemical species generating free radicals like 
O2
-, add methyl or ethyl groups to nucleotides or oxygenate bases (e.g. Guanine), respectively 
(Prakash et al, 2000). Two of the most common types of base modifications in this context are O6-
methylguanine or 8-oxo-G which lead to C to T transitions. Some alkylating agents, e.g. nitrogen 
mustard, used for cancer treatment, are able to produce interstrand crosslinks (ICLs) like cisplatin, 
(McHugh et al, 2001). Alkylating agents (like MNNG) because the same type of mutations and arise 
from exogenous sources (see chapter 1.2.2).  
1.2.2 Exogenous DNA damage sources 
Another source of DNA damage is radiation. Ionizing radiation, α-, γ- or X-Rays, create double strand 
breaks directly by attacking the DNA backbone (Vignard et al, 2013). This endangers the constitution 
of the whole genome, due to the fact that its interference with both strands carries a high potential 
for loss of genetic information.  
Intercalating agents, like ethidium bromide and Benzo[a]pyrene (pollution, tobacco smoke), 
respectively attack the minor or major groove of the DNA double helix (Hess et al, 1997a; Yielding et 
al, 1979). Resembling a DNA nucleotide during S-phase, DNA polymerases create insertions while 
using it as template. This leads to frameshift mutations in daughter chromatids, and is in most cases 
much more severe regarding protein coding than missense mutations.  
1.2.3 UV induced bulky DNA lesions in human DNA 
One of the most extensive and omnipresent environmental mutagen is ultraviolet (UV) radiation (in 
particular UVA and UVB light, see Figure 1). Its energy creates a photochemical reaction and its 
efficacy depends on the wavelength. By energy absorption, in most cases adjacent pyrimidines are 
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covalently linked together or with other molecules, e.g. in the presence of psoralen, leading to the 
formation of dimers (Hearst et al, 1984; Markovitsi et al, 2010). The maximum absorption of DNA 
bases is 254nm (UVC), a wavelength, which is quantitatively absorbed by ozone and oxygen in the 
atmosphere but widely used in science because it ensures the highest rate of UV lesion formation 
(Rastogi et al, 2010). 
Beside the spore photoproducts, specific for anhydrously living prokaryotes, the most commonly 
generated UV adducts in the DNA are cyclobutane pyrimidine dimers (CPDs; 75%) and 6, 4 
pyrimidine-pyrimidones (6-4PPs; 25%) and their Dewar isomers (Rastogi et al, 2010; Yokoyama et al, 
2012) (see Figure 4). The relevant main difference between these two lesions is the intensity of the 
kink they are introducing into the DNA backbone. 6-4PPs are characterized by a strong bending of 
about 44°C while CPDs show only about 9°C in rotation of the two bases towards each other (Kim & 
Choi, 1995; Suquet & Smerdon, 1993), which results in implications for the different modes of 
damage recognition (see chapter 1.3.4.1).  A model of the chemical structure of the two DNA lesions 
is depicted in figure two. 
  
 
Extensive base modifications of the DNA, introduced by alkylating and crosslinking agents as well as 
UV irradiation, are comparatively huge lesions, which distort the structure of the α-helix and 
introduce kinks in the DNA backbone (so called bulky lesions). They are able to block polymerases 
and stall replication forks through this conformational change and, if left unrepaired, create 
mutations all over the genome during replication by the action of error-prone translesion synthesis 
Figure 4: UV lesions of DNA 
UV light induces pyrimidine 
dimers between adjacent 
nucleotide of the same DNA 
strand.  
A) 6-4PPs are developed by 
covalently linking the C6 atom 
of the 5’ base with the C4 of 
the 3’ nucleotide. In this 
context it has been found that 
T-T and T-C are more abundant 
than C-T or C-C sequences. Due 
to extensive base skewing, 6-
4PPs are known to introduce a 
strong bending in the DNA 
backbone.  
B) CPDs arise by coalescence of 
the C5 and C6 positions of two 
neighboured pyrimidines 
mainly introducing small kinks 
into the DNA backbone (the 3’ 
base is twisted around at the 
position of the N‑glycosidic 
bond).  
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(TLS) DNA polymerases (Branzei & Foiani, 2010; Hanawalt, 1989; Zhang et al, 2000a; Zhang et al, 
2000b) (see chapter 1.3.6). The UV signature, a C to T transition or CC to TT, is a typical mutation that 
has been found in p53 genes of squamous cell carcinomas (Brash et al, 1991). Beside other ways of 
appearance, it is produced by the action of translesion polymerase η, which is error free upon CPDs, 
but can produce this UV mutation pattern “unintentionally” e.g. at the sites of uracil containing CPD 
(after deamination of cytosine) (Masutani et al, 2000). Other (indirect) influences on the UV 
signature are reviewed in (Ikehata & Ono, 2011). 
1.3 Cells treat (UV) damage 
A lot of different DNA repair pathways have developed as an answer to the extensive amount of 
diverse mutagens (see chapter 1.2). This includes direct reversal (photolyase), Mismatch repair 
(MMR), Double strand break (DSB) repair, Base excision repair (BER) pathways etc. (reviewed in 
(Lombard et al, 2005)). This thesis concentrates on UV-dependent DNA damage and the responsible 
Nucleotide excision repair (NER) as well as translesional synthesis.  Principally, all the repair pathways 
work in concert and are connected to the DDR in a cell cycle dependent manner (see chapter 1.3.1). 
The NER mainly works during G1-Phase (see chapter 1.3.2), whereas translesion synthesis is generally 
restricted to S-phase (see chapter 1.3.6).  
1.3.1 The universal DNA damage response (DDR) 
In order to guard the integrity of the genome and the genetic information content, evolution 
developed a rash of molecular mechanisms that are embraced by the term 'DNA damage response’ 
(DDR). It is initiated by blocked polymerases or stalled replication forks and consists of a 
phosphorylation signal cascade (Giglia-Mari et al, 2011; Hoeijmakers, 2001). The DDR is in principle 
found among all species (Britt, 1996; Brown et al, 1999; DiRuggiero et al, 1997). Beside the so called 
SOS-response in prokaryotes it includes a broad range of DNA repair pathways, damage tolerance 
mechanisms, and cell-cycle checkpoint control steps in humans (Jackson & Bartek, 2009; Opperman 
et al, 1996; Sutton et al, 2000).  
Persisting DNA damage results in the coverage of ssDNA by Replication Protein A (RPA) (Wold, 1997). 
An additionally existing primer-template junction leads to subsequent recruitment of ATM (PI3K-like 
kinases ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3-related) in mammals 
(Budzowska & Kanaar, 2009; D'Amours & Jackson, 2002; Ray et al, 2013). ATM and ATR 
phosphorylate the checkpoint effector kinases CHK2 and CHK1, respectively. This prevents 
replication of damaged DNA by activating p53 and p21, which in turn results in G1/S (ATM) or G2/M 
(ATR) checkpoint arrest to amongst others allow DNA repair (see Figure 5). 
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Regarding the permanent mutagenic influence on the genome (see chapter 1.2) the DDR is an 
essential cellular process to secure genetic informational content and to avoid cellular malfunction 
and oncogenic transformation (Sertic et al, 2012). 
1.3.2 Nucleotide excision repair (NER) 
Some of the candidate genes, to date or in future, used as biomarkers for the cancer development or 
chemical tumor treatment perspectives are components of the Nucleotide excision repair (NER) 
pathway (Li et al, 2013a). The NER is the one and only error-free repair pathway in mammals which is 
able to repair bulky lesions (see chapter 1.2) in the DNA, characterized by a thermodynamically 
destabilized DNA duplex (Hess et al, 1997b). It was first discovered while observing the gap filling 
step utilizing unscheduled DNA synthesis (UDS, see chapter 3.5.2) in living cells in 1964 (Pettijohn & 
Hanawalt, 1964; Rasmussen & Painter, 1964). Since that time the understanding of this complex 
repair mechanism expended quickly, especially since it was associated with Xeroderma pigmentosum 
(XP) (see chapter 1.1.1), a genetic disorder with deficiency regarding NER and the removal of UV 
induced DNA adducts (see chapter 1.2.3) (Cleaver, 1968). Today, 50 years later, it is well known that 
it involves over 30 proteins (Le May et al, 2010). Some of them are conserved over the three major 
organism: archaea, prokarya and eucarya  (Rouillon & White, 2011). 
There are extensive differences between prokaryotes and eukaryotes, especially humans (Morita et 
al, 2010). In contrast to the human set of proteins (>30), bacteria carry out the NER using only four 
proteins (UVR) (Truglio et al, 2006). The heterodimer UVR-AB constantly scans the DNA for damages 
and binds to them. Subsequently an exchange between UVR-A and UVR-C is triggered and the 
Figure 5: DNA damage response 
The DNA damage response (DDR) 
is mainly initiated by cellular 
signals like persisting DNA 
damage and stalled replication 
forks. The signaling cascade 
involves several kinases: sensors 
(ATM, ATR), adaptors (e.g. BRCA1 
in UV response; not shown), 
transducer kinases (CHK1,2) and 
effector proteins and pathways 
(cyclin B,E and CDK1,2 as well as 
cell cycle checkpoints). This 
signaling cascade ensures a 
chronological delay of cellular 
processes and proliferation to 
allow sufficient repair of DNA 
damages and lesions or promote 
(p53-dependent) apoptosis. 
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heterodimer UVR-BC, both subunits are carrying a nuclease activity, excises the fragment (Kisker et 
al, 2013). DNA polymerase II (often UVR-D in this context) synthesizes the new strand and seals the 
nick. Prokaryotic organisms also express photolyases performing direct reversal repair of UV induced 
DNA lesions (Zhang et al, 2013a). In eukaryotic organisms the protein products of the corresponding 
genes are probably converted into blue light receptors, whereas this repair pathway was 
evolutionary assumed by the NER (Kanai et al, 1997).  
Human NER was reconstituted in vitro with 17 core components including the XP proteins XPA – XPG 
(Aboussekhra et al, 1995; Biggerstaff & Wood, 1999; Shivji et al, 1999; Tapias et al, 2004). In contrast 
to other repair pathways the NER shows a broad bandwidth of substrates/lesions to be recognized. 
This DNA repair pathway is able to act in a cell-cycle independent manner and is both, a signal and an 
effector of the DNA damage response (DDR) (see chapter 1.3.1) (Giannattasio et al, 2010; Ray et al, 
2013; Sertic et al, 2011; Sertic et al, 2012). The pathway is a sequential succession of molecular 
assembly steps carried out by several factors with special functions and features, which can be 
divided into three main stages: first the recognition of a DNA lesion, second the incision complex 
formation and DNA unwinding, and third the endonucleolytic incision around the lesion including gap 
filling, as it is briefly summarized in Figure 6, see a detailed description of NER in chapter 1.3.4 
(Scharer, 2013).  
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Figure 6: Nucleotide excision repair  
The eukaryotic NER is subdivided into two coexisting damage recognition sub pathways, the 
transcription coupled repair (TCR) and Global genome repair (GGR). During GGR the XPC- and XPE 
complex serve as a lesion sensor, in the TCR pathway the RNA polymerase II together with the CUl4-
CSA complex and CSB detect the DNA adduct. Subsequently incision complex formation and DNA 
unwinding is performed by the recruitment of TFIIH (harbors helicase activity), XPG, RPA, and XPA. 
The endonucleases XPF-ERCC1 and XPG perform two incisions of the damaged strand upstream and 
downstream of the lesion. This results in the release of a DNA damage containing oligonucleotide 
and gap filling synthesis by action of RFC, PCNA and DNA polymerases δ/ε followed by the finalizing 
ligation by ligase I. (http://www.genome.jp)  
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1.3.3 Damaged chromatin and Nucleotide excision repair 
The human genome is organized in 46 chromosomes and more or less tightly packed in either eu- or 
heterochromatin (Consortium, 2004; Oberdoerffer & Sinclair, 2007). Before the core reaction of NER 
is discussed I want to take a closer look into the consequences of chromatin structures in the context 
of NER. 
Euchromatin, the light variant of packaged nucleic acids, is the predominant form (about 92-99%). It 
is often associated with actively transcribed genes (Consortium, 2004) (see chapter 1.3.4.1.2), 
because its structure ensures accessibility to the naked DNA for transcription factors and associated 
proteins. In contrast heterochromatin is the tightly packed variant of DNA and can be subdivided into 
two subclasses, constitutive and facultative heterochromatin. It has extensive implications for gene 
expression by silencing (Haaf & Schmid, 2000; Johnson et al, 2013).  
The molecular mechanism of NER in the context of chromatin is poorly understood and 
underrepresented in the NER research due to the fact, that the most results elucidated are produced 
utilizing in vitro assays with naked DNA (Tapias et al, 2004). However, it is well known, that UV 
induced lesions (CPDs, 6-4PPs) in heterochromatin are repaired much more slower than in unpacked 
DNA (Ura et al, 2001) because the NER needs chromatin relaxation for bubble unwinding (see 
chapter 1.3.4.3) and the incision process (see chapter 1.3.4.4). This is performed in a p53 dependent 
manner (Rubbi & Milner, 2003). Especially in actively transcribed genes chromatin shows an 
inhibitory effect to the removal of CPDs (Bohr et al, 1985).  
CPDs require recognition of both, the XPC-complex and the Cul4-DDB-complex, in future named the 
XPE-complex (see Figure 6) (Fitch et al, 2003b). The CUL4A E3 ligase of the XPE-complex needs DDB2 
for recognition of UV lesions in chromatin, ubiquitinates XPC (see chapter 1.3.4.1.1), and (mono-) 
ubiquitinates the histones H2A, H3 and H4, resulting in a quicker dissociation of nucleosomes in high-
salt conditions due to a weaker interaction between histones and the DNA  (Guerrero-Santoro et al, 
2008; Itoh et al, 1999; Li et al, 1993; Sugasawa et al, 2005; Wang et al, 2006). Pines and co-workers 
further showed the interaction between PARP1, thus poly(ADP-ribosyl)ated UV-damaged chromatin, 
with DDB2.  
Furthermore, the INO80 remodeling complex (INO80 and ARP5) was found to be essential for the 
removing of the relevant UV-induced lesions (see chapter 1.2.3) and that it binds the XPE-complex 
(DDB1) (Jiang et al, 2010). Hara and Sancar found that the removal of 6-4PPs, not CPDs, from 
nucleosomal DNA is stimulated by the SWI/SNF chromatin remodeling complex from Saccharomyces 
cerevisiae (Hara & Sancar, 2003). Its human homolog, the BAF/PBAF-complex, stimulates the removal 
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of both types of UVC-derived lesions in a histone H3 hyper acetylating fashion (Hargreaves & 
Crabtree, 2011; Kuper & Kisker, 2012).  
This diversity suggests a great establishment and importance in the cellular functions of chromatin 
remodeling complexes. They are linked to NER via its damage recognition sensors of the Global 
genome repair (GGR) (see chapter 1.3.4.1.1). XPG and XPF were found to be associated with the 
CCCTC-binding factor (CTCF), a chromatin organizer, and trigger gene looping between promoter and 
terminator and the demethylation of activated genes (Le May et al, 2012) (see chapter 1.4.4). 
Furthermore, the PCNA interacting protein p21, which is a competitor of XPG, was associated with 
p300 recruitment and subsequent Histone acetyl transferase (HAT) activity, which is required for the 
chromatin remodeling prior to NER in response to UV (see chapters 1.4, 6.2).  
The factor histone chaperone CAF-1 is believed to be responsible for the re-remodeling of chromatin 
after repair (Gaillard et al, 1996; Gaillard et al, 1997). 
1.3.4 NER steps in detail 
The NER is divided into different subsequent steps. The assembly of the proteins is also illustrated in 
Figure 6. 
1.3.4.1 Damage recognition 
The damage recognition step of the NER pathway can be divided into two sub pathways, the 
transcription coupled repair (TCR, see chapter 1.3.4.1.2) and the Global genome repair (GGR, see 
chapter 1.3.4.1.1) (Gillet & Scharer, 2006; Hanawalt & Spivak, 2008). It involves two completely 
different sets of proteins (see Figure 6) to initially detect the same bulky lesions in different cellular 
contexts using conserved β-hairpin structures (Kuper & Kisker, 2012). However, they are still able to 
recruit the same factors, downstream of damage recognition (see chapter 1.3.4.2, 1.3.4.3), for 
further processing until the DNA lesions are removed in an error-free manner (see chapter 1.3.4.4). 
1.3.4.1.1 Damage monitoring during Global genome repair (GGR) 
The XPC-complex (XPC-HR23B-CETN2, see Figure 6) shows high affinity for both, damaged and 
undamaged DNA, acts as an universal damage sensor, and discovers various DNA lesions, while 
(strand wise) constantly scanning the genome for aberrations (Goosen, 2010; Reardon et al, 1996; 
Shell et al, 2013). HR23B stabilizes the XPC-complex and stimulates XPC activity during Nucleotide 
excision repair in vitro and CETN2 is involved in recruitment of XPA (see chapter 1.3.4.2) (Nishi et al, 
2013; Sugasawa et al, 1996). Recognition of DNA damage triggers XPC-HR23B disruption and XPC 
stays left-behind at the site of DNA damage (Bergink et al, 2012). Due to the different degree in helix 
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distortion by the diverse lesions, XPC shows a great affinity for 6-4PP but not for CPDs (see chapter 
1.2.3) (Fitch et al, 2003b).  
Recruitment of XPC to and efficient repair of CPDs, but not 6-4PPs, needs an additional factor, the 
XPE-complex (see Figure 6) (Fitch et al, 2003a; Sugasawa et al, 2005). DDB2 is the catalytic 
component of this complex which is known to be defective in XPE-patients and is able, due to its 
hydrophobic binding pocket, to bind to both types of UV-induced lesion (Scrima et al, 2008; Tang & 
Chu, 2002; Yeh et al, 2012). The E3 ubiquitin ligase Cul4-RBX1 of the XPE complex, beside its function 
in chromatin relaxing (see chapter 1.3.3), poly-ubiquitinates XPC, thereby enhancing its binding 
affinity for the CPD lesion, and auto-ubiquitinates its own complex partner DDB2, preceding its 
degradation (Groisman et al, 2003; Takedachi et al, 2010).  
XPC was also found to interact with the basal transcription factor IIH (TFIIH), which can be due to the 
fact that there is a handover of TFIIH between XPC and XPG during NER (see Figure 6). But an 
additional role of XPC in terms of transcription cannot be excluded to any extent (Drapkin et al, 1994; 
Schaeffer et al, 1993). Maybe, this also accounts for the observed self-downregulation of XPC mRNA 
levels in XPC patients (Schafer et al, 2013a).  
1.3.4.1.2 Damage recognition during Transcription coupled repair (TCR) 
In regions of actively transcribed genes (strands) the elongating RNA polymerase II itself serves as the 
initial damage detector if it is stalled (or back-tracked) at a DNA damage site and ensures rapid 
removal of bulky lesions in a complex with CSA, CSB and XPA binding protein 2 (XAB2) (see Figure 6) 
(Hoeijmakers, 2001; Nakatsu et al, 2000; Svejstrup, 2002). Although the nucleosome structure in 
transcribed regions is transiently opened, CSA is believed to play a role in euchromatin relaxing 
because it was found together with the XPE complex (Groisman et al, 2003). Also CSB, an ATPase and 
member of the SWI2/SNF2-family, shows chromatin remodeling functions in TCR context by inter alia 
recruiting the p300 Histone acetyl transferase (Fousteri & Mullenders, 2008; Fousteri et al, 2006; 
Newman et al, 2006). Furthermore CSB seems to be one major factor in downstream recruitment 
and coordination of the other NER factors. It was shown to interact directly with the RNA polymerase 
II, CSA, and XPG (see chapter 1.4) (Henning et al, 1995; Sarker et al, 2005; Tantin et al, 1997). It is 
speculated that it serves as a kind of placeholder that keeps the transcription bubble opened before 
RPA and XPA are recruited (see chapter 1.3.4.2) (Hanawalt & Spivak, 2008). Both CS-proteins are able 
to recruit XAB2 to sites of UV damage, which is essential for RNA recovery after UV irradiation 
(Kuraoka et al, 2008). XAB2 interacts with the polymerase, CSA, and CSB. It furthermore probably 
recruits XPA, and plays a pivotal role in TCR, transcription and mRNA splicing (Kuraoka et al, 2008; 
Lagerwerf et al, 2011; Park et al, 1995).  
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1.3.4.2 Damage demarcation 
RPA is mainly active during S-phase, covering long single stranded stretches of DNA und thus 
preventing it from degradation, hydrolysis or endonucleolytic digestion (Wold, 1997). Furthermore 
persisting RPA is a major signal in the cellular process for ATR-dependent activation of cell cycle 
checkpoints (see chapter 1.3.1) (Cortez, 2005). However, in the context of NER RPA is recruited to 
sites of ongoing repair after XPC-HR23B and TFIIH are bound to the DNA (Overmeer et al, 2011). RPA 
has repair coordination and incision stimulating activity, and further seems to stabilize this ternary 
complex (XPC-TFIIH-RPA) by binding to the undamaged DNA strand (Aboussekhra et al, 1995; de Laat 
et al, 1998; Mocquet et al, 2008). Afterwards XPA is recruited to sites of lesion potentially by the 
interaction with the two large subunits of RPA (RPA70, RPA32) (Saijo et al, 2011). The interaction 
between RPA and XPG has been demonstrated by He and colleagues (He et al, 1995). 
XPA has a higher affinity to kinked DNA than to lesion containing DNA and interacts with TFIIH, 
RPA,XPC-HR23B, DDB2, ERCC1, and PCNA (Scharer, 2013). XPA is a very crucial factor for functional 
NER and is believed to check the correct composition of the complex at the 5’ side of the bubble or 
maybe plays a role in identifying the lesion containing strand (Krasikova et al, 2010; Nouspikel, 2009). 
It is posttranslational acetylated (deacetylated by SIRT1, ensuring optimal NER (Fan & Luo, 2010)) and 
its protein level is regulated by the circadian clock as well as the ubiquitin proteasome (Kang et al, 
2011). It was further shown to be dominantly localized in the nucleus during G1- and G2-phase in 
dependency of p53 (Li et al, 2011a; Li et al, 2011b). But due to its protein size (31 kDa) one might 
speculate about an active export mechanism rather than an import mechanism, because proteins 
with a size of <40kDa are able to perform sufficient passive diffusion through nuclear pores 
(Chatterjee & Stochaj, 1998). However, during S-phase the main part of the XPA protein fraction 
remains in the nucleus, underlining its role in replication. 
1.3.4.3 The preincision complex (bubble formation) 
Whether the NER is initiated by the GGR or TCR, the next recruited essential factor for the preincision 
complex formation is the transcription factor IIH (TFIIH) (see Figure 6). It consists of two 
subcomplexes: the CAK-complex (CDK7 etc.) and the core-complex (p34, p44, p52, p62, TTDA, XPB 
and XPD), see Figure 7.  
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Figure 7: Transcription factor IIH (TFIIH) 
TFIIH mainly consists of the helicase function bearing core complex (XPB, p52, TTDA, p62, p34, p44, 
and XPD), the CAK (Cyclin activated kinase) complex (Cdk7, Cycl H, Mat1) and of late XPG (see 
chapter 1.4) (Egly & Coin, 2011). The molecular structure indicates a ring complex with kinase head.  
 
XPD serves as a molecular bridge between those two subcomplexes and is also found in a free 
cellular CAK-XPD complex during mitosis (Chen et al, 2003; Compe & Egly, 2012). XPG is designated 
the eleventh subunit of TFIIH, because it was found together with the transcription factor and is 
believed to strengthens the association between both subcomplexes (Egly & Coin, 2011; Ito et al, 
2007; Mu et al, 1995). During GGR and TCR, TFIIH is recruited via direct interaction with XPC-HR23B 
or by XPA, respectively. (Park et al, 1995; Riedl et al, 2003)  
In vitro footprinting experiments revealed that once XPC-HR23B is bound to a DNA lesion the double 
helix structure is slightly opened from -3 to +6 (nucleotide positions around the lesion) which is 
further extended (-6 to +6) by arrival of TFIIH (Tapias et al, 2004). Human XPG arrives at the 
preincision complex in a DDB2-independent manner and is believed to be recruited after XPA binding 
or, in case of TCR, possibly by its CSB binding ability (Araujo et al, 2001; Bertani, 1951; Coin et al, 
2008). Structural characterization of Saccharomyces cerevisiae repair complexes indicated for the 
displacement of Rad4 (XPC homolog) by Rad2 (XPG homolog) in dependency of TFIIH-presence 
(Lafrance-Vanasse et al, 2013). XPC is displaced by TFIIH which precedes the binding of RPA and XPA, 
which ensures the opened state of the bubble (Hanawalt & Spivak, 2008; Tapias et al, 2004). This 
recruitment promotes CAK-dissociation from core-TFIIH, CAK is dispensable for functional NER (Arab 
et al, 2010; Coin et al, 2008). XPG’s binding was shown to further extend the DNA melting and hence 
bubble formation (Tapias et al, 2004).  
However, the CAK-complex is known to phosphorylate the CTD of the RNA polymerase II prior to 
elongation during transcription, possibly in a XPB-dependent manner (Egly & Coin, 2011; Larochelle 
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et al, 2012; Zhu et al, 2012). In the NER context, the CAK complex dissociates from the core complex, 
probably due to steric reasons, but surely prior to DNA melting and the anchoring of TFIIH to the 
DNA in an ATP-dependent manner (Araujo et al, 2000; Coin et al, 2008; Tapias et al, 2004). The two 
conserved helicases XPB (3’-5’) and XPD (5’-3’) carry the main catalytic activity of TFIIH during NER. 
XPB’s ATPase activity [stimulated by the general TFIIH stabilizer p8 and potentially p52 (Compe & 
Egly, 2012; Fregoso et al, 2007)], but not its helicase function as well as XPD’s helicase and ATPase 
activity, are essential for NER and the preincision complex formation (Coin et al, 2007; Winkler et al, 
2000). The C-terminal end of XPD and thereby the p44-XPD interaction is crucial for open complex 
formation (Coin et al, 1998a; Coin et al, 1998b; Dubaele et al, 2003). Furthermore, XPD has a 
conserved damage verification function by an iron-sulfur cluster channel, which is too tight for a 
helix-distorted single stranded DNA, e.g. by a bulky lesion (Mathieu et al, 2013; Naegeli et al, 1992). 
This fact is nowadays seen as an important trigger to complete preincision complex assembly with 
the recruitment of RPA, XPA and XPG (Scharer, 2013). 
After anchoring TFIIH to the site of DNA damage by XPA and RPA, the two endonucleases XPF/ERCC1 
(3’) and XPG (5’) are recruited (see chapter1.3.4.4). 
1.3.4.4 Dual incision complex and gap filling 
The structure specific endonuclease XPG (see chapter 1.4) is strongly associated with basal 
transcription and the TFIIH complex. It is recruited to the DNA lesion as the first of both 
endonucleases, probably together with or prior to TFIIH, but surely in dependency of ATP and 
functional TFIIH (Evans et al, 1997; Harrington & Lieber, 1994; Hohl et al, 2003; Sarker et al, 2005; 
Scharer, 2008a; Wakasugi & Sancar, 1998; Zotter et al, 2006). Furthermore, arrival of XPG opens the 
repair bubble until it is completely opened from position -19 to +8 (Tapias et al, 2004). The second 
endonuclease, the heterodimer XPF-ERCC1, whereas XPF offers the catalytic activity, is recruited via 
the interaction between ERCC1 and XPA (Enzlin & Scharer, 2002; Li et al, 1994). The assembly of the 
two nucleases occurs in a directed fashion due to the polarity and direction of the preassembled 
components, especially RPA (de Laat et al, 1998). The catalytic activity of both endonucleases is 
revealed in the only one formation possible, due to the tight opening of the bubble, in which 
XPF/ERCC1 is bound to the DNA at the 5’ side and XPG at the 3’ side of the lesion (O'Donovan et al, 
1994a).  
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The first incision is performed 5’ of the DNA lesion by XPF/ERCC1 in dependency of XPG’s presence 
(see Figure 8) (Staresincic et al, 2009). Also the dephosphorylation at S751 of XPB, most probably 
induced by PP2A, is a prerequisite for XPF-ERCC1 incision, but not for DNA unwinding (Ariza et al, 
1996).  This secondary modification is restricted to the NER context, because the S751, in vivo and in 
vitro created, phosphorylation status (by casein kinase II) leaves TFIIH transcriptional activity 
unaffected (Coin et al, 2004). The first endonucleolytic cut creates a lesion containing single stranded 
DNA flap with a free 5’ end and an unbound 3’ hydroxyl group at the dsDNA-ssDNA junction. The 
latter is part of a primer for the elongation by DNA polymerases (e.g. δ or ε and κ), able to synthesize 
according to the undamaged template strand (Lehmann, 2011; Ogi et al, 2010).  
After the first incision took place, PCNA (see chapter 1.3.5), the clamp loader RFC, and a polymerase 
are recruited. The arrival of PCNA was shown to be in dependency of RPA- and XPG-presence, 
furthermore the catalytic activity of XPF is required (Mocquet et al, 2008; Staresincic et al, 2009). The 
Figure 8: Dual Incision during NER  
 
1) After XPC-HR23B diffusion the stable 
complex consists of TFIIH, XPA, RPA and 
recruits the 5’ endonuclease. 
 
 
 
2) Subsequently ERCC1-XPF cuts 5’ of the 
lesion (-17 to -20 nts). 
 
 
3) Intermediate state: XPF-ERCC1 and 
TFIIH are depleted and in turn RFC, PCNA 
and e.g. Pol δ are recruited and start the 
polymerization reaction (approximately 
50% repair synthesis) with the 
undamaged strand as a template. 
 
 
4) The conformational change in the 
whole complex triggers the 3’ XPG 
endonuclease activity (+9 to +20 nts) and 
a 24-32 nts long, DNA base adduct 
containing, oligonucleotide is released.  
 
 
5) The polymerization reaction is 
completed and either 
Fen1/LigaseIII/XRCC1 or XRCC1/LigaseIII 
close the nick. 
(Staresincic et al, 2009; Tapias et al, 
2004) 
Intermediate 
state 
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repair synthesis immediately starts prior to the second cut by XPG in a RFC-dependent manner 
(Mocquet et al, 2008; Staresincic et al, 2009). The clamp loader RFC, which is needed for Pol δ, but 
not for PCNA recruitment (PCNA self loading), is in turn recruited to the NER incision complex in a 5’ 
incision- and RPA-dependent manner and facilitates XPF release (Mocquet et al, 2008; Overmeer et 
al, 2010). This probably ensures avoidance of persisting single stranded gaps which in turn would 
lead to checkpoint activation (see chapter 1.3.1) or maybe Exo1 recruitment, like it was shown in 
yeast and human cells (Giannattasio et al, 2010; Sertic et al, 2011) (see chapter 1.5.1.2). For their 
activation, translesion polymerase κ requires ubiquitinated PCNA, polymerase δ requires RFC and 
PCNA, and polymerase ε requires the modified version of RFC (Ctf18 containing) (Lehmann, 2011; Ogi 
et al, 2010). RPA is released from the undamaged strand as soon as Pol δ is recruited, most likely due 
to action of the polymerase itself (Mocquet et al, 2008). This intermediate state is an ongoing field of 
investigation, and is the key question of this thesis (see chapter 1.6).  
However, XPG (see chapter 1.4) performs the second cut on the 3’ side and the lesion containing 
oligonucleotide (24-32 nts) is released together with XPG and TFIIH, maybe because the lesion still 
stucks in XPD’s DNA binding pocket (see chapter 1.3.4.3) (Hu et al, 2013; Kemp et al, 2012; Moggs et 
al, 1996). During the intermediate state a ‘cut-patch-cut-patch’ mechanism is postulated for the 
action of both endonucleases, in reference to early investigations on excision repair in bacteria 
(Hanawalt & Haynes, 1967; Staresincic et al, 2009). 
After TFIIH’s binding to ATP the excised oligonucleotide is released and bound by RPA, that is able to 
protect the oligo from degradation to a certain extent, but will although lead to its slow degradation 
to 6- or 7-mers with a proportion of 2-mers (mean 3.7), maybe by the action of 5’-3’ exonucleases 
(Galloway et al, 1994; Kemp et al, 2012; Weinfeld et al, 1986). The created short ssDNA fragments 
should be able to activate ATM, linking the excision process to the general DNA damage response 
(see chapter 1.3.1) (Jazayeri et al, 2008). However, the suggestion that all dimers will be degraded to 
2-mers at the end, because this would make excretion more easily, lacks its proof. Only very little is 
known about the export and excretion of the dimers, although they were detected in urine (Ahmad 
et al, 1999; Cooke et al, 2001). Furthermore, short oligonucleotides, especially 2-mers, were detected 
increase the melanin production in living cells (Eller et al, 1997). 
Finally, in non-dividing cells DNA ligase III, XRCC1 and Pol δ and in replicating cells either Pol ε and 
DNA ligase I or DNA ligase III, XRCC1 and Fen1 (see chapter 1.5.1.1) are required for completion of 
repair synthesis and nick sealing (Moser et al, 2007). 
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1.3.5 Proliferating Cell Nuclear Antigen (PCNA) acts during and after dual incision 
Proliferating Cell Nuclear Antigen (PCNA) was discovered in 1978 only in nuclei of dividing cells, acts 
as a homotrimer and comprises ring structure as depicted in Figure 9, and ten years later it was 
established as an essential factor for replication (Bravo & Celis, 1980; Miyachi et al, 1978; Prelich et 
al, 1987a; Prelich et al, 1987b). Until today, PCNA is an intensively studied protein, principally well 
known regarding its mode of action (DNA sliding clamp), structure, and conservation (Krishna et al, 
1994a; Krishna et al, 1994b; Warbrick, 2000). PCNA is furthermore linked to other pathways than 
replication, e.g. DNA repair (NER, BER, MMR, DSB repair) (Jonsson & Hubscher, 1997; Kelman, 1997; 
Kelman & Hurwitz, 1998). Due to sequence homologies of the conserved PCNA interacting peptide 
(PIP) motif for PCNA interaction (see chapter 1.4.2), a lot of binding partners (p21, Fen1 (see chapter 
1.5.1.1), Cdc27/p68 (Pol δ subunits), XPG (see chapter 1.4), MCMT, WRN, RFC1, DNA ligase 1, and 
Ung2) were identified (Warbrick, 2000). The consensus sequence of the PIP-box is [QXXhXXaa], Q is 
glutamine, h is a moderately hydrophobic residue, a is an aromatic side chain (normally FF), and x is 
any residue. This thesis concentrates on some of the interactors of PCNA, having an impact on the 
recent question (see chapter 1.6).  
PCNA acts as a homotrimer in eukaryotes and every monomer has three potential peptide 
interaction sites, with a conserved hydrophobic pocket, which enables PCNA to interact with diverse 
binding partners (at once), e.g. several polymerases (Indiani et al, 2005; Krishna et al, 1994b). A 
major PCNA binding protein is its inhibitor, the CDK7 inhibitor, p21 (Warbrick et al, 1995). P21 
inhibits both bindings of PCNA to either DNA or to polymerases during replication, and furthermore 
regulates PCNA during DDR (see chapter 1.3.1) (Podust et al, 1995; Shivji et al, 1998). XPG was found 
to inhibit p21 binding of PCNA (Mocquet et al, 2008; Warbrick, 2000; Warbrick et al, 1997). However, 
the residence time of PCNA at areas of ongoing DNA synthesis in replication or repair context is 
significantly different and enhanced at damaged site in an ubiquitination dependent manner (Essers 
et al, 2005). Furthermore Essers and colleagues showed a reduced resident time of an ubiquitination-
defective PCNA mutant, linking its ubiquitination rather to the stabilization of TLS polymerases at UV 
lesion than to its recruitment. This is consistent with the observation of direct interactions between 
PCNA and TLS polymerases, as well as ubiquitin independent recruitment (see chapter 1.3.6). 
PCNA interacts with several eukaryotic polymerases (δ, η, ζ) on recombination DNA intermediates (Li 
et al, 2013b). The processivity of Pol δ increased after p68 (Pol δ subunit) phosphorylation mediated 
PCNA recruitment and it was long thought, that the translesion polymerase η is recruited to DNA 
damage sites in a PCNA ubiquitination (K164) dependent manner (see chapter 1.3.6) (Rahmeh et al, 
2012; Stelter & Ulrich, 2003). Therefore secondary modifications, like ubiquitination, sumoylation, 
acetylation and phosphorylation, all leading to diverse cellular events, were an extraordinary 
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element of PCNA biology (Ulrich & Takahashi, 2013). I will focus on the conserved K164 mono-
ubiquitination- dependent recruitment of translesion polymerases (Stelter & Ulrich, 2003). This 
highly conserved lysine of the human PCNA is either Rad6-Rad18 (E2-E3, respectively) dependently 
mono-ubiquitinated, or further poly-ubiquitinated by the Ubc13-Mms2 complex (E2) via the en bloc 
attachment of up to four K63 ubiquitin molecules at once (Hoege et al, 2002; Masuda et al, 2012). 
The latter is associated with template strand switching (Ulrich & Takahashi, 2013). Rad18 is recruited 
to PCNA in a RPA (RPA74) dependent manner (Yang & Woodgate, 2007). 
The multi subunit complex replication factor C (RFC) loads PCNA on the template in an ATP-
dependent manner (Mossi & Hubscher, 1998). Clamp loader are highly conserved structures, but the 
interaction with PCNA is not (Uhlmann et al, 1997). However, Ligase I and RFC share one binding 
motive in a conserved fashion, what raises the possibility of a displacement by each other or 
simultaneous binding of two different monomers of PCNA (Mossi & Hubscher, 1998). The RFC 
complex acts as a highly processive compartment of the replication machinery, whereas the 
polymerase is distributive and even PCNA’s processivity is dependent on the presence of RFC, which 
remains at the 3’ terminus during elongation (Masuda et al, 2007). RFC is responsible for the 
persistence of PCNA at sites of local UV damage (Overmeer et al, 2010). Furthermore, human PCNA 
was found to be sumoylated at K164 in a DNA and DNA damage independent manner, but in 
dependency of RFC (Gali et al, 2012). Gali et al. further showed that sumoylation rather has an 
inhibitory effect and prevents double strand break initiated homologues recombination (HR) and the 
formation of double strand breaks at stalled replication forks. These facts indicate great importance 
of the RFC-PCNA interaction. 
In the context of NER, the RFC arrival at damaged (immobilized) DNA was facilitated by RPA and 
triggers XPF-release (Mocquet et al, 2008). It is assumed, that RFC and XPG concomitantly recruit and 
stabilize PCNA, what in turn triggers RPA and XPG release, Pol δ recruitment, and subsequent DNA 
synthesis. Thus, PCNA recruitment demands on the 5’ incision by XPF/ERCC1. XPG is acetylated in 
vitro in a p300 dependent fashion, and this attachment is inhibited by PCNA and is in turn dependent 
on the interaction between p21 and PCNA (Tillhon et al, 2012). XPG is known to inhibit p21 binding 
to PCNA (see chapter 1.4). However, the cyclin-dependent kinase (CDK) PCNA inhibitor p21, which 
degradation promotes PCNA-dependent DNA repair, was also found to inhibit efficient ubiquitination 
of PCNA (via CDK, no direct interaction) (Soria et al, 2006). This fact raises the question about a role 
of ubiquitin in DNA repair beside translesion synthesis. The interaction between XPG and PCNA is 
extensively reconsidered in the respective section (see chapter 1.3.6) and in the next chapters (see 
chapters 4 and 5). 
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PCNA binds amongst others Fen1, a factor involved in long patch BER and Okazaki fragment 
maturation, and stimulates its nucleolytic activity up to 50-fold (see chapter 1.5.1.1) (Li et al, 1995; 
Wu et al, 1996). Fen1, like XPG, competes with p21 for binding via the conserved PIP box (Gary et al, 
1997; Warbrick et al, 1997). Further, PCNA-Fen1 interaction was identified as the trigger leading to 
Fen1 cleavage in a defined in vitro system (Craggs et al, 2013).  
Another binding partner of PCNA is the replicative DNA ligase I in G1- and S- phase in a cell cycle 
regulated dephosphorylation dependent manner (S66 of LigI), linking PCNA and the 
dephosphorylation apparatus (Montecucco et al, 1998; Rossi et al, 1999). XRCC1 directly interacts 
with PCNA only in S-phase (Fan et al, 2004). 
PCNA interacts with several eukaryotic polymerases (δ, η, ζ) on recombination DNA intermediates (Li 
et al, 2013b). The processivity of Pol δ increased after p68 (Pol δ subunit) phosphorylation mediated 
PCNA recruitment and it was long thought, that the translesion polymerases are recruited to DNA 
damage sites in a strictly PCNA ubiquitination (K164) dependent manner (see chapter 1.3.6) (Rahmeh 
et al, 2012; Stelter & Ulrich, 2003).  
PCNA acts as a ring shaped homotrimer and should be able to bind more than one reaction partners 
at once. During this thesis, and especially for the drawing of the model (see Figure 27), the “revolver 
barrel” picture of PCNA is taken as a basis, like it was proposed before (Yang & Woodgate, 2007). 
PCNA, stably attached to the DNA (or in a cycle of recurring loading and unloading) by RFC, is able to 
deliver three reaction partners/proteins/protein complexes (“bullets”) to sites of ongoing replication 
or DNA repair at the same time, and is able to exchange the several enzymes very quick during the 
reactions. This includes nucleases (XPG, Fen1, and Exo1), several polymerases, DNA ligases and other 
scaffold proteins (Rev1, XRCC1) (see chapters 1.3.6, 1.4, and 1.5).  
1.3.6 Translesion synthesis 
Processive replicative polymerases are elongating with a rate of 1000 nucleotides per second, and 
are normally unable to incorporate nucleotides opposite of a DNA base adduct (with a few 
exceptions, e.g. PolI) (Lehmann et al, 2007; Pages & Fuchs, 2002). In contrast, low fidelity translesion 
polymerases are able to use damaged DNA as a template and incorporate nucleotides in an accurate 
or mutagenic fashion, due to a wider nucleotide binding pocket. However, the frequency of wrong 
incorporation of a nucleotide by a translesion polymerase, acting on an undamaged template, was 
estimated 1:30 for Pol η (Masutani et al, 2000).  
The Y-family polymerase η is encoded by the POLH gene and in the eighth complementation group of 
genetically defective XP-Variant patients with mutations mostly compromising the DNA binding 
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ability of Pol η (Biertumpfel et al, 2010; Gratchev et al, 2003) (see chapter 1.1.1). XP variant patients 
exhibit all major symptoms of the XP disease (sunlight induced pigmentation changes and a higher 
incidence of tumor formation of sun exposed areas), indicating a general role for translesion 
synthesis in preventing cells from malignant transformation (see chapters 1.2, 1.3 &).  
Like XPG (see chapter 1.4), Y-family polymerases normally comprise three conserved domains 
postulated to be important for PCNA interaction (see chapter 1.3.5), the PIP-box and two ubiquitin 
binding domains (zinc-finger UBZ and hydrophobic UBM) (Bienko et al, 2005; Freudenthal et al, 2010; 
Ulrich & Takahashi, 2013). The simultaneous binding to PCNA via both ubiquitin binding domains (in 
a flexible arm of the molecule) is expected.  
Pol η is able to bypass CPDs, but not 6-4PPs (see chapter 1.2.3). 6-4PPs are probably mostly repaired 
by Translesion (TLS) polymerases Rev1 and, in particular Pol ζ, like it was seen in mouse embryonic 
fibroblasts (Temviriyanukul et al, 2012). A clear evidence in human cells is missing, but Rev1 seems to 
have a great influence on PCNA ubiquitination dependent post UV survival (McCulloch et al, 2004; 
Qin et al, 2013; Yao et al, 2001). Pol η was able to bypass TT dimers with high efficacy and to 
incorporate two adenines in an accurate fashion (Masutani et al, 2000). The error prone mutagenity 
arises from bypassing other types of lesions like AP-sites, 8-oxoguanine, and benzo[a]pyrene with 
varying incorporations (mostly A/T mutation pattern, which was for instance found in hyper mutated 
regions of immunoglobulin genes) and also by the creation of deletions (Faili et al, 2004; Franklin et 
al, 2004; Zhang et al, 2000a).  
The recruitment of TLS polymerases (e.g. Pol η) to sites of DNA damage is strongly dependent on 
PCNA-mono-ubiquitination (Bienko et al, 2005). Contrary, during ICL repair TLS is performed in a 
PCNA ubiquitination independent manner (Hendel et al, 2011; Hicks et al, 2010) (see Figure 9). In this 
context, inhibitors of the PIP-box of TLS polymerases were sufficient to decrease PCNA-mediated 
synthesis after cisplatin treatment (Actis et al, 2013). This can be explained by the existence of direct 
non-canonical interactions between PCNA and translesion polymerases, e.g. three hydrogen bonds 
between Pol η and PCNA (Leu711-Gln125, Leu704-His44, Gly700-Ile255) (Hishiki et al, 2009).  
Rev1 is special among translesion synthesis polymerases and possesses the unique ability to use 
dCMP (Yang & Woodgate, 2007). Furthermore it comprises a BRCT-domain, which was shown to 
facilitate PCNA-binding as well as two UBM domains and most probably fulfills a structural rather 
than catalytic role (Pustovalova et al, 2013). As it was demonstrated in human and murine cells, 
beside its ability to perform TLS, Rev1 is able to act as a scaffold, coordinating other translesion 
polymerases (η, ζ, κ, ι, all share a common Rev1 interacting region) and their association with PCNA 
(Hendel et al, 2011; Yang & Woodgate, 2007) (see Figure 9). The regulation of the different 
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polymerases is not understood yet and discussed in detail in the actual review from Sale, Lehmann 
and Woodgate (Sale et al, 2012). 
 
Furthermore Essers and colleagues showed a reduced resident time of an ubiquitination-defective 
PCNA mutant, linking its ubiquitination rather to the stabilization of TLS polymerases at UV lesion 
than to its recruitment, consistent with the observation of direct interactions between PCNA and TLS 
polymerases (see chapter 1.3.5) (Essers et al, 2005). 
The C-terminal domain of Pol η binds to both, Rad18 and PCNA, and promotes ubiquitination, 
independent of its nuclease function. This C-terminus of Polη is homologues to the XPG N-terminus 
(Durando et al, 2013; Fagbemi, 2012). Pol η expression is regulated by RPA and p53 in response to 
UV, noteworthy Pol κ was recruited in case of a catalytically defect mutant of Pol η.  
However, the interaction between Pol η or Rev1 and ubiquitinated PCNA is much stronger compared 
to PCNA alone and probably a recruitment enhancing signal as well as an accessory factor for 
polymerase switch (Yang & Woodgate, 2007). 
1.4 Detailed description of XPG 
XPG was discovered as an NER-associated and XP-causing enzyme in the late 1970s by cell-fusing 
experiments and later by complementation studies using cloned cDNA (Keijzer et al, 1979; Scherly et 
al, 1993). It was first expressed and isolated as recombinant protein in Sf9 cells after polyhedrosis 
virus infection and identified as magnesium-dependent single stranded endonuclease (O'Donovan et 
al, 1994b). Moreover XPG is a structure specific endonuclease, a member of the Flap endonuclease 
Figure 9: Ubiquitination independent 
Translesion synthesis (TLS) activity of 
Rev1 
The upper picture depicts seven 
interactions required for complete 
Rev1-dependent TLS involving 
ubiquitinated PCNA.  
The lower picture explaines the 
stabilization of the complex 
independent of PCNA 
ubiquitinylation, with a sufficient 
number of residual four interactions. 
The ternary complex presented here 
(PCNA, Rev1, Polymerse) acts as a 
scaffold for recruitment of several 
other polymerases. (Hendel et al, 
2011) 
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family (Fen1- family) (see chapter 1.5.1.1) and responsible for the 3’ cut during NER (see chapter 
1.3.2) (Lieber, 1997; O'Donovan et al, 1994a). XPG is an essential protein in both pathways, GGR and 
TCR (see chapter 1.3.4.1) and is, additionally involved in other repair pathways and in association 
with TFIIH also involved in basal transcription (Scharer, 2008a). Moreover, the length of XPG protein 
accounts for the XPG/CS phenotype, instead of simply XP, like no other factor (see chapter 1.1.2) (Ito 
et al, 2007). Beside its major function, during the last years, XPG’s contribution to more and more 
other cellular processes was identified (see chapters 1.4.3, 1.4.4). 
1.4.1 XPG patients demonstrate multiple functions of XPG 
To date 21 Xeroderma pigmentosum patients with 28 disease-causing mutations were identified and 
assigned to the complementation group G (XP-G) (Schubert et al, 2013; Soltys et al, 2013). The 
clinical spectrum (see Figure 2) shows a very diverse picture with eight patients exhibiting XP, three 
XP patients with late onset CS and the majority of ten patients suffers from severe XP/CS (Schafer et 
al, 2013b). Among the patients with known genotypes people with (mild) simple XP phenotype 
mostly still possess about at least one full-length allele with a point mutation in one of the two 
endonuclease domains (see Figure 10) and thus exhibit residual repair capacity (Scharer, 2008b). The 
fraction of patients with additional late onset CS symptoms is of special attention, because it includes 
two patients (XP3BR, XPCS1BD) with more or less full-length splicevariant expression, protecting the 
patients from at least the early onset of CS symptoms, because their dominant alleles express only 
truncated (a) version(s) of the protein (Lalle et al, 2002; Thorel et al, 2004). It is quite well 
established, that without these full-length isoforms, the truncated XPG proteins would not be 
capable to maintain interaction between XPG and TFIIH, what causes combined XPG-CS with an early 
onset of CS symptoms (see chapter 1.1.2) (Emmert et al, 2002; Ito et al, 2007; Nouspikel et al, 1997). 
The genotypes of the most XPG/CS patients supports this suggestion (Scharer, 2008b), but there are 
a few exceptions. The patient XPCS4RO has a point mutation in the N-domain leading to an amino 
acid substitution (P72H) and subsequent destabilization (or degradation) of the (full-length) protein 
(Zafeiriou et al, 2001). One of the most recent reports accounts two severely affected XP/CS patients 
with at least one full-length allele but with a point mutation in the I-domain (see Figure 10) resulting 
in a stable expression but a defective NER and impaired TFIIH (XPD) binding (Schafer et al, 2013b). 
However, the majority of the patients of the rare XPG complementation group are hardly concerned 
with classical XP and additional CS symptoms, punctuating the influence of XPG to the general 
transcription machinery (see chapter 1.4.3).  
XPG mice, with the corresponding E791A endonuclease mutation, showed a classical XP phenotype 
with UV hypersensitivity (Tian et al, 2004). Knockout mice with a truncation mutation (nts264-380) 
display a severe XP/CS phenotype with growth retardation and early death (three weeks) (Harada et 
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al, 1999). This supports the strict genotype-phenotype correlation between the constitution of XPG 
and the clinical consequences. 
Noteworthy and with respect to the clinical reference, SNPs of XPG were investigated regarding the 
possible predictive value for cancer progression and chemotherapeutic efficacy. One study showed a 
significant correlation between the NSCLC (non small cell lung carcinoma) and rather the CT+TT than 
CC genotype of rs22961471 for the therapeutic prognostic value (Yuli et al, 2013). Another study 
correlated the polymorphisms in the XPG gene with an 11 times increased mortality rate of 
melanoma patients (Li et al, 2013a). 
1.4.2 Established functional domains of XPG 
The XPG/ERCC5 gene is located at chromosome position 13q32.1-q33.1 (Takahashi et al, 1992) and 
encodes for an 1186 amino acid (133kDa) protein (Dunand-Sauthier et al, 2005) with several domains 
(see Figure 10). 
 
Figure 10: Domains of XPG 
The box names are depicted in the cyan rectangle (Red boxes = endonucleolytic N + I domains, green 
boxes = nuclear localization signals (NLS), blue boxes = PCNA interacting peptides (PIP), purple box = 
ubiquitin binding domain (UBM, also referred as the D1 domain), yellow box = spacer, black box = 
conserved D2 domain). The grey lines indicate interactions with several binding partners of XPG.  
 
XPG is a structure (junction) specific endonuclease that binds to disturbed dsDNA via interactions 
with the phosphate backbone on the face of the helix (Hohl et al, 2003) (see Figure 11, additionally se 
Figure 13). The endonuclease activity is assigned to the two-tailed highly conserved N- and I-boxes, 
which are separated by a spacer (Harrington & Lieber, 1994) (see Figure 12). These two domains 
contain essential residues for the endonuclease activity of XPG (e.g. D77, E791, D812) and are 
proposed to associate with each other in the quaternary structure (XPG plus dsDNA) (Constantinou 
et al, 1999; Mueser et al, 1996; Wakasugi et al, 1997). During this study, the endonuclease defective 
E791A and D77A mutants were constructed by introducing point mutations leading to (as indicated) 
amino acid (aa) exchanges at this sites.  
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Three nuclear localization signals (NLS) were identified with varying activity (NLS-A = 40%, NLS-B & -C 
= 100%) (Knauf et al, 1996). The N-terminal NLS-A with 40% activity was sufficient to transport 
truncated XPG variants into nuclei (Lehmann, 2013). 
The spacer region is a 600 aa long DNA patch with highly acidic residues (especially in D1), which 
supplies the substrate specifity for bubble structures to XPG (Hohl et al, 2003; Sarker et al, 2005; 
Scherly et al, 1993). It binds the TFIIH-components XPB and XPD (residues 1-377) (Dunand-Sauthier et 
al, 2005; Iyer et al, 1996; Thorel et al, 2004). Hybrid enzyme constructions revealed, that Fen1 (see 
chapter 1.5.1.1) with the XPG spacer between the N- and I- domains showed features of both 
nucleases, Fen1 and XPG, and was able to cut bubble and flap structures and partially complement 
XPG-deficient cells in vivo but not in vitro (Hohl et al, 2007).  
Furthermore, the spacer region contains a small N-terminal PIP domain (found in several XPGs of 
different species) and an evolutionally conserved ubiquitin binding domain (UBM)  (Hofmann, 2009). 
The PIP-N domain was mutated at the essential proline P179A and the ubiquitin domain with two 
point mutations at the highly conserved residues L196 and P197 to alanine. The latter two have 
previously been shown to completely abolish ubiquitin binding in the same fashion like a deletion 
mutant (Fagbemi, 2012). 
The domains D1 & D2 are highly conserved in higher eukaryotes (drosophila, xenopus laevis, mouse, 
human) but not in S. cerevisiae and not in S. pombe suggesting a differential role of XPG in these 
organisms (Houle & Friedberg, 1999).   
Furthermore, interactions of XPG with RPA, CSB, PCNA, and WRN were reported (see chapter 1.3.5) 
(Gary et al, 1997; He et al, 1995; Iyer et al, 1996; Trego et al, 2011). The patches 1-377 and 747-928 
of XPG were also shown to interact with XPB and XPD. Monomeric XPG is uniformly distributed 
throughout the cell and translocates upon UV irradiation into the nucleus. Besides, XPG binds to NER 
complexes for approximately four minutes with a half-life of 200 seconds and UV-damage sites via its 
TFIIH interactions in vitro (Park et al, 1996; Zotter et al, 2006). A single mutation of an essential 
residue in the PIP-box of XPG (R992A/E) showed a slightly reduced NER activity in a luciferase 
Figure 11: Structures cleaved by XPG 
The endonuclease XPG cuts one 
strand of dsDNA with splayed arm 
structures, free 5’ ssDNA flaps and 
bubble structures (indicated by 
orange arrows). (Cloud et al, 1995; 
Fagbemi et al, 2011) 
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reporter gene assay (Gary et al, 1997). During this thesis a mutant, where the two essential residues 
for PCNA interaction F996 and F997 were mutated to alanine, FF is used (see chapter 4.2.1).  
Several splicevariants (isoforms) of the XPG gene were identified on mRNA- and protein expression 
level in samples of diverse human fibroblasts (wt) and other human cell types (Emmert et al, 2001). 
One truncated splicevariant, isoform VI (725 + 11 intronic aa), was used during the experiments of 
this thesis. The functionality of Isoform VI and its significance during NER will be amongst others 
investigated in this thesis (see chapter 4.2.1). The artificially created truncated Del variant (948 aa) 
was used as a control (Gary et al, 1997). Furthermore several double and triple mutants were 
created. 
Very little is known about XPG’s secondary modifications, but it is possible that its activity is at least 
in part modulated by phosphorylation like it was postulated in the past, because several potentially 
strong phosphorylation sites were identified in silico, e.g. serine 310 (http://www.phosphosite.org) 
(Savas & Ozcelik, 2005). However, XPG is proposed to be phosphorylated by TFIIH as part of 
modulation of the later recruitment of downstream synthesis factors, but a clear proof remains 
missing (unpublished data in (Winkler et al, 2001)). Tillhon and colleagues reported acetylated XPG in 
a p300/CBP- dependent manner. However, XPG acetylation was inhibited by PCNA in a p21- 
dependent manner and was associated with proper DNA repair synthesis (Tillhon et al, 2012).  
1.4.3 Structural and endonucleolytic function of XPG during NER and transcription 
The occurrence of XP/CS phenotype is thought to be developed in XPG patients (see chapter 1.1.2) as 
the consequence of an encoded C-terminally truncated protein and thus a destroyed TFIIH 
interaction (in particular the abolished interaction between the CAK- and the core complex of TFIIH, 
see Figure 7) and the subsequent failure during the transactivation of nuclear receptors (Ito et al, 
2007; Scharer, 2008b). Contrary, the recent work from our lab reports three XP-G/CS patients 
expressing full-length XPG protein, which points towards the identification of essential residues 
involved in this process (Schafer et al, 2013b). 
Beside its endonucleolytic activity during NER, XPG comprises several structural roles: the 
stabilization of TFIIH during formation of the transcription bubble, inducing the first cut by XPF-
ERCC1, and protecting PCNA from interference by its inhibitor p21 (Evans et al, 1997; Ito et al, 2007; 
Mocquet et al, 2008; Staresincic et al, 2009) (see chapter 1.3.5). XPG was also shown to interact 
stably with transcription bubbles independently of a lesion, underlining its general role in basal, TFIIH 
associated, transcription (Sarker et al, 2005).  
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Sarker and colleagues furthermore demonstrated in vitro, that the binding of XPG around the entire 
bubble is performed rather by the spacer than by the C-terminal region (PIP- box, D2, NLS-B,-C; see 
chapter 1.4.2) of XPG. Neither the spacer nor the C-terminal end of XPG (>1012 aa) are required for 
endonucleolytic activity but for stable bubble binding in an ATP-dependent manner, preferentially 
with bubble-Pol II complexes, rather than with bubbles alone. Thus, the ATPase activity of CSB (see 
chapter 1.3.4.1.2) induces a conformational change in Pol II, which physically and functionally 
separates both activities, the binding of XPG to the (lesion containing) DNA and its endonucleolytic 
activity, into two subsequent steps.  
The spacer (aa86 – aa765) is not required for full TFIIH interaction, what narrows the interaction 
domains down, compared to Iyer et al., to aa1-85 (see Figure 10) (Iyer et al, 1996; Sarker et al, 2005). 
In this context the GST-tagged C-terminal domain of XPG alone was sufficient to stimulate CSB 
ATPase activity in presence of a transcription bubble (Sarker et al, 2005).  
Another function of XPG in transcriptional context was reported by Le May and colleagues in the year 
2012. They revealed, that DNA breaks and DNA demethylation events at promoters of activated 
genes are dependent on XPG’s endonuclease activity, allowing recruitment of the CTCF chromatin 
organizer and stabilizing XPF at the terminator of the gene, leading to loop formation between these 
regions and control of gene expression (Le May et al, 2012). In yeast, the transcriptional mediator 
(subunit med17) was found to recruit Rad2 (XPG homolog of s. cerevisiae) to transcriptional sites in 
the absence of exogenous genotoxic stress (Eyboulet et al, 2013). Further a med17 mutant showed 
decreased occupancy of Rad2 at transcriptionally active genes (Pol II, III) after UV irradiation, 
demonstrating the tight connection between transcription and DNA repair. Noteworthy, Rad2 was 
also found to be involved in the regulation of the cell-cycle and actin dynamics in S. cerevisiae after 
UV irradiation (Kang et al, 2014). The fact that Rad2 was found to be transcriptionally active in an 
endonucleolytic  independent manner  supports the idea of a dual or multiple role for XPG and the 
implications for the XP/CS combined phenotype (see chapter 1.1.2) (Lee et al, 2002; Scharer, 2008b).  
1.4.4 Involvement of XPG in other (DNA repair) pathways 
Like XPC, CSA, and CSB are correlated with the removal of oxidative damage, XPG-CS patients have 
been found to be defective in, especially mitochondrial, Base excision Repair (BER) (Cooper et al, 
1997; D'Errico et al, 2006; Dianov et al, 1999; Kamiuchi et al, 2002). The XPG protein enhances the in 
vitro repair of oxidative damage by recruiting NTH1 to damaged sites and stimulating its glycosylase 
activity in an endonuclease- independent fashion. This connects XPG to the base excision repair 
pathway and this potentially combines deficiencies in oxidative damage removal, in addition to 
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transcriptional deficiencies, with the XP-G/CS phenotype (see chapter 1.1.2) to (Bessho, 1999; 
Klungland et al, 1999; Melis et al, 2013).   
XPG was found to interact directly with the Werner syndrome (WS) WRN 3’-5’ RecQ-like helicase, 
stimulating its activity and cooperatively annealing two single strands together during DNA 
replication or rather at stalled replication forks (Trego et al, 2011). WRN defective genes cause the 
Werner syndrome (WS), which is another progeroid disease as XP, associated with defects in Base 
excision repair, premature aging, chromosomal stability, and shows increased cancer development 
(Rossi et al, 2010).  
WS- cells are sensitive to cisplatin, which causes DNA lesions repaired by the NER pathway (see 
chapter 1.3.2). WRN co-localizes with RPA (in a conserved fashion) in response to DNA damaging 
agents (Hyun et al, 2012; Sakamoto et al, 2001). Furthermore, WRN causing deficiency in PolII-
transcription leads to speculations if this association is maybe more important in the cellular context 
and for XP/CS phenotype development than it has been assumed (Balajee et al, 1999; Harrigan et al, 
2006). However, more elucidations are required. 
XPG is not essential for, but able to stimulate hairpin removal of (CAG)n/(CTG)n DNA hairpins, 
normally repaired by the Hairpin repair pathway (HRP), by enhancing cleavage 5’ of the structure, 
demonstrating the manifold structures cleaved by XPG  (Hou et al, 2011; Zhang et al, 2012). 
1.5 Other Nucleases investigated during this study 
This thesis investigates a possible backup mechanism for the function of XPG in living cells. Some 
candidates for the fulfillment of this position are summarized below. 
1.5.1 Structurally XPG-related nucleases 
XPG is part in the highly conserved endonuclease Fen1- superfamily. Relevant family members for 
this thesis are presented. 
1.5.1.1 Flap endonuclease 1 (Fen1) 
Eukaryotic polymerases do not have a 5’ nuclease activity like prokaryotic polI and use Fen1 (DNase 
IV) for cleavage of single stranded flaps during Okazaki fragment maturation (Burgers, 2009; 
Lyamichev et al, 1993). The structure specific flap endo-/exonuclease 1 (Fen1) is highly conserved 
and comprises distinct domains like the required N- and I- domain for nuclease function and a PIP- 
box for PCNA interaction as well as the C-terminal domain carrying two nuclear localization signals 
(see Figure 12, more detailed domain description see Figure 10) (Gary et al, 1997; Knauf et al, 1996; 
Lieber, 1997). Fen1 contains a spacer region, which is pretty short in comparison to XPG (70 amino 
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acids, helical loop) and responsible for DNA-flap binding and thus activation of nuclease activity 
(Storici et al, 2002). 
Fen1 is associated with several DNA repair pathways like Mismatch repair (MMR) and long patch 
Base excision repair (BER) (Lieber, 1997). In the context of BER, the NTH1 glycosylase (in XPG 
dependent manner, see chapter 1.4) is the damage sensor and creates an AP (apurinic) site for AP 
endonuclease 1, which is able to cut the phosphate backbone and leave a 3’OH and 5’-deoxyribose 
phosphate (dRP) (Haukanes et al, 1990; Hazra et al, 2001). In most cases, Pol β recruited to the AP 
site is able to excise the 5' (dRP) and perform single nucleotide Repair (SN-BER) (Frosina et al, 1996). 
But sometimes the lyase activity of Pol β is inhibited by the presence of an oxidized or reduced dRP, 
Pol β performs a strand displacement, resulting in a longer flap (2-12 nts) and a substrate for Fen1 in 
the same fashion as during Okazaki fragment maturation (Klungland & Lindahl, 1997; Prasad et al, 
2000; Sattler et al, 2003). Unlike XPG (see chapter1.4), Fen1 is inhibited by folded flap structures like 
hairpins but nevertheless it is able to cut upstream of a hairpin, possibly occurring during end 
resection in trinucleotide repeat replication (Balakrishnan & Bambara, 2013). Fen1 is involved in the 
recovery from UV-light-induced replication inhibition and is induced by p53 (Christmann et al, 2005). 
Fen1 also displays a Gap endonuclease (GEN) activity, which is connected to WRN, telomere stability 
and probably apoptosis (Liu et al, 2006; Saharia et al, 2008).  
Its small protein size of 42kDa is sufficient to diffuse freely through nuclear pores (Qiu et al, 2001). 
However, to reach a practical rate of nuclear migration, Fen1 needs active Import into the nucleus. It 
was found in a complex with importin α in a c-terminal and NLS dependent manner and under UV in 
S-phase (de Barros et al, 2012).  
A free 5’ single stranded flap capped with a TT CPD lesion was digested in in vitro nuclease assays in 
dependency of S. pombe Fen1 (Yoon et al, 1999). The model suggests the extrusion of the dsDNA by 
the action of the DNA polymerase, expanding the flap from 2nts to 9-11 nucleotides, thus making it a 
substrate for Fen1 digestion and subsequent nick sealing by a ligase. However, the NER reaction 
bubble displays a DNA lesion positioned exactly 9-11 nucleotides upstream of the downstream 3’ 
branch (Tapias et al, 2004). During the intermediate state with the presence of a defective XPG, the 
putative action of DNA2 performing strand shortening, possibly until it drops off at the lesion, would 
lead to a structure which was shown to be cleaved by s. pombe Fen1. 
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Fen1 is essential for Okazaki fragment maturation during replication and cuts the displaced RNA 
primer endonucleolytically (also see chapter 1.5.2) (Li & Kelly, 1984). Among other structures (see 
Figure 13),  ssDNA and RNA 5’ flaps, which occur due to the action of processive polymerases, are 
digested by Fen-1 together with a little portion of the newly synthesized initiator DNA before Ligase I 
seals the nick.  
 
 
  
Figure 12: Fen1 superfamily 
domain conservation 
The Fen-1 family nucleases 
comprise the highly conserved 
N- and I domains, bearing the 
nuclease function. The PCNA 
interaction is conserved, 
despite the PIP-box sequence is 
partially different. (adapted 
from Lieber, 1997) 
(Cann & Ishino, 1999; 
Matsumiya et al, 2002; Patoli et 
al, 2013) 
Figure 13: Structures 
cleaved by Fen1 
Red arrows = endo-
nuclease activity of Fen1, 
thickness indicates 
strength of the substrate 
(Lieber, 1997). 
Additionally, structures 
demonstrateably cleaved 
by XPG are also 
illustrated (see chapter 
1.4). 
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The short flap degradation (long flaps see chapter 1.5.2) during replication most commonly occurs as 
nick translation (see Figure 14), the iterative cycle between Pol δ unwinding the fragment and Fen1 
cutting the short (often 1nt) flap until the initiator RNA is degraded (Burgers, 2009). Fen-1  has about 
30 interaction partners, among them PCNA (see chapter 1.3.5), DNA2 (see chapter 1.5.2), BLM, RPA 
(see chapter 1.3.4.2), and WRN (Balakrishnan & Bambara, 2013). Fen1 is believed with a size of about 
42kDa only to maximally bind two or three partners at once, raising the fact that there is a sequential 
hand off process between Fen1 and its several partners (Chapados et al, 2004; Prasad et al, 2011). 
However, the endonuclease activity of Fen1 is increased up to 50 fold by binding one of its partners 
(Balakrishnan & Bambara, 2013). Binding to the trimer PCNA displays the key interaction in this 
context. PCNA acts like a molecular switch, with each PCNA monomer bound to either Pol δ, Fen1 
and Ligase I (Dionne et al, 2003).  
Also longer flaps do occur, which lead to hairpin formation (e.g. trinucleotide repeats; due to 
sequence context) or subsequent coating by RPA, which prevents Fen1 binding to the flap or its 
nuclease activity, respectively (Bae et al, 2001; Lieber, 1997; Rossi & Bambara, 2006). Recruitment of 
a ligation system consisting of Fen1 and Ligase I is one possibility for the cell to terminate NER and 
close the nick after DNA resynthesis (Mocquet et al, 2008). 
For complete catalytic activity, beside divalent metal ions, Fen1 needs a free 5’ end to be stably 
recruited and loaded onto the ssDNA by threading the DNA through a hole in the molecule (Bae et al, 
2001; Lieber, 1997; Rossi & Bambara, 2006). This interaction bends the junction, also conferring 
structure specifity to Fen1 and probably hinders other nucleases with similar substrates (ssDNA-
dsDNA junction: GEN1, Exo1, XPG) from wrong cleavage (Patel et al, 2012; Sobhy et al, 2013) (also 
see chapter 1.5.1.2). Furthermore, Fen1 needs a short 3’ flap (1nt) for proper DNA binding and 
catalysis (Finger et al, 2009). 
Secondary modifications of Fen1, same nuclease family like XPG (see chapter 1.4) occur in broad 
range incl. acetylation (by p300, e.g. in response to UV), on four specific lysine residues with an 
increasing rate of inhibition of Fen1’s (substrate binding) activity proportional to the degree of 
acetylation (Hasan et al, 2001a; Hasan et al, 2001b). Acetylation also regulates RPA binding to ssDNA 
and strand displacement activity of Pol δ suggesting a defined acetylation based cellular mechanism 
to enhance safety/fidelity to the removal/repair of longer flaps during LP-BER (Balakrishnan & 
Bambara, 2013).  
Phosphorylation of Fen1 inhibits its nuclease activity and prevents PCNA from binding, and was 
further shown to regulate its nucleolar localization as well as the UV repair capacity (Guo et al, 2008; 
Henneke et al, 2003). The methylation of Fen1 prevents its phosphorylation but leaves the 
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interaction with PCNA unaffected (Guo et al, 2010; Zheng et al, 2011). This raises speculations about 
methylated Fen1 at the arrival and phosphorylated Fen1 after cleavage during handover with Ligase 
I. The phosphorylation also triggers its ubiquitination and subsequent sumoylation followed by 
degradation, for instance in G2/M phase, whereby Fen1 activity logically peaks in S phase (Guo et al, 
2012). This illustrates the additional layer of regulation of Fen1, one of the most extensive studied 
proteins in the Fen1 superfamily, and rises implications for other family members, e.g. XPG (see 
chapter 1.4). 
The Fen1 superfamily (e.g. GEN1, Exo1, XPG) shares conserved sequence homologies regarding the 
DNA binding mechanism, a helical gateway consistent of a K+ bridge, the H2TH (helix-2turn-helix) 
motif, and a helical turn, which are able to recognize several structures in sequence independent 
manner (Grasby et al, 2012; Tsutakawa et al, 2011; Tsutakawa & Tainer, 2012).  
Fen1, as already mentioned above, interacts with more than 30 proteins and is implicated in several 
pathways like apoptosis and DNA repair, the resolution of stalled replication forks, the removal of 
hairpins, and telomere replication, designating the multiplayer Fen1 as a tumor suppressor (Zheng et 
al, 2011). However, the occurrence of ssDNA flaps with free 5’ ends if the second 3’ cut by XPG is 
missing. This structure was assumed to be target for Fen1 and it was speculated about a backup 
mechanism of NER by Fen1 before (Godon et al, 2012; Matsumoto, 2001). Moreover, a potential 
backup mechanism for XPG during NER was postulated before, in order to explain the Fen1 UV 
resistance capacity (Matsumoto, 2001). However, the Rad27-Rad2 mutant (Fen1-XPG homologues in 
yeast) displayed no synergistic negative effect regarding the cellular UV damage repair capacity (Qiu 
et al, 1998). 
1.5.1.2 Exonuclease 1 (Exo1) 
There is evidence for the recruitment of Exonuclease 1 (Exo1) to sites of local damage in presence of 
a huge overload of UV-derived DNA lesions or the inhibition of DNA repair synthesis by polymerase 
inhibitors, nucleoside analogues or an endonuclease defective XPG in yeast and human cells 
(Giannattasio et al, 2010; Overmeer et al, 2011; Scharer, 2013; Sertic et al, 2011). However, Exo1 
activity promotes processive end resection over long stretches of dsDNA resulting in huge ssDNA 
gaps. This was shown to be covered by RPA and resulted in the activation of ATM/ATR DDR pathway 
in non-dividing cells (see chapter 1.3.1).  
Exo1 is Fen1 family member and shares features with the respective family members Fen1 and XPG 
(see chapters 1.4, 1.5.1.1). Despite sequence homologies, especially concerning the nuclease domain 
and a proposed similar mechanism of DNA binding, Exo1 was similarly shown to interact with PCNA. 
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Noteworthy, the Exo1-PCNA interaction confers processivity to the nuclease, like it was shown in 
vitro DSB repair assays (Chen et al, 2013; Constantinou et al, 1999; Grasby et al, 2012).  
The human homologue of Exo1 displays the same exo- as well as endonuclease activities like human 
Fen1 (Lee & Wilson, 1999). However, s. cerevisiae exo1-/- cells are not sensitive to UV and are able to 
perform normal NER. The possibility, that the respective homologues of Fen1 and Exo1 provide 
convertible back up pathways for both, replication and UV response, was assumed since 
overexpression of Exo1 in fission yeast is lethal after UV damage (McCready et al, 2000). 
1.5.2 DNA2 
Longer 5’ ssRNA/DNA RPA coated flaps (>25nts) can occur during replication to a minor extend 
(Burgers, 2009). These are first shortened by the action of the helicase/nuclease DNA2 to short flaps 
(2-6nts), afterwards RPA is displaced, and leaves a substrate for Fen1 (see Figure 14).  
 
Figure 14: Okazaki Fragment maturation 
Long flap processing requires DNA2 whereas Fen1 activity is sufficient to cleave short flaps during 
nick translation. At the end of both sub pathways the RNA primer is removed and a recruited ligase 
seals the nick (Burgers, 2009). 
 
DNA2 has two key features, helicase and nuclease function, but rather its helicase function than its 
nuclease function is essential for replication (Budd & Campbell, 2000). DNA2 acts on longer flaps 
(~30nts), preferentially coated with RPA, the activator for DNA2, cutting it down to a short flap which 
is substrate for Fen1 (2-6nts) (Burgers, 2009). DNA2 is strongly stimulated (ATPase, helicase, and 
nuclease activity) by acetylation (Balakrishnan et al, 2010). 
DNA2 and Fen1 work in a tight connection, DNA2 overexpression is able to compensate a defective 
Fen1 and vice versa, and a double mutant is lethal in s. cerevisiae (Budd & Campbell, 2000). Like 
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Fen1, DNA2 is also inhibited by the formation of hairpins (HRP). These structures are in turn is a 
target for helicase PIF1, probably leading to an unwinding of the whole Okazaki fragment and 
recruitment of Pol δ (Pike et al, 2009; Pike et al, 2010; Ryu et al, 2004).  
1.6 Aim of research  
The aim of this study is to further investigate the multifunctional endonuclease XPG and its biological 
and functional roles during Nucleotide excision repair (see chapter 1.3.2). The biochemical roles of 
XPG are very diverse due to its manifold interactions with several binding partners in cell nuclei (see 
chapter 1.4). The specification of the XPG interactions, with regard to its functional domains, and its 
influence on NER, is analyzed in this thesis on the supposition of the following three guiding 
objectives:  
The first aim was to explore XPG deficient patients and expand the scientific knowledge about 
spectrum of physiologically occurring XPG mutations as a model for XPG protein functions (see 
chapter 1.1). In this context, the identification and characterization of the disease-causing mutation 
of a new XPG patient XP172MA is displayed. The genotype-phenotype correlation during this thesis 
narrows down the TFIIH interaction domain of the XPG N-terminus. 
The second task was to examine if the functional XPG-PCNA interaction is responsible for PCNA 
recruitment during NER. I’ve created several mutants of XPG with specific PCNA- and ubiquitin- 
interaction abolishing mutations (see chapters 1.3.5, 1.4.2, and 4.2.1). These mutants are analyzed 
with several functional assays to determine their NER activity (HCR), their influence on the 
immediate DNA repair synthesis (UDS) and, at least in part, their ability to recruit PCNA to local UV-
damage sites (Triple-IF) (see chapters 3.5.1, 3.5.2, 3.5.4). 
The third objective was to investigate a potentially alternative pathway during the very last steps of 
NER in dependency of the presence of a functionally constricted XPG, e.g. truncated or endonuclease 
defective. The DNA structure during the intermediate state of dual incision raises the possibility of 
DNA2 and/or Fen1 recruitment to sites of ongoing NER and is similarly investigated in this thesis (see 
Figure 8, see chapter 1.5). 
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2 Materials 
2.1 Biological material 
2.1.1 Bacterial strains 
Escherichia coli (E. coli) DH5  [F-, endA1, glnV44, thi-1, recA1, relA1, gyrA96, deoR, nupG, 
Φ80dlacZΔM15, Δ(lacZYA-argF)U169, hsdR17(rK- mK+), λ–,] (Hanahan, 1983) was used as host strain 
for plasmid DNA amplification. 
2.1.2 primary fibroblast cell culture 
Functional assays were performed using three different fibroblast cultures. WT41, WT-thilo and 
XP172MA derived from a skin punch biopsies of two healthy and a XP donor, respectively (see 
chapter 3.3.1). XP20BE (Moriwaki et al, 1996), a Xeroderma Pigmentosum (XP) group G fibroblast 
culture, was purchased at the Coriell cell repository (Cat. No. AG08803, Camden New Jersey, USA). 
HeLa cells (immortal, cervical cancer, donor: Henrietta Lacks) were purchased at the ATCC (Manassas 
Virginia, USA) (Scherer et al, 1953).  
2.2 Devices 
Table 1: Devices 
 
Description  Label  Supplier 
Agarose gel melting Microwave NN-5253 
Panasonic, Hamburg, 
GER 
Agarose gel trays and chambers  Blue Marine 200 Serva, Heidelberg GER 
 
Spezial Gelelektrophoresekammer 
für Agarosegele 
Hardware & service, 
Friedland GER  
Aqua bidest. supplier  arium® 611 VF Sartorius, Göttingen GER 
Autoclave DE-65 Systec, Wettenberg GER 
Bacterial culture  Erlenmeyer flask (200ml, 500ml) VWR, Darmstadt GER 
Centrifuges Mikro 220 Hettich, Tuttlingen GER 
 
Benchtop centrifuge 5415, 1-15 Sigma, Munich GER 
 
Sorvall RC 6+ 
Thermo Scientific, 
Waltham USA 
Centrifuges Mega fuge 1,0R, model G25 
Thermo Scientific, 
Schwerte, GER 
 
MC 6 centrifuge 
Sarstedt, Nümbrecht 
GER 
 
Capsule HF-120 Tomy Seiko JPN 
Counting chamber Neubauer cell counting chamber Brand, Wertheim GER 
Dish washer Miele professional Miele, Gütersloh GER 
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Dispenser Multipette® plus 
Eppendorf, Hamburg, 
GER 
Drier SL 50 
Memmert, Schwabach 
GER 
Freezing  Cryo 1°C cooler VWR, Darmstadt GER 
fridges and freezers GUS 34420 Bosch, Stuttgart GER 
 
Arctis (-20°C) AEG, Nürnberg GER 
 
Ultra low MDF-473V (-80°C) Sanyo, Munich GER 
 
glassline (+4°C) 
Liebherr, Ochsenhausen 
GER 
Gel documentation system Biodoc controller + CCD-camera 
Biometra, Göttingen, 
GER 
 
UV-table Fluo-Link 
Biometra, Göttingen, 
GER 
 
video graphic printer UP-890CE Sony, Berlin GER 
 
video monitor wv-BM 900 
Panasonic, Hamburg 
GER 
Glasspipettes Blau Brand (5,10,20,25ml) Brand, Wertheim GER 
 
Hirschmann EM (5,10,20,25ml) 
Hirschmann, Eberstadt 
GER 
Ice machine ZBE 30-10 Ziegra, Isernhagen GER 
Imaging devices LAS 4000 Fujifilm, Düsseldorf GER 
Incubators CO2-Incubator, MCO-18AIC Sanyo, Munich, GER 
 
Incubator model 200 
Memmer, Büchenbach, 
GER 
 
Shaker Thermotron Infors, Bottmingen SWZ 
Laboratory hood not specified 
Norddeutsche Laborbau, 
Quickborn GER 
Liquid nitrogen container Chronos Biosafe 
Messer Griesheim, Bad 
Soden GER 
 
Apollo Biosafe  
Messer Griesheim, Bad 
Soden GER 
Luminescence measurements 
GlomaxTM 96 Microplate 
Luminometer 
Promega, Mannheim 
GER 
Microscopes 
Axiovert 100 fluorescence 
microscope 
Carl Zeiss, Oberkochen 
GER 
 
Axiovert Imager.M1 
Carl Zeiss, Oberkochen 
GER 
 
BZ-9000 
Keyence, Neu-Isenburg 
GER 
Mobile pipettor Pipetboy acu 
Integra Biosciences, 
Fernwald, GER 
pH-Meter digital pH-meter, pH 525 Schütt, Göttingen GER 
Pipettes 
Transferpette® S  (1000, 
100,20,10µl) 
Brand, Wertheim GER 
Post UV survival measurment Elisa Reader Tecan, Männedorf GER 
Power supply Mini Power Rack P20 
Biometra, Göttingen, 
GER 
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Protein concentration DU 640  Spectrophotometer Beckmann, Munich GER 
Scales MC1 AC210S Sartorius, Göttingen GER 
 
Analytic balance BP2100 Sartorius, Göttingen GER 
SDS gel chamber Mini-PROTEAN Tetra Cell Biorad, Munich GER 
 
Hoefer SE600 Ruby GE Heathcare 
Spectrophotometer DU 640  Spectrophotometer Beckmann, Munich GER 
 
NanoVuePlus 
GE Healthcare, 
Buckinghamshire UK 
Sterile bench Technoflow 2F180-11 GS 
Integra Bioscience, 
Fernwald GER 
Tamping machine Tecnomara, Tecnoplug 
Integra Bioscience, 
Fernwald, GER 
Thermal Cycler Arktik Thermal Cycler 
Thermo Scientific, 
Waltham USA 
 
T Gradient Thermo Block 
Biometra, Göttingen, 
GER 
Thermoblocks Thermomixer 5436 
Eppendorf, Hamburg, 
GER 
UV-irradiation UVC 500 crosslinker 
Amersham Biosciences, 
Glattburg CH 
Vortexer Vibrofix VF1 Electronic 
IKA Labortechnik, 
Staufem, GER 
Water bath 1003 
GFL, Großburgwedel 
GER 
Western Blot development LAS 4000 Fujifilm, Düsseldorf GER 
Western blot equipment Mini Rocking Platform 
Biometra, Göttingen 
GER 
 
Trans-Blot®TurboTM Transfer 
System 
Biorad, Munich GER 
 
2.3 Disposables 
Table 2: Disposables 
 
Label Supplier 
96 well GlomaxTM 96 Microplate Promega, Mannheim GER 
Blotting paper extra thick Biorad, Munich GER 
Cell culture flasks (25 cm3, 75 cm3, 175 cm3) 
Greiner bio-one, Frickenhausen 
GER 
Cell scraper 25 cm 
BD Biosciences, Pharmingen, 
Oxford UK 
Combitips advanced (5ml) Eppendorf, Hamburg GER 
Conical tubes (Falcon 15 ml & 50 ml) Sarstedt, Nümbrecht GER 
Cryo boxes Nunc, Wiesbaden GER 
Cryo tubes 2ml 
Greiner bio-one, Frickenhausen 
GER 
Glass cover slips, optical planed Thermo Fisher, Karlsruhe GER 
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Glass cover slips, round, 20mm Roth, Karlsruhe GER 
Isopore membrane filters 5µm  
merck Millipore, Darmstadt 
GER 
Kimtech wipes 
 
Mini TGX Gels Biorad, Munich GER 
Multiply µStrip Pro 8-strip Sarstedt, Nümbrecht GER 
Nitrocellulose, 0.45 µM Protran BA85 Whatman, Madstone UK 
Object slide 
Thermo Scientific, 
Braunschweig GER 
Parafilm® Pechiney Plastic Packaging 
Petri dishes 
Greiner bio-one, Frickenhausen 
GER 
Pipette tips (10 μl, 200 μl & 1000 μl) Sarstedt, Nümbrecht GER 
Polystyrene round bottom tube BD Falcon, Heidelberg GER 
Reaction tubes (0,5 ml, 1,5 ml & 2 ml) Eppendorf, Hamburg GER 
Scalpel, disposable Feather, Osaka JPN 
Syringes, single use (2 ml, 5 ml, 10 ml & 20 ml) Braun, Melsungen GER 
Sterile filters (pore size 0.2 μm & 0.45 μm) filtropur S (plus) Sarstedt, Nümbrecht GER 
Tissue culture plates (24-, 96-well) Greiner 
Toothpick Fackelmann, Hersbruck GER 
Wadding  Brand, Wertheim GER 
Weighing paper (round/folded, 125mm) Schleicher & Schüll, Dassel GER 
2.4 Chemicals, media and reagents 
Table 3: Chemicals, media and reagents 
 
Chemical/Reagent Supplier 
2-propanol JT Baker, Deventer NED 
6x loading dye 
Fermentas, St. Leon-Rot, 
GER 
Agarose Saekem® 
Fluka Chemie, Neu-Ulm, 
GER 
Alexa Fluor® 488 Azide  
Life technologies, 
Darmstadt GER 
Ammonium chloride (NH4Cl) Merck, Darmstadt GER 
Ammonium persulphate (APS) Sigma-Aldrich, Munich GER 
Ampicillin Sigma-Aldrich, Munich GER 
Aqua ad iniectabilia Braun, Melsungen GER 
Attractene Transfection Reagent Qiagen, Hilden GER 
Boric acid Merck, Darmstadt GER 
Bovine serum albumine (BSA) PAA, Coelbe GER 
Bradford Mix Roti® Quant Roth, Karlsruhe GER 
Bromphenol Blue Sigma-Aldrich, Munich GER 
BSA (bovine serum albumin) NEB, Ipswich USA 
Calcium chloride (CaCl2) Merck, Darmstadt GER 
Complete ULTRA Tablets Mini EDTA Roche, Mannheim GER 
Dimethylsulfoxide (DMSO) Sigma-Aldrich, Munich GER 
Materials 
40 
Dithiothreitol (DTT) Sigma-Aldrich, Munich GER 
dNTPs 
Fermentas, St. Leon-Rot, 
GER 
Dulbecco’s modified Eagle’s medium (DMEM) PAA, Coelbe GER and others 
Ethanol (analytical grade) Merck, Darmstadt GER 
Ethidium bromide (1%) Roth, Karlsruhe, GER 
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich, Munich GER 
Fetal Bovine Serum (FBS) Biochrom AG, Berlin GER 
Gene Ruler (100bp #SM0241, 1kb #SM0311) DNA Ladder 
Fermentas, St. Leon-Rot, 
GER 
Glycerol Merck, Darmstadt GER 
Glycine (C2H5NO2) Sigma-Aldrich, Munich GER 
HCl Merck, Darmstadt GER 
Hi-Di Formamide 
Applied Biosystems, Foster 
City, USA 
Isopropanol (C3H7OH) Merck, Darmstadt GER 
Kalium hydrogen phosphate (KH2PO4) Merck, Darmstadt GER 
kanamycin sulfate Roth, Karlsruhe GER 
LB Agar 
Life technologies, 
Darmstadt GER 
LB Broth Base (Bertani, 1951) 
Life technologies, 
Darmstadt GER 
Magnesium chloride (MgCl2) Merck, Darmstadt GER 
Marker VI,protein ladder 
Applichem,Chicago Illinois, 
USA 
Methanol (CH3OH) 
Mallinckrodt Baker, 
Griesheim GER 
N,N,N,N-tetramethyl-ethane-1,2-diamine (TEMED) 
 
Nail polish (Last Forever) 
P2 Kosmetik GmbH, Wr. 
Neudorf GER 
Nonidet P40 Sigma-Aldrich, Munich GER 
Paraformaldehyde (PFA) Merck, Darmstadt GER 
Penicillin-Streptomycin (100x) PAA, Coelbe GER 
Phenylmethanesulfonylfluoride (PMSF) Sigma-Aldrich, Munich GER 
Ponceau S Sigma-Aldrich, Munich GER 
Potassium Chloride (KCl) Merck, Darmstadt GER 
Protease Inhibitor Cocktail (P2714) Sigma 
Sodium acetate Sigma-Aldrich, Munich GER 
Sodium Chloride (NaCl) Merck, Darmstadt GER 
Sodium dodecyl sulfate (SDS) Roth, Karlsruhe GER 
Sodium hydrogen phosphate (Na2HPO4 x 2H2O) Merck, Darmstadt GER 
Sodium hydroxide (NaOH) Merck, Darmstadt GER 
Succrose/ Saccharose Sigma-Aldrich, Munich GER 
Trifluoroacetic acid (TFA) Sigma-Aldrich, Munich GER 
Tris-Base Merck, Darmstadt GER 
Triton X-100 Merck, Darmstadt GER 
Trypanblue Sigma-Aldrich, Munich GER 
Trypsin/EDTA Biochrom AG, Berlin GER 
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Tween20 Merck, Darmstadt GER 
Vectashield Mounting Medium for Fluorescence H-1000 
Vector Laboratories, 
Burlingham CA/USA 
Vectashield Mounting Medium for Fluorescence with DAPI 
H-1200 
Vector Laboratories, 
Burlingham CA/USA 
β-mercaptoethanol (C2H6OS) Merck, Darmstadt GER 
 
2.5 Antibodies 
Primary and secondary antibodies were used according to manufacturer's instructions and 
concentrations are listed in the respective method sections. PBS supplemented with 1% FBS was 
used as diluent.   
Table 4: Primary antibodies  
 
Label Dilution Host Isotype/clone Supplier 
CPD  1:1000 mouse TDM-2, IgG2a κ 
Cosmo Bio co., LTD, Tokyo JPN 
(Mori et al, 1991) 
PCNA  1:50 rabbit FL-261 Santa Cruz, Dallas USA 
XPG 1:500 rabbit A301-484A, IgG Bethyl, Montgomery USA 
Β-Actin 1:5000 mouse 
anti human β-actin 
clone  AC-74 
Sigma-Aldrich, Munich GER 
Dilutions were carried out in 5% FBS in PBS or blocking solution (Western Blot). 
Table 5: Secondary antibodies 
 
Label Dilution Host Isotype/clone Supplier 
Alexa Flour® 594-conjugated, 
anti-mouse (RED) 
1:500 goat AffiniPure F(ab’)2 Dianova, Hamburg GER 
Marina Blue anti rabbit (DAPI) 1:500 goat IgG 
Life technologies, 
Darmstadt GER 
Alexa Flour® 405-conjugated 
anti rabbit (DAPI) 
1:500 goat IgG 
Life technologies, 
Darmstadt GER 
 
2.6 Enzymes 
Table 6: Enzymes 
 
Label Supplier 
CIAP (calf intestinal alkaline phosphatase) 1u/μl MBI Fermentas, St. Leon-Rot GER 
DNaseI Promega, Mannheim GER 
DpnI 10 u/ l MBI Fermentas, St. Leon-Rot GER 
KpnI 10u/ l NEB, Ipswich USA 
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Pfu DNA Polymerase MBI Fermentas, St. Leon-Rot GER 
Phusion DNA Polymerase 
Finnzymes, Thermo Fisher, 
Waltham USA 
RNase A Sigma-Aldrich, Munich GER 
T4 DNA Ligase 1u/ l MBI Fermentas, St. Leon-Rot GER 
Taq DNA Polymerase MBI Fermentas, St. Leon-Rot GER 
XbaI 10 u/ l NEB, Ipswich USA 
 
2.7 Buffers and solutions 
Unless otherwise noted all buffers and solutions are prepared in autoclaved aqua bidest. For sterile 
filtration 0,2 µm filters and a syringe with an appropriate volume were used. 
Table 7: Buffers and solutions 
 
Application  Designation Recipe 
Cell culture Freezing medium 
40% DMEM 
40% (v/v) FBS 
20% (v/v) DMSO 
 
DMEM complete 
DMEM 
10% (v/v) FBS 
1% (v/v) P/S 
 
10x PBS, pH 7.2 
1.5 M NaCl 
30mM KCl 
80mM Na2HPO4 x 2H2O 
10mM KH2PO4 
Bacterial culture Ampicillin Stock solution 
10% m/v, sterile filtered, 
deployed 1:1000 in LB 
 
Calcium-Glycerol buffer 85% CaCl2, 15% glycerol 
Agarose gel electrophoresis Running buffer TBE 
89mM Tris base 
89mM Boric acid 
2mM EDTA 
 
6x DNA loading buffer 
0.5 M EDTA 
50% (v/v) Glycerol or 
Saccharose 
0.01% Brompehnol Blue 
Protein Biochemistry Paraformaldehyde (PFA) 
3.7% w/v (basic pH shift 
for pre- dissolving using 
1M NaOH) 
   
 
Sucrose-solution 
2% PFA w/v (basic pH 
shift for pre- dissolving 
using 1M NaOH), 0.5% 
Triton X-100, 300mM 
sucrose  
 
PBS-Tween 
0.05% (v/v) Tween20 in 
PBS 
 
Immunoblot transfer buffer, pH8.3 0.192M Glycine 
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0.025M Tris-Base 
20% MeOH (v/v) 
0.01% SDS 
 
Ponceau S-solution 
0.2% (v/v) Ponceau S 
3% (v/v) TFA 
 
SDS running buffer, pH 8.3 
0.192M Glycine 
0.025M Tris-Base 
0.1% SDS 
 
SDS Page sample buffer, pH 4,7 
30mM Tris 
3% SDS 
15% Glycerine 
0,04% Brompehnol Blue 
before use add 10% β-
mercaptoethanol 
 
2.8 Deoxyribonucleotides 
All oligonucleotides were synthesized by Sigma-Aldrich Co. LLC. Restriction site sequences were 
introduced at the 5’ end of the complementary primer annealing sequence extended upstream by a 
codon for proper enzyme binding (marked italic). Oligonucleotides used for quick-change 
mutagenesis included maximally two adjacent altered nucleotides flanked by 10 to 15 
complementary bases, forward and reverse primers were placed in the same sequence context. 
Sequencing primers were designed for 55°C annealing temperature (see chapter 3.2.3.2) 
Table 8: Primers for quick change mutagenesis 
 
Description Sequence 5'-3' 
E791A_for 
E791A_rev 
CCCATGGAAGCAGCCGCGCAGTGCGCC 
GGCGCACTGCGCGGCTGCTTCCATGGG 
 
(Constantinou et al, 1999) 
QC_D77A-for CGTCCTATTTTTGTGTTTGCTGGGGATGCTCCAC 
QC_D77A-rev GTGGAGCATCCCCAGCAAACACAAAAATAGGACG 
QC XPG_PIP-N_1_for GCATTACAGGAAGAGGCCTTTCATAATCCTCA 
QC XPG_PIP-N_1_rev TGAGGATTATGAAAGGCCTCTTCCTGTAATGC 
UBM_QC_1a_for 
UBM_QC_1a_rev 
 
UBM_QC_2a_for 
UBM_QC_2a_rev 
GAGGACTTCAGCAGCGCGCCCCCTGAAGTAAA 
TTTACTTCAGGGGGCGCGCTGCTGAAGTCCTC 
 
GACTTCAGCAGCGCGGCCCCTGAAGTAAAGC 
GCTTTACTTCAGGGGCCGCGCTGCTGAAGTC 
 
Table 9: Primers for cloning 
 
Description Sequence 5'-3' 
DNA2-for_BamHI TAG GGATCC – CTGTCTACAGTTTGCGATCC 
DNA2-rev_XhoI TAG CTCGAG - CCTAGTATGAAAAGGCAAGGG 
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JL_5-UTR-KpnI-cl-f TTAGGTACC- GTGCAGTCCGTCGTAGAAG 
PCNA -Del2_Rev TAGTCTAGA-CGATCCCTTCGAGTCATCCAC 
PCNA-cl_II_for_KpnI TAGGAATTC-CGGCTATTCTCGCAGGATCAG 
PCNA-cl_II_rev_XbaI TAGTCTAGA-TGCGACAAATTCATTACAAATGGC 
 
Table 10: Sequencing primers  
 
Description Sequence 5'-3' 
DNA2_1100_for GCCTGCCAACCATCTAGA 
DNA2_1700_for CCAGAATCAACTTTGTTCAG 
DNA2_2300_for CCATCCAATATTTTCCCGT 
DNA2_2800_for GTAACAGAAGCCAAACTCA 
DNA2_500_for AGCTCTGATCCAGCCACA 
M13_rev CAGGAAACAGCTATGAC 
pcDNA3.1_rev TAGAAGGCACAGTCGAGG 
T7 TAATACGACTCACTATAGGG 
XPG_2472-2492 CGGATCGCTGCTACTGTCACC 
XPG_302-323 AAACCAAGCACTTAAAGGAGTC 
XPG_594r4 TGCTGCTGTAGACGAAGGC 
XPG_594r86 CCTGTCAGTTTGCAAGAAACA 
XPG_966-985 CAACATTCAGGACACATCCG 
XPG_Ex8_for_SS CTCGGAAGAAAGTGAATCTG 
XPG_Ex8_rev_SS CACTTCTGCAACTGTCTTAGC 
XPG_g2397 for ACAACTCTGAGAGGGACGAC 
XPG_g285rev CCCCATCAAACACAAAAATAGG 
XPG_T10 ACCTCTATGTTTTGCCTCCTT 
XPG_xp5100 TAAGACCTAATCCTCATGACA 
 
2.9 Plasmids 
Table 11: Plasmids 
 
Label Supplier Application 
172MA_pcDNA3.1(+) (XPG patient) (Lehmann, 2013) Functional assays 
IsoVI_pcDNA3.1(+) (XPG isoform) (Lehmann, 2013) Functional assays 
pBactin-PCNA-Del Dr. Ron Gary, UNLV (Gary et al, 1997) subcloning 
pBactin-PCNA-FF Dr. Ron Gary, UNLV (Gary et al, 1997) subcloning 
pcDNA3.1(+) Life technologies, Darmstadt GER,  cloning 
pcmvLuc Promega, Mannheim GER HCR 
pResQ shFEN3 3XF-FEN1 D181A Addgene plasmid 17753, Sheila Stewart subcloning 
pResQ shFEN3 3XF-FEN1 wt Addgene plasmid 17752, Sheila Stewart subcloning 
pRL-CMV Promega, Mannheim GER HCR 
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2.10 Reaction systems 
Table 12: Reaction systems 
 
Label Supplier 
BigDye  Terminator v3.1 Cycle Sequencing Kit Applied Biosystems, Foster City USA 
CellTiter 96  Non-Radioactive Cell Proiferation Promega, Mannheim GER 
Click-iT EdU Alexa Fluor 488 Imaging Kit Life technologies, Darmstadt GER 
Click-iT® Cell Reaction Buffer Kit Life technologies, Darmstadt GER 
Dual-Luciferase Reporter Assay System Promega, Mannheim GER 
NucleoBond  Xtra MiDi/Maxi Machery + Nagel, Düren GER 
NucleoSpin  Gel extraction and PCR Clean Up Machery + Nagel, Düren GER 
NucleoSpin  Plasmid Machery + Nagel, Düren GER 
QIAamp DNA Blood Kit Qiagen, Hilden GER 
RevertAid H Minus First Strand  cDNA synthesis Kit MBI Fermentas, St. Leon-Rot GER 
RNase free DNase Set Qiagen, Hilden GER 
RNeasy Mini Kit Qiagen, Hilden GER 
WesternBreeze Chemilumonescent Immunodetection 
Systems anti mouse/rabbit 
Applied Biosystems, Foster City USA 
 
2.11 Software, online tools and databases 
Table 13: Software, online tools and databases 
 
Label Supplier/web adress Application 
BZ-II Analyzer 
BZ-II Viewer 
Keyence Triple-IF 
Axiovert Axiovision 100 Carl Zeiss, Jena GER Fluorescence microscope 
Blast http://blast.ncbi.nlm.nih.gov/Blast.cgi Primer check 
Chromas Lite 2.1 Technelysium, South Brisbane AUS Sequence analysis 
Double Digest Finder NEB, Ipswich USA Restriction digestion 
e!Ensembl http://www.ensembl.org Genome browser 
Endnote X1.0.1 Thomson Reuters, New York USA Literature management 
GenBank http://www.ncbi.nlm.nih.gov/genbank/ 
Genbank accession 
number 
Glomax  Software Promega, Mannheim GER HCR 
Image J National Institutes of Health 
Western blot 
quantification 
Ligation Calculator 
http://www.insilico.uni-
duesseldorf.de/Lig_Input.html 
Ligation 
LSM Image Browser Carl Zeiss, Jena GER 
secondary antibody 
decision 
Microsoft Office Microsoft, Unterschleißheim GER Word, Excel, Powerpoint 
MultAlin http://multalin.toulouse.inra.fr/multalin alignments 
Photoshop CS3 Adobe, Munich GER UDS quantification 
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Pubmed http://www.ncbi.nlm.nih.gov/pubmed Literature request 
Reverse Complement 
http://www.bioinformatics.org/sms/rev_ 
comp.html 
In silico  Sequence 
translation 
Sigma Blot Systat Software, Erkrath GER Graphs, statistic 
Tm caculator 
http://www6.appliedbiosystems.com/support/ 
techtools/calc/ 
annealing temperature 
of primers 
Translate tool http://web.expasy.org/translate 
DNA to protein sequence 
translation 
Vector NTI Life technologies, Darmstadt GER 
Sequence and plasmid 
design 
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3 Methods 
3.1 Microbiological Methods 
3.1.1 Autoclavation and sterilization 
Thermostable buffers and solutions, as well as bacterial media, microbiotically contaminated 
Erlenmeyer flasks and laboratory S1 waste, were autoclaved for 20 minutes at 121°C and three 
bar. Thermally instable buffers and liquids were sterile filtered. Glass pipettes and miscellaneous 
glass was washed in a dish washer (40°C, program F) and subsequently sterilized and dried at 
190°C and 70°C for 4 hours, respectively. Prior to the use in cell culture all glass pipettes were 
plugged with wadding. Plastic pipette tips were autoclaved for 20 minutes at 121°C and three 
bar and subsequently dried at 70°C for 4 hours. 
3.1.2 Culture and storage of E. coli 
Liquid Escherichia coli (E. coli) cultures were grown overnight at 37 °C in lysogeny broth (LB) and 
under aerobic conditions in an incubator shaker. For small volumes (4 ml) conical 15 ml tubes were 
used at 200rpm, for large volumes (100 ml) Erlenmeyer flasks at 180rpm. LB liquid medium or LB 
agar plates were supplemented with antibiotics according to the required resistance for plasmid 
amplification (ampicillin 100µg/ml, kanamycin 50µg/ml). E. coli cultures intended for competent cells 
(see chapter 3.1.4) were grown without any antibiotics until the optical density (see chapter 3.1.3) 
indicated for achievement of the logarithmic growth phase. LB media were prepared according to 
the manufacture’s assignment. For long-term storage, 800 μl of an E. coli o/n culture was trenchantly 
mixed with 200 μl 100 % glycerol and stored at -80 °C. 
3.1.3 Photometric measurement of optical density of bacterial cultures 
Calculation of the optical cell density (OD) of bacterial cultures was done at 600nm in 1ml 
volume using a Spectrophotometer and the knowledge of the Lambert-Beer law. A value of 0.5 at 
the OD600 accounted for the achievement of the logarithmic growth phase. Pure autoclaved LB 
medium served as blank.  
3.1.4 Preparation of chemically competent Escherichia coli 
The E. coli strain DH5α was used as host for plasmid amplifications (see chapters 3.2.2.2, 3.3.4) and 
hence for the preparation of chemically competent cells. The underling mechanism is unknown in 
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detail. It involves the perforation of bacterial cell-wall and -membranes and its positive charging 
which enables these cells to uptake negatively charged DNA. 
A single colony of plated DH5α cells was picked to inoculate a 10ml overnight culture (see chapter 
3.1.2). This preparatory culture was poured into 190ml of autoclaved LB medium on the next day and 
the cell suspension grew until OD600 reached 0.5 (see chapter 3.1.3). Following, the cells and used 
buffers were kept at 4°C all the time. After centrifugation [4000rpm, 10min] the pellet was 
resuspended in 25ml of 100mM MgCl2 solution and incubated on ice [5min]. The dissolution was 
centrifuged again [4000rpm, 10min] and the pellet was resuspended in 5ml of 100mM CaCl2 solution 
for incubation [4°C, 20min] and subsequently centrifuged again. Finally, the pellet cells were 
resuspended in 1ml calcium-glycerol buffer and immediately frozen in aliquots of 50µl using liquid 
nitrogen. In this vein produced competent cells were stored at -80°C and used for transformation 
with a transformation efficacy of about 105 to 106 colonies per µg DNA (see chapter 3.1.5). 
3.1.5 Transformation of E. coli 
Transformation is the genetic alteration of a prokaryotic cell by transfer of foreign DNA and used for 
amplification of recombinant plasmid DNA (Hanahan, 1983).  
Chemically competent DH5α (see chapter 3.1.4) were defrosted on ice and an appropriate amount of 
plasmid DNA was added (100ng for re-transformation of plasmid preparations (see chapter 3.2.2.2) 
or 5µl of quick-change (see chapter 3.2.3.3) or ligation (see chapter 3.2.3.3.3) reactions). After an 
incubation time of 30min on ice, which leads to the stable attachment of the nucleic acid to the cell 
membrane, a heatshock was performed [45sec, 42°C] with a subsequent chill-on-ice step (2min) to 
increase the uptake of DNA into the cells. In order to cure the perforated bacteria 450µl of liquid LB 
was added, followed by an incubation of 1hr at 37°C under shaking conditions. Finally the whole 
transformation reaction (quick-change mutagenesis and ligation) or a small portion (re-
transformation, dilution plating to pick single colonies) was plated on LB agar dishes supplemented 
with the according antibiotic (resistance is encoded on the used plasmid) to achieve selection of 
successfully transformed E. coli clones. 
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3.2 Molecular methods 
3.2.1 Purification and concentration of nucleic acids 
Purification and concentration of nucleic acids was either achieved by ethanol precipitation (see 
chapter 3.2.1.1) or the use of the ‘Gel extraction and PCR Clean Up’ Kit according to the 
manufacturer’s instructions or a combination of both. 
3.2.1.1 Precipitation of nucleic acids 
Polar molecules dissolve well in also polar resolvents. Like water, DNA is a polar molecule because of 
its highly negatively charged sugar-phosphate backbone. Water binds positively charged ions, e.g. 
Na2+, and solubilises salt very well and a DNA molecule has the same properties. Ethanol is much less 
polar compared to water, which means that adding ethanol to solution disrupts the bindings of 
charges by water. If enough of it is added (above 64% of ethanol in solution), the electrical attraction 
between phosphate groups and any positive ions present in solution becomes strong enough to form 
stable ionic bonds (Green et al, 2012).  
A tenth part of the sample volume of high salt sodium acetate concentrations (3M) and 2.5 times 
sample volume of 96% ethanol (analytical grade) were added to the DNA containing sample. After 
intense vortexing and 30min of high speed centrifugation (14000rpm) the supernatant was 
discarded.  Next, 300µl of 70% ethanol was added to wash the pellet followed by centrifugation 
[10min 14000rpm]. Subsequently the ethanol was pipetted off and the pellet was dried [5min, 42°C] 
on a thermoblock with tubes open. Finally the pellet is resuspended in water.  
After plasmid preparation (see chapter 3.2.1.1) the DNA containing solution is precipitated with 2-
propanol (70% final concentration) instead of sodium acetate and Ethanol. Vortexing and washing 
steps stayed equal. 
3.2.1.2 Concentration determination 
Measurement of the concentration of nucleic acids was done at an absorption of 260nm in a 
volume of 2µl using the NanoVue®. Autoclaved bidest water served as blank, the concentration 
was calculated by the device using standards conversion factors for DNA, RNA and 
oligonucleotides (50, 40 ,and 20, respectively). The quotient OD260/OD280 was used as a purity 
control and always above 1.6. 
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3.2.2 Isolation of nucleic acids 
3.2.2.1 Extraction of nucleic acids from agarose gels 
Prior to cloning (see chapter 3.2.3.4), DNA fragments of different size were extracted and purified 
from 1% agarose gels (see chapter 3.2.2.1) using the NucleoSpin  Gel extraction and PCR clean up 
Kit by Machery and Nagel according to the instructions of the manufacturer. The DNA containing 
bands were uncovered due to Ethidium bromide intercalation and short time visualization by UV light 
and subsequently cut out with a clean scalpel. 
3.2.2.2 Plasmid DNA preparation 
Plasmid preparation from bacteria was first described in the nucleic acids research journal (Birnboim 
& Doly, 1979) as rapid alkaline extraction procedure and is, in principle, unaltered used in 
laboratories since that time. It makes use of the unequal behaviour of different DNA molecules of 
different size in solution after denaturation. The harvested E. coli cultures (see chapter 3.1.2) in mini 
(4ml), midi (100ml) or maxi (400ml) format were centrifuged [4000rpm, 10min] and in a first step 
gently treated with RNase prior to the cell lysis step under basic conditions (e.g. by the use of NaOH). 
By the incubation at room temperature [5min] cellular proteins as well as dsDNA (chromosomal and 
plasmids) were denatured and nucleic acids consequently strand separated. The following 
neutralization step involves an acidic buffer (e.g. potassium acetate) which leads to renaturing of 
small molecules (e.g. plasmids) and the precipitation of large molecules (genomic DNA, Proteins, and 
membrane components). This white mass is sedimented by centrifugation and the supernatant is 
transferred to glass silica columns which are able to bind the intact plasmid DNA. These columns as 
well as the required buffers and enzymes were provided by Machery + Nagel. The suitable Kit for 
each culture volume was used according to the manufactures manuals. After elution in appropriate 
volumes precipitation was carried out using 2-propanol (see chapter 3.2.1.1). The concentration of 
the plasmid DNA was determined like described (see chapter 3.2.1.2). 
3.2.2.3 Preparation of eukaryotic nucleic acids 
Total RNA and genomic DNA were isolated from 2*106 to 5*106 wildtype or patient fibroblast cells 
(see chapter 3.3.1). RNA samples were further processed during cDNA synthesis (see chapter 3.2.3.1) 
in an mRNA specific manner. 
For RNA isolation cells were centrifuged, the supernatant was decanted and the pellet resuspended 
in 600µl RLT buffer (supplemented with 1% (v/v) β-Mercaptoethanol) and, as the case may be, stored 
at -80°C for maximally a few days. This buffer was provided by Qiagen in the RNeasy Mini Kit and 
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further processed by following the instructions of the appendent handbook. The optional DNase 
digestion was obligatorily done using the RNase free DNase Set provided by Qiagen. 
Genomic DNA was prepared using the QIAamp DNA Blood Kit and the corresponding manufacturer’s 
instructions. The concentration of both eukaryotic nuclei acids was determined like described (see 
chapter 3.2.1.2). 
3.2.3 Enzymatic manipulation of nucleic acids 
3.2.3.1 Complementary DNA (cDNA) synthesis 
Prepared RNA samples (see chapter 3.2.2.3) were used for cDNA synthesis using the Revert Aid H 
Minus First Strand cDNA Synthesis Kit according to Fermentas’ instructions. The predesigned 18-mer 
oligonucleotides dT anneal specifically with the poly(A)-tail of messenger RNA (mRNA). Thus only 
stably transcribed genes are part of the cDNA pool generated by the reverse transcriptase 
polymerase (virus derived polymerases).  
Maximally 5µg of total RNA were used for pre-annealing of 0.5µg oligo dT [5min, 70°C] in a reaction 
volume of 20µl. After 1min on ice the premix (buffer, RNase inhibitor, dNTPs) was added an 
incubated for 5min at 37°C. The subsequently added reverse transcriptase polymerized at for 60 min 
at 42°C and additionally for 10min at 72°C. In that fashion synthesized cDNA was stored at -20°C prior 
to the use in PCR reactions (see chapter 3.2.3.2). 
3.2.3.2 Polymerase chain reaction (PCR) 
The Polymerase chain reaction was first described in 1986 (Mullis et al, 1986). It is until now routinely 
used in laboratories for almost exponential DNA amplification of a specific sequence. It involves 3 
consecutive steps which are repeated several times (cycles, n): strand separation (denaturation), 
primer annealing and elongation (polymerization).  
The target sequence is encoded on the added template which can be genomic dsDNA, cDNA or even 
whole cells (colony PCR). Prior to the Primer annealing step an obligatory denaturation step is 
performed to trigger strand separation. For each amplification reaction of a certain DNA fragment 
two primers are designed for either leading or lagging strand (double stranded cDNA exists from the 
beginning of the 2nd amplification round). Primer for sequencing (see chapter 3.2.4.2) and cloning 
(see chapter 3.2.3.4) design was performed regarding six properties: 
- 18 to 24 nucleotides in length with a GC-content of 40% to 60%  
- Strong 5’ (GC-rich), weak 3’ (AT-rich) binding 
- Melting temperature between 50 to 60 °C (insofar as possible) 
- No primer dimer or palindromic (self annealing) sequence 
- Uniqueness of the primer sequence (BLAST) 
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Processive DNA polymerases with high accuracy derived from thermostable organisms are used to 
polymerize dNTPs, starting from the 3’ OH-ends of specifically designed primer oligonucleotides 
according to the complementary template sequence. The denaturation and elongation time, if 
necessary also the annealing temperature, were set according to manufacturer’s specifications. With 
the beginning of the 3rd cycle the PCR works with an exponential (2n, optimal conditions postulated) 
rate of amplification of a certain DNA fragment with a distinct size (number of base pairs, see chapter 
3.2.4.1).  
Reactions were done in a volume of 50µl and an average PCR program was configured in the 
following fashion (insofar as applicable): 
- 98°C, 30s initial denaturation 
- 98°C, 20s denaturation  
50-60°C, 20s primer annealing  
72°C, 3.5 min elongation  
- 72°C, 10min remaining elongation 
3.2.3.3 Site directed mutagenesis (Quick change) 
Site directed mutagenesis is a PCR application (see chapter 3.2.3.2) and used for specific mutagenesis 
of one or two adjacent bases of a protein coding DNA sequence in order to introduce point 
mutations and thus change the amino acid sequence. 125 ng of cloned plasmid vectors (see chapter 
3.2.3.4) were used as template. A complementary primer pair was designed to anneal as >30mer, at 
least 15 nucleotides flanked up- and downstream of the position of interest, according to leading 
(for) and lagging (rev) strand sequence. The PCR reaction was performed with an extended 
elongation time in order to amplify the whole plasmid (18 cycles). After the PCR reaction took place, 
a DpnI restriction digestion was performed [20U, 2h, 37°C] followed by heat inactivation [20min, 
80°C]. DpnI is a type II restriction endonuclease that is able to cut methylated DNA, thus only the (not 
mutated) template DNA. Bacterial transformation (see chapter 3.1.5) was done for clone selection. 
3.2.3.3.1 Restriction digestion 
Either DNA fragments or plasmid vectors were digested with appropriate restriction enzymes 
according to the design of the cloning strategy (see chapter 3.2.3.4), in volumes of 50µl or 100µl, 
respectively. Suitable buffers for single or double digestions were used according to the enzyme 
providing company’s description. Restriction digestions were performed o/n with 30 units per 
enzyme at 100% activity in the relevant buffer. Lower activities led to higher input of enzyme. Finally 
the reactions were precipitated (see chapter 3.2.1.1) and the DNA resuspended in an appropriate 
volume prior to gel extraction (50µl, see chapter 3.2.2.1). 
35 cycles 
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3.2.3.3.2 Dephosphorylation 
Digested vectors (see chapter 3.2.3.3.1) were dephosphorylated to prevent re-ligation of the 
linearized vector. 20µg of the plasmid DNA was used for the treatment with calf intestinal alkaline 
phosphatase (CIAP). Reactions were carried out in a volume of 50µl and unit calculation was done 
according to the manufacturer’s instructions. The reaction was incubated [37°, 1h] following enzyme 
inactivation [65°C, 15min]. Afterwards, ethanol precipitation (see chapter 3.2.1.1) was done. 
3.2.3.3.3 Ligation 
DNA strands polymerize by covalent phosphodiester bonds between free 3’ hydroxyl and 5’ 
phosphate ends of adjacent nucleotides. The used T4 DNA ligase catalyzes this reaction in an ATP-
dependent manner and is used to conjugate linearized vectors and inserts (see chapters 3.2.3.3.1, 
3.2.3.4). The molecular vector: insert ratio of 1:3 was calculated with the help of an online tool and 
either 20 or 100ng of vector were used depending of the amount of insert DNA available. Reactions 
were carried out using 20U ligase in a reaction volume of 20µl either 1h at room temperature or 
overnight at 16°C. 
3.2.3.4 Molecular cloning 
Molecular cloning involves several subsequent steps and leads to artificial recombinant DNA 
plasmids used for overexpression of certain proteins in functional assays (see chapter 3.5). The 
cloning strategy, developed with the help of vector NTI, depends on the nature of the MCS of the 
vector and the sequence of the DNA molecule to insert. To make sure the used restriction enzymes 
do not cut inside the gene the whole sequence has to be checked for the absence of the appropriate 
restriction site(s). Forward and reverse primers were designed to amplify the DNA sequence of 
interest by PCR (see chapter 3.2.3.2) and restriction sites were attached to the 5’ end of the primers 
according to the need of the vector MCS. After vector (see chapter 3.2.2.2) and DNA fragment 
(insert) preparation (see chapter 3.2.2.1) the yielded nucleic acids were digested (see chapter 
3.2.3.3.1). The linearized vector was dephosphorylated (see chapter 3.2.3.3.2) and ligated with the 
insert DNA (see chapter 3.2.3.3.3). After transformation (see chapter 3.1.5) single colonies were 
analyzed by (colony) PCR (see chapter 3.2.3.2) and sequencing (see chapter 3.2.4.2). 
3.2.4 Analysis of DNA 
3.2.4.1 Agarose gel electrophoresis 
Agarose gel electrophoresis is a tool to separate DNA molecules according to their shape 
(supercoiled, coiled or linear) and most importantly size (bp). Nucleic acids are highly negative 
charged and migrate in an electric field towards the anode through the homogeneous agarose gel 
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matrix with a certain speed proportional to their lengths. DNA fragments either yielded by PCR (see 
chapter 3.2.3.2) or restriction digestion (see chapter 3.2.3.3.1), and also linearized vectors, were 
utilized in agarose gels of different concentrations (w/v) of 0.7% to 2.0% according to their expected 
size, e.g. 5kbp plasmids or small 50bp fragments, respectively. Gel electrophoresis was used for 
analytical questions (10µl volume per probe) or preparative application (50µl volume), the latter 
prior to gel extraction (see chapter3.2.2.1) and ligation (see chapter 3.2.3.3.3). At least one 
convenient DNA ladder (4µl) was used in a single lane for size discrimination of the different 
fragments. Before loading of samples on the gel they were mixed with an appropriate volume of 6x 
loading dye. TBE was used for gel preparation and as running buffer and consequently to establish 
the electric field, voltage 70 – 130 V, between cathode and anode. The gels were incubated in a 
0.01% (v/v) ethidium bromide bath (a DNA intercalating agent) for 5min. The uptake of this 
fluorescent dye and hence DNA fragments were visualized using a 312nm UVA lamp. 
3.2.4.2 Sequencing 
Sequencing was developed as chain termination method by Frederick Sanger and colleagues (Sanger 
et al, 1977). In principle, it works like a PCR (see chapter 3.2.3.2) and uses, beside normal dNTPs, in a 
proportion of 1% dideoxynucleotides (ddATP, ddCTP, ddGTP, or ddTTP) which lack the 3‘ hydroxyl 
group and hence are deficient in polymerization. The traditional version involves PAA-gel 
electrophoresis for separation of the randomly chain disrupted DNA fragments of each reaction with 
one of ddNTPs. According to the fragment length, positions of the respective nucleotide can be read 
out. The modern version of Sanger sequencing utilizes labeled ddNTPs with 4 different fluorescent 
dyes all emitting light at diverse spectral colors. This allows polymerization reactions for all four 
nucleotides in one tube and discrimination by excitation of these dyes by certain wavelengths using a 
capillary sequencer with a laser and fluorescence detector.  
Reactions were carried out in a volume of 10µl using beside the appropriate volume of buffer and 1µl 
Big Dye Ready reaction Mix (of the corresponding Kit; incl. polymerase), 300-500ng of plasmid 
template DNA (~9 kbp) and 5pmol of the required sequencing primer.  A standard sequencing 
reaction was performed with the following program: 
- 96°C, 30sec 
- 55°C, 15sec 
- 60°C, 4mins 
Afterwards, the reactions were alcohol precipitated (see chapter 3.2.1.1) and the pellet was gathered 
in 10µl Hi-Di formamide. The DNA sequence (chromatograph) was analyzed with Chromas Lite. 
26x 
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3.3 Cell culture methods 
3.3.1 Culture of cells and preparation of primary cell cultures 
Adherent primary fibroblasts were obtained from skin punch biopsies of healthy donors (wildtype) or 
patients (XP172MA) ordered at the Coriell Cell Repositories (XP20BE).  Hair, fat, and keratinocytes 
were removed from human skin probes which were then cut into small pieces of about 1-4 mm2. 
These slices were arranged all over the entire area of a 175 cm2 culture flask with gaps of several 
centimeters in between in every direction. After short desiccation incubation [15 min] at room 
temperature with open lid under the sterile bench, 25 ml of DMEM cell culture media (complete) 
was gently pipetted into the flask followed by incubation for at least one week without touching. 
All cultures, also purchased XP20BE cells, were incubated in a humified atmosphere at 37 °C and 5 % 
CO2 until they reached confluency. Afterwards they were trypsinized at 37°C for 5 min with an 
appropriate amount of trypsin (ground had to be covered). This reaction was stopped using 2.5-fold 
FBS-containing DMEM media followed by centrifugation [1000 rpm, 5min] and pellets resuspended 
in adequate DMEM or PBS volumes. The cells were either used for freezing (see chapter 3.3.2), cell 
counting (see chapter 3.3.3), or functional assays (see chapter 3.5). The re-seeding of primary 
fibroblast was performed with a cell density of at least 40% confluency. 
3.3.2 Freezing and thawing cells 
In order to freeze primary fibroblasts for later thawing and re-seeding only early passages (as far as 
passage 7) of confluent cell culture flasks were trypsinized at 37°C for 5 min with an appropriate 
amount of trypsin (ground had to be covered), centrifuged [1000 rpm, 5min] and resuspended in 1ml 
DMEM (complete). Afterwards 0.5ml were mixed with 0.5ml freezing medium in precooled cryo 
tubes and after scarfing subsequently frozen cautiously o/n in cryo 1°C cooler filled with 2-propanol 
at -80°C (approximately 1 °C/min). On the next day the cryo tubes were transferred into cryo boxes in 
liquid nitrogen for permanent storage at -196°C. 
For thawing of cells the stored cryotubes were gently de-frosted at room temperature and directly 
transferred into 10ml DMEM (complete) and subsequently centrifuged. The supernatant was 
decanted, to dispose the DMSO in the freezing medium, and the sediment was resuspended in an 
appropriate volume of DMEM (complete) prior to re-seeding in cell culture flasks or cell counting 
(see chapter 3.3.3). 
3.3.3 Cell counting 
To perform functional assays (see chapter 3.5) cells had to be seeded in a certain density in 24-well 
plates (approximately 40-50% confluency) and therefore the cell number was calculated using a 
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Neubauer cell counting chamber. Therefore 10µl of the cell suspension was mixed with 90µl 
trypanblue by pipetting several times, a glass cover slip was put on the Neubauer chamber and 10µl 
were of the mixture were used for counting. Four large squares (each one mm2) were counted, in 
total a volume of four mm3, and the cell number was multiplied by 2500 to estimate the total 
number per ml and again by 10 because of the dilution factor in trypanblue. The Neubauer chamber 
was cleaned in water and 70% ethanol. 
3.3.4 Transient transfection 
Transient transfections were carried out using the nonliposomal lipid Attractene, a transfection 
reagent provided by Qiagen. It forms complexes with plasmid DNA which are assimilated by 
eukaryotic cells like micelles via endocytosis. Therefore cells were seeded, 20000 cells per well in 24-
well format or 9*105 in petridishes, respectively (see chapter 3.3.1), and incubated o/n for adhering. 
On the next day total either 250ng or 4µg of one or more plasmids were diluted in DMEM to either 
60µl or 300µl final volume, either 0.6µl or 15µl of Attractene was added and instantly vortexed for 
several seconds in either 24-well or petridish format, respectively. During the incubation time of 15 
minutes at room temperature the wells were soaked and filled with 500µl fresh DMEM (complete). 
Afterwards the plasmid DNA containing transfection mix was put drop wise onto the cells and 
incubated in a humified atmosphere [5% CO2, 37°C] for five to six hours. The medium was removed 
and the wells filled with ~1ml of fresh complete DMEM and incubated two or three days, to allow 
(over-) expression of the recombinant proteins (see chapter 4.2.1).  
3.4 Biochemical methods 
3.4.1 Preparation of whole cell protein lysates 
After harvesting using trypsin (see chapter 3.3.1), the cells were washed twice with PBS and a 
subsequent centrifugation step [5Min, 4000rpm]. The resulting pellet was resuspended in a small 
volume of a PMSF and proteinase stop containing PBS buffer. In an iterative cycle of three times 
repeating a freeze-thaw step, in the liquid nitrogen bath and on ice, respectively, was performed. 
This step lyses the cells and prepares the proteins. Subsequently centrifugation follows [10min, 14 
000rpm, 4°C], which leads to the pelletization of cell debris and the dissolving of the proteins in the 
buffer. The supernatant was transferred into a new cup and photometrically quantified by the 
Bradford method (see chapter 3.4.2) (Bradford, 1976). The protein lysates were adjusted with an 3% 
SDS and 10% β-mercaptoethanol containing SDS page sample buffer and boiled at 95°C for 10min. 
Afterwards the yield was stored at -20°C. 
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3.4.2 Bradford protein quantification method (Bradford, 1976) 
For photometric quantification of protein concentrations, 1µl of protein lysate (see chapter 3.4.1) 
was mixed with the ready to use Bradford solution according to the manufacture’s advice and 
photometrically measured (OD595). Concentrations were normalized with the help of a BSA 
calibration curve (serial dilutions, 0-10μg/ml).  
3.4.3 Polyacrylamide gel electrophoresis (SDS-Page) (Laemmli, 1970)  
Proteins were separated by size in an electric field using SDS-Page (polyacrylamide gel 
electrophoresis). The SDS molecule, a negatively charged strong detergent agent, disturbs via its 
aliphatic tail the tertiary structure of proteins and transfers a negative overall charge to each protein. 
This enables a fractionization mainly by size according to the molecular weight (kDa) during 
electrophoresis. Prior to each supply of the samples (see chapter 3.4.1) to the gel, the probes were 
boiled (95°C) for 5min, again. The Biorad Mini Protean Tetra Cell system with a precast 4 % to 15 % 
polyacrylamide gradient Mini TGX gels were used according to manufacturer’s instructions. 
3.4.4 Western Blotting 
For immunochemical analysis the separated proteins in a SDS-Page gel (see chapter 3.4.3) are 
transferred (“blotted”) onto a nitrocellulose membrane. In analogy to the technically related method 
used for blotting of RNA onto membranes, developed by the British biologist Edwin Southern, the 
method described here was named “western blot”. 
The Biorad Transblot Turbo System was used to perform a semidry-blot with a current of 0.6A and 
maximal voltage of 12V for 10-15min. A Ponceau S staining of the SDS gel was performed to check for 
the integrity of the protein transfer. After blotting, the nitrocellulose membranes were incubated 
with blocking solution (Western Breeze kit) for 1h. As well as mono- and polyclonal antibodies 
diluted in blocking solution (concentrations see Table 4) were incubated together with the 
membrane overnight at 4°C (shaking). Afterwards the membranes were washed four times for 5min 
with washing solution and incubated with the secondary antibody (anti-mouse or anti-rabbit) for 
30min at RT. Further washing (four times for 5min and rinsed two times with aqua bidest) 
subsequently follows the adding of the chemiluminescent substrate. The LAS4000 was used for the 
detection of the chemiluminescent signal (Image reader for 30sec – 5min using the Increment Super 
setting). Bands were densiometrically quantified using Image J. Normalization was performed using 
the β-Actin housekeeper.  
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3.5 Functional Methods 
3.5.1 Host Cell Reactivation assay (HCR) 
The Host Cell Reactivation (HCR) reporter gene assay measures the Nucleotide excision repair (NER) 
in actively transcribed genes. This reporter gene assay deploys the defect expression of (unrepaired) 
(UV-) damaged cDNA sequences (Protic-Sabljic & Kraemer, 1985) as readout for the NER capacity and 
is by default used for complementation group assignment of XP patients. Moreover, it can be used 
for either DNA repair capacity assessment of different fibroblast cells or, like it was done during this 
thesis, of transfected (repair-) gene variants in NER deficient patient cells. 
XPG deficient XP20BE cells (see chapter 1.4) and, as a positive control, wildtype fibroblasts were 
seeded (see chapter 3.3.1) and (among other complementation plasmids) transfected (see chapter 
3.3.4) with plasmids coding for firefly (100ng) and renilla (50ng) luciferases. The plasmid coding for 
firefly luciferase is divided into two fractions prior to transfection. One fraction is irradiated with 750 
J/m2 of UVC light, a second fraction stays untreated. For irradiation, the plasmid-containing solution 
(250ng/µl) was drop wise (~3-4µl per drop) distributed over the surface of the petridish. The always 
unirradiated renilla luciferase serves as control for normalization of transfection efficacy and 
transcriptional activity of the respective gene variants. Additionally, a complementation plasmid 
(100ng) was added which was either an empty vector (negative control in XP20BE or in wt-
fibroblasts, too keep luciferase plasmid concentrations unaltered), wt-XPG or an XPG-variants (see 
chapter 4.2.1). 
After an incubation time of three days, which allows sufficient repair of the photoproducts created 
by UVC-irradiation and protein expression of the luciferases, the wells were washed with 1ml PBS 
and lysed in 80µl of a special lysis-buffer provided by Promega’s HCR kit [45min, RT]. Thereafter, the 
cells were scraped off and 40µl of each well was used for luminescence measurements in a white 
GlomaxTM 96 microplate. Here 80µl of each luciferase substrate are subsequently added and 
luminescence is quantified using the GlomaxTM luminometer (in RLUs). The buffers provided by 
Promega are designed for successive measurement of both luciferases, meaning the firefly substrate 
(beetle luciferine) contains a stop-solution to quench the luminescence after the measurement, 
before the renilla substrate (coelenterazine) was added. Thus it is possible to measure both 
luciferase activities in one well. 
The relative repair capacity is estimated using this formula: 
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The estimated mean values depicted in the figures derived from at least nine independent 
experiments. The errorbars were calculated using error propagation of the SEM of each fraction 
(normalized damaged and undamaged). For statistical analysis the student’s T-Test was performed. 
3.5.2 Unscheduled DNA Synthesis (UDS) 
Unscheduled DNA Synthesis (UDS) was first published in the late 1960s (Cleaver, 1968; Painter & 
Cleaver, 1969) and is a method for (quantitative) measurement of DNA repair synthesis in non-
dividing cells. It used incorporated radioactive labeled nucleotide analogs as marker for DNA 
synthesis after damage and was since that time a tool for complementation group assignment of XP 
patients (Lehmann & Stevens, 1980). This method was further improved (Limsirichaikul et al, 2009) 
and nowadays utilizes the terminal alkyne EdU, a thymidine analogs which is able to covalently bind 
to an Alexa Fluor®488 azide via a copper-catalyzed click reaction. This in turn can be visualized by e.g. 
a fluorescence microscope (Chehrehasa et al, 2009). 
On the first day 20 000 cells have been seeded (see chapter 3.3.1) on round glass cover slips in 24-
well plates and were incubated until the next day [37°C, 5%CO2]. All buffers and solutions used 
during the procedure had to be prepared according to manufacturer’s instruction (Click-iT EdU Alexa 
Fluor 488 Imaging Kit). 48 hours after transfection (see chapter 3.3.4) the UDS assay starts directly 
with the UVC irradiation (20 J/m2) of the cells to induce UV damages in the genomic DNA. Therefore 
the medium was soaked off the wells and the cells were washed once with PBS and soaked again. 
Subsequently, the irradiation was carried out without any liquid on the cells to avoid refraction of the 
UV light. EdU was added to DMEM without any accessories, mainly without FBS, in a concentration of 
10µM (1:1000) and 500µl were put on the cells per well. During the following incubation [2hrs, 37 °C, 
5% CO2] the thymidine analogs were incorporated into the DNA in the course of (repair) synthesis. 
After washing the cells with PBS three times they were prefixed with 0.5ml sucrose-solution per well 
for 20min at room temperature. After washing with PBS (3 times) cells were blocked with 10% (v/v) 
FBS in PBS for 30min at 37°C. During this blocking step, maximally 15min prior to use, the reaction 
cocktail for the copper-catalyzed click reaction was composed according to protocol provided by life 
technologies (in the dark). In case of sole used Alexa Fluor® 488 azide (dissolved in 100µl DMSO) 50% 
more of it, compared to the amount in the Click-It EdU kit, were added. After soaking the blocking 
solution, contrary to the manufacturer’s instructions, 250µl of the cocktail reaction were used per 
well and incubated for 30min at room temperature. After washing the cells three times with PBS-
Tween a terminal fixation step is performed with 3.7% PFA for 20min at room temperature. Finally, 
cells were washed with PBS again three times and the glass cover slips were put upside down onto 
object slides prepared with one drop, big as a pinhead, of DAPI-containing mounting medium. After 
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affixing the glass cover slips onto the object slides, using a clear nail polish, the probes were dried 
and kept at 4°C over night. 
For visualization of UDS the object slides were put on a fluorescence microscope and pictures were 
made using the Axiovision software and appropriate filters for Alexa Fluor®488 and DAPI with an 
exposure time of 7000ms and about 100ms, respectively. The pictures were automatically merged by 
the program.  
        
Figure 15: Measurement of Unscheduled DNA synthesis (UDS) 
Description: yellow arrows = measurement followed by subsequent cytoplasm fluorescence 
measurement of the corresponding cell for subtraction. Red arrows = excluded from measurement 
(S-phase nuclei and unspecific cell structures). Pink arrows = excluded from measurement (missing of 
DAPI staining). Brown arrows = excluded from measurement due to graining likely marking 
replication, that just started had started.  
 
Photoshop® CS3 was used for quantification. The monograph (black/white) picture of the FITC 
channel (Alexa Fluor®488) of each slide was used and the gray level per square pixel in nucleus and 
cytoplasm (auto fluorescence) was estimated per cell and subtracted from each. This gains net 
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intensity of DNA repair synthesis. In this context DAPI served as nuclear stain for orientation. Nuclei 
in s-phase, which had an obviously strong glow, were excluded from the measurement. Each result 
was quantified as the mean/median whereat minimum 300 cells (nuclei) were analyzed, derived 
from at least three independent experiments. For statistical analysis the Mann-Whitney-U-Test for 
abnormally distributed values was used. 
3.5.3 Immunofluorescence  
Indirect immunofluorescence is a widely used technique that utilizes primary antibodies (see Table 4) 
to detect specific target antigens and, targeting these, fluorescent-labeled secondary antibodies (see 
Table 5) for visualization (Odell & Cook, 2013).  Target antigens are either conformational epitopes, 
e.g. the tertiary structure of proteins or structures like DNA UV damages, or linear epitopes, the 
primary amino acid sequence of certain peptides or proteins.   
In order to perform Immunofluorescence analysis adherent fibroblast cells, wildtype or XP20BE, were 
seeded on glass cover slips in 24-well plates (20 000 cells per well, see chapter 3.3.1) and transfected 
(see chapter 3.3.4) with the desired XPG-variant or the empty vector on the next day. An incubation 
time of 48 hours ensures the adequate (over-) expression of the proteins. 
Thereafter the conditioned medium was soaked off and preserved for later, the cells were washed 
once with PBS. Prior to UVC irradiation the cells were wetted with 1µl PBS and an isopore membrane 
(5µm) was applied onto the cells. This membrane contains tiny holes whereby punctual UV damages 
(spots) are introduced into the cells nuclei (DNA), which serve e.g. as locations for NER factor 
recruitment (Zorn et al, 1979). Irradiation was carried out with a UVC source and energy of 150 J/m2. 
Directly after irradiation the kept conditioned medium was pipetted into the wells (500µl per well), 
the isopore membrane was removed and the different wells were incubated for the estimated 
timeline [37°C, 5% CO2].  
At the particular points in time, the cells were washed three times with PBS and fixed with 3.7% PFA 
supplemented with 0.1% Triton X-100 or ice cold methanol (PCNA staining) for 15min at room 
temperature. (At this stage an additional optional step can be performed. The appliance of a signal 
enhancer (life technologies) [diluted 1:1 in bidest, 200µl/well; 30min at RT], but this was not done 
during this thesis.) After washing, three times with PBS, a DNA denaturing step [20min, RT] follows. 
In case of DNA damages (6-4PP or CPD) 2M HCl was used, 0.2M NaOH during triple staining (see 
chapter 3.5.4). Next the samples were washed extensively with PBS (at least 5 times) and 
subsequently blocked with 10% FBS in PBS for 30min at 37°C to avoid unspecific antibody binding. 
Further the cells were washed again with PBS (three times), the primary antibody was applied, as 
indicated (see Table 4), onto the cells and incubated [30min, 37°C]. Followed by a 3x washing step 
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with PBS-Tween the secondary antibody, targeting an epitope of the primary antibody’s species, was 
diluted as indicated (see Table 5) and disposed over the samples and incubated [30min, 37°C]. In case 
of 6-4PP staining a third “antibody” was used. The well established biotin-streptavidin signal 
enhancing mechanism was implemented. Herein, a biotinylated secondary antibody is recognized by 
a fluorescent label streptavidin molecule. After incubation with the labeled antibodies the cells were 
washed extensively (three times PBS-Tween, 2 times PBS) and subsequently mounted using an 
appropriate mounting medium. A clear nail polish serves as glue for fixing the glass cover slips onto 
the object slides. Pictures were taken using Axio M1 fluorescence microscope and the corresponding 
filter set to the fluorescent dye of the secondary antibodies (plus Axiovision software). 
3.5.4 Triplestaining – simultaneous detection of DNA damage, DNA repair synthesis and 
PCNA recruitment (Triple-IF) 
The Triplestaining (Triple-IF) is a combination of UDS (see chapter 3.5.2) and immunofluorescence 
(see chapter 3.5.3) and is, in this fashion presented here, conducted the first time ever. It allows 
simultaneous investigation of repair synthesis and recruitment of NER factors to sites of DNA damage 
in living cells.  
After seeding cells (see chapter 3.3.1) prior to transfection (see chapter 3.3.4) an incubation of 48 hrs 
[37°C, 5% CO2] ensures proper (over-)expression of the relevant proteins. Before the procedure 
starts with the prefixing step of UDS (see chapter 3.5.2) the irradiation was carried out with 5µm 
isopore filters like it is done prior to immunofluorescence staining (see chapter 3.5.3). Additionally, 
the pre-fixed cells were washed twice with ethanol to ensure the removal of superfluid pseudo-
liposomal complexes (due to transfection) with absolute and 70% ethanol respectively for five 
minutes. Like UDS, cells were blocked with 10% FCS prior to the adding of the UDS reaction cocktail, 
but in contrast to the UDS, the terminal fixation step was carried out using ice cold methanol [20min, 
RT], followed by a denaturing step using 0.2M NaOH [20min;RT]. In the following the respective 
primary antibodies against DNA damages (CPD) and proteins (PCNA) are added together, as mixture 
of the specified dilutions (see Table 4), to the cells prior to the adding of the fluorescent secondary 
antibodies. All washing, incubation and visualizing steps are done like denoted in the 
immunofluorescence protocol (see chapter 3.5.3).   
Analyzes was carried out using the Keyence microscope. Pictures of single cells were taken using the 
Z-stack (2-4 pictures) option independently in three channels. The wavelength of the channels was 
set according to the requirements of the secondary antibodies and UDS (see Table 5, see chapter 
3.5.2). Using the analysis software (BZII-Analyzer), Z-stack pictures were merged to single pictures. 
Afterwards, haze reduction (sharpening) was performed (just brightness, automatic). Subsequently, 
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the black balance option was used to blank the cytosolic background fluorescence (automatic, value 
always 128). This was performed separately for all three channels and the single pictures were 
overlayed to create a merge picture (see Figure 25). Red spots indicate CPD staining without UDS or 
PCNA recruitment. Yellow spots display a clear specific merge for CPD and UDS, which turns more 
into orange color if PCNA is also present. However, this should not be taken too serious, because it 
also can lead to misinterpretation because of the nuclear PCNA background staining.  
3.5.5 Post-UV cell survival estimation (MTT assay) 
Primary fibroblasts were seeded (see chapter 3.3.1) in a density of 3000 cells/well in 100 l culture 
medium on a 96-well plate. On the next day, the medium of the wells was soaked and washed, and 
the rows of the 96-well plate were incubated with an increasing dose (ranging from 4 up to 180 J/m2) 
UVC light. Subsequently, cells were incubated [37°C, 5% CO2, 48hrs] with fresh DMEM. Afterwards, 
15 l dye-solution [MTT (3-(4,5-Dimethylthiazole-2-yl)-2,5-diphenyl-tetrazoliumbromid)- containing] 
was added to each well and the plates were again incubated [37°C, 5% CO2, 4hrs]. In this time the 
cells are metabolizing MTT by the action of mitochondrial dehydrogenases resulting in a blue colored 
formazan salt. After four hours the reaction is stopped by adding 100 l Stop-solution (dimethyl 
sulfoxide or sodium dodecyl sulfate diluted in hydrochloric acid) to each well and insoluble formazan 
is dissolved into a colored solution. Subsequently, the plate was incubated over night at room 
temperature to achieve cell lysis (light protected). The absorbance at 570nm of each well was 
measured using the Tecan Elisa reader. According to the amount of formazan (metabolized MTT) the 
cell viability was estimated. The solutions from the colorimetric CellTiter96  Non-Radioactive Cell 
Proliferation Assay, provided by Promega, also called MTT-Assay, were used. 
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4 Results 
4.1 Identification of a novel XPG patient and the corresponding mutant allele 
with consequences for the functional XPG-TFIIH interaction 
The University medical center Göttingen (UMG) collaborates with the university clinic Mannheim. 
Prof. Ernst G. Jung is a specialist for Xeroderma Pigmentosum (XP) (see chapter 1.1) patients and 
established a XP cell- and database from 1970 until his retirement in the year 2000. We, the 
department of Dermatology at the university clinic Göttingen (UMG), continued his research. We 
assumed the cell- and database with already established 100 cases from Mannheim and further 
expanded it to about 150 patients to date.  
During the phenotype-genotype correlation studies I performed molecular and functional 
characterization of a patient with suspicion of severe XP/CS (see chapter 1.1.2). The 5-years-old 
Turkish girl (XP172MA) from a consanguineous family exhibits XP symptoms (e.g. freckling on UV 
exposed skin areas) as well as mental retardation, microcephaly, and cerebellar atrophy. We 
performed molecular-genetic analysis approved by our local ethics committee and according to 
Declaration of Helsinki principles.  
Primary XP172MA skin fibroblasts revealed a severely reduced post UV-cell survival as assessed by 
the post-UV survival assay (see Figure 16) (see chapter 3.5.5). The LD50 value calculated was 
extraordinarily reduced (4 J/m2 UVC) in patient’s cells compared to wildtype fibroblasts (175 J/m2), 
like it is characteristic for a serious XP disease. 
 
Further, the host cell reactivation (HCR) assay was used to determine the cellular NER capability (see 
chapter 3.5.1). Wildtype fibroblasts have a relative NER capacity of about 16% while the patient cells 
Figure 16: Post UV survival of 
XP172MA 
The cell metabolism of patient’s 
fibroblasts was highly reduced after 
exposure to UVC light in a dose-
increasing manner (0-180 J/m2). 12 
J/m2 UVC light is sufficient to 
decrease cell viability of XP172MA by 
90%. In contrast the viability of 
wildtype cells was unaffected at this 
dose.  
 
Results 
65 
exhibited a decreased repair capacity of only 0.1% (see Figure 17). Complementation using a 
wildtype XPG cDNA encoding expression vector for co-transfection resulted in an increased repair 
capacity of XP172MA cells of 10.5% close to normal repair level assigning the patient to the rare XP-G 
complementation group. 
  
Sequencing of chromosomal and complementary DNA (mRNA derived) (see chapters 3.2.3.1, 3.2.4.2) 
was performed to specify the disease-causing mutation responsible for XP172MA’s XP/CS phenotype. 
It revealed an unusual homozygous genomic deletion of approx. 6.7 kbp using g285for (ex1) and 
g870rev (ex6) primers (see Table 10). The deletion starts at the end of intron1-2 at position 7440 and 
ends in intron5-6 at position 14166, thereby retaining nine bases of intron5-6 (positions 141  44-
14152) (according to GenBank accession number NM.000123.2).  
Additional sequencing of the XPG cDNA, with the same primers mentioned above, identified two 
variants, resulting from the deletion of the exons 2-5 (see Figure 18) (see chapter 3.2.4.2). Both 
splicevariants comprise a deletion between exons one and five. Furthermore the PCR (see chapter 
3.2.3.2) with patient’s cDNA as template revealed a band approx. 450 bp shorter than wt, consistent 
with the sequencing result (data not shown).  
  
Figure 17: Assignment of 
XP172MA to XP Complementation 
group G 
Co-transfection of XP172MA cells 
with XPG cDNA expression vector 
increased the NER capability in a 
highly significant manner. 
In contrast to other results in this 
work, the HCR assay was carried 
out in 6-well format by using the 
lipofectamine transfection agent 
(Qiagen). 
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Figure 18: XP172MA alleles 
Variant one consisted of an in-frame deletion of the last four bases of exon 1 and the entire exons 2-
5. The predicted protein is truncated missing aa29-175. In variant two 36 more basepairs of exon 1 
were deleted together with exons 2-5 also leading to a truncated in frame XPG protein lacking aa17-
176.  
 
Several further arguments underline the correct identification of the disease-causing mutation in the 
XP172MA patient. Using Qiagen QuantiTect Primer Assays (annealing sequence in the N-terminus of 
XPG), designed to prime in the deleted stretch, zero mRNA expression was detected due to the 
missing template in the cDNA of the patient (data not shown). Furthermore protein expression of the 
longer variant was observed by western blotting, utilizing an anti-XPG antibody utilizing (Lehmann, 
2013) (see chapter 3.4.4). Janin Lehmann furthermore displayed in her master thesis (under my 
supervision) the nuclear localization of the GFP-tagged recombinant shorter XP172MA protein. Both 
findings clarify, that the corresponding protein is expressed in a stable fashion and does not underlie 
enhanced proteosomal digestion. Hence, the identified huge in frame chromosomal deletion is 
causes the XP/CS complex phenotype of patient XP172MA due to the non-functionality of the 
mutated XPG protein during NER. The combined XP/CS phenotype can be explained by missfunction 
of the XPG protein during transcription, especially displaying impaired TFIIH interaction (see chapter 
1.4).   
This shows the importance of genotype-phenotype correlation studies. Physiologically occurring XPG 
variants in humans demonstrate the clinical effects. Due to the patient XP172MA alleles, I have to 
narrow down the functional XPG-TFIIH interaction region (see chapter 5.2). These results will soon be 
available in the British journal of Dermatology (under revision). 
4.2 The functional interaction between PCNA and XPG is essential during NER 
The investigated XPG protein is multifunctional in several cellular pathways (see chapter 1.4). 
Furthermore, it administrates a lot of interactions with several proteins, e.g. PCNA (see chapter 
1.3.5). To shed a light on the functionality and interactions of XPG, I created, amongst others, several 
PCNA interaction compromising site specific mutants of XPG, including an ubiquitin interaction (see 
Table 14, see Figure 19) (see chapters 4.2.1, 3.2.3.4).  
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4.2.1 XPG mutants created and used during this study 
The XPG mutants created and used during this project as well as the corresponding domains of the 
proteins are marked in Figure 19. Quickchange mutagenesis was performed to create the in vitro 
endonuclease defective mutants E791A and D77A as well as the corresponding double mutant and 
E791A-FF (DM_E/FF) mutant. The PCNA interaction defective mutants FF and Del were a gift from 
Prof. Ronald Gary and subcloned into the same vector (pcDNA3.1 (+)), used for cloning of all XPG 
mutants (see chapter 3.2.3.4). Fen1 and D181A were purchased from addgene.org, a good 
expression level was detected using western blotting (data not shown). DNA2 and IsoVI were cloned 
from human cDNA with specific primers, IsoVI by Janin Lehmann under my supervision (Lehmann, 
2013). PIP and UBM single, double, and triple mutants were also mutated via quick change 
mutagenesis (see chapter 3.2.3.3). Table 14 and Figure 19 illustrate these features with regard to the 
consequences on protein level.  
Table 14: Recombinant mutants of XPG and other enzymes used during this thesis  
 
Nature Description Defect 
Full lenght XPG E791A, D77A Endonuclease defective XPG (Constantinou et al, 1999) 
 
DM_E/D Endonuclease defective double mutant E791A & D77A 
 
FF PIP-box mutated XPG F996A and F997A (Gary et al, 1997) 
 
DM_E/FF 
Endonuclease defective + PIP-box mutated double mutant 
E791A, FF 
 
UBM 
Ubiquitin Binding defective XPG, L196A and P197A 
(Fagbemi, 2012) 
 
PIP 
PCNA binding compromised XPG, PIP-N domain, P179A 
(Fagbemi, 2012) 
 
UBM-PIP 
Ubiquitin Binding defective + PCNA binding compromised 
double mutant UBM, PIP-N 
Truncated XPG Isoform VI (IsoVI) 
physiological relevant XPG splicevariant, 746aa (Lehmann, 
2013) 
 
Del artifically truncated XPG, 948aa (Gary et al, 1997) 
Other nucleases Fen1 Flap endonuclease 1, 42.5 kDa (380 aa) 
 
D181A Endonuclease defective Fen1 
 
DNA2 Nuclease/Helicase, 45 kDa 
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Figure 19: Mutated residues of XPG 
The names of mutants used during this study are depicted above, vertical lines indicate for the 
mutation sites, the dotted lines show sites of truncations (IsoVI additionally comprises 11 intronic 
residues depicted by the black arrow to the right) (references in text, see chapter 1.4.2).  
 
The expression of several mutants was exemplarily monitored on protein level using western blotting 
(see Figure 20) (see chapter 3.4.4). The test comprises wildtype XPG (WtXPG), ubiquitin binding 
defective (XPG-UBM), in all probability PCNA and ubiquitin binding defective (XPG-PIP-UBM), 
truncated variants of XPG (IsoVI, Del), as well as endonuclease defective XPG (E791A, D77A).  
 
Figure 20: Overexpression of XPG mutants in HeLa cells  
48h hours after transfection the cells were lysed and the proteins were harvested, 
electrophoretically analyzed and blotted for immunochemical analysis (see chapter 3.4.4). The XPG 
blot is depicted on top; β-actin for normalization is displayed on the bottom. The small black 
numbers indicate the x-fold expression enhancement after normalization in comparison to 
untransfected HeLa cells. XPG, has a molecular mass of 133 kDa, but migrates at a size of ~180 kDa 
due to its highly acidic patches (isoelectric change). The β-actin protein has a size of 47 kDa. Both 
truncated mutants also migrate higher than their predicted molecular mass. Green arrow = IsoVI 
(MW: ~82,5kDa), red arrow = Del (MW~100kDa). 
 
All cloned variants are overexpressed in the desired fashion in HeLa cells, quite differently, from 2 up 
to 30 fold compared to wildtype, whereas the poorly expressed endogen XPG of the HeLa control is 
not detectable at all (see Figure 20). The estimated expression level methodically depends on several 
factors (transfection efficacy, protein preparation efficacy, blotting efficacy) and the differences of 
the respective mutants will not be further discussed. The experiments were done in numerous 
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repeating (HCR) or with a high number of analyzed cells (UDS) to minimize the influence of 
methodically unavoidable differences (see chapters 3.5.1, 3.5.2). 
4.2.2 Immediate Unscheduled DNA repair synthesis (UDS) of XPG mutants 
In order to investigate the responsibility and ability of XPG to recruit PCNA and subsequently start 
DNA repair synthesis (UDS, see chapter 3.5.2), several XPG mutants were created and transiently 
transfected into XP20BE cells (see chapters 3.3.4, 4.2.1). The UDS assay was performed two hours 
after UV irradiation of these (probably) complemented cells and the amount of DNA synthesis within 
this short time was quantified. The depicted UDS levels in Figure 21 display the immediate repair rate 
in dependency of the XPG-mutants. 
 
Figure 21: UDS results of XPG mutants  
The grey bars represent the mean values of UDS (see chapter 3.5.2) of XP20BE nuclei two hours after 
irradiation. The cells were transiently transfected with several XPG mutants (see chapter 4.2.1).  The 
small black horizontal lines of each bar indicate the median value. Significance levels were correlated 
using the Mann-Whitney U-Test for abnormally distributed series of measurements (***=p<0.001, 
**=p<0.01, *=p<0.05, n.s. = not significant; e.v. = empty vector; DM = double mutant). The small fat 
vertical lines, in the left of each significance comparison, mark the reference group (see also Table 
14, Figure 19).   
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All analyzed XPG mutants display a significantly enhanced UDS level compared to the empty vector 
negative control (Del: p<0.01, all others: p<0.001; Mann-Whitney-U-test). IsoVI, a preselected 
isoform of XPG with NER capacity (using HCR, see chapter 3.5.1), is the exception in this case, with a 
non-significant outcome (Lehmann, 2013). However, a control of diluted IsoVI 1:2 with empty vector 
displayed a significant enhancement (p<0.001; Mann-Whitney-U-test) compared to the empty vector 
(see Figure 26). This fact probably displays the problems of cells due to overexpression of a 
recombinant protein. 
The comparison of the UDS median values after complementation in most of the cases shows a 
highly significant decrease of all mutants compared to the wildtype XPG positive control (DM_E/D: 
p<0.05, all others: p<0.001; Mann-Whitney-U-test). The wildtype XPG itself transferred about 40-50% 
activity to XP20BE cells, compared to WT fibroblast of a healthy donor (see Figure 26). However, this 
is in a range like it was expected with a transfection efficacy of about 50% (data not shown). 
All endonuclease defective mutants show a highly significant increase (p<0.001; Mann-Whitney-U-
test) compared to the XPG FF mutant (see Figure 21), which in turn is nonsignificantly different 
compared to the truncated XPG variants (Del, IsoVI) (Mann-Whitney-U-test). The double mutant FF-
E791A indicates no significant difference compared to the PIP-box FF single mutant (Mann-Whitney-
U-test). 
Both truncated proteins lack the I-domain (endonuclease) as well as the C-terminal canonical PIP-box 
(see chapter 4.2.1). Both XPG variants complement the UDS assay on the same level. IsoVI is not 
significantly enhanced compared to the empty vector (Mann-Whitney-U-test), whereas Del 
complements with the lowest significance of all complementations (p<0.01; Mann-Whitney-U-test). 
Taken together, the immediate DNA repair synthesis rate is mainly dependent on an intact PIP-box. 
Endonuclease defective mutants also show a decreased UDS rate compared to wildtype, 
nevertheless, UDS is still remarkably increased compared to PIP-Mutants or truncated XPG proteins 
(p<0.001; Mann-Whitney-U-test). 
To investigate the influence of the N-terminally located PCNA interaction domains, PIP-N and UBM, 
single, double, and triple mutants on the basis of wt-XPG, FF, E791A, and IsoVI were created (see 
chapters 3.2.3.3, 4.2.1, Figure 19). XPG defective XP20BE cells were transiently transfected (see 
chapter 3.3.4) with the mutant XPG cDNA expression vectors and analyzed regarding the immediate 
DNA repair synthesis response utilizing UDS (see Figure 22). 
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Figure 22: UDS results of PIP-N and UBM mutants  
A) XPG b) FF c) E791A and d) IsoVI were used as template for additional mutagenesis of the PIP-N and 
UBM domain of XPG (see chapter 4.2.1). The small black horizontal lines or the white box of each bar 
indicate the median value of UDS two hours after irradiation. Significance levels were correlated 
using the Mann-Whitney U-Test for abnormally distributed series of measurements (***=p<0.001, 
**=p<0.01, *=p<0.05, n.s. = not significant; e.v. = empty vector). The small fat vertical lines, in the left 
of each significance comparison, mark the reference group.   
 
Compared to wt XPG the single PIP-N mutation alone (see chapter 4.2.1) was sufficient to reduce the 
immediate UDS (see chapter 3.5.2) rate, measured two hours after UVC irradiation, in a highly 
significant manner (p<0.001; Mann-Whitney-U-test) (see  Figure 22a). The XPG-UBM mutant showed 
also a significant decrease compared to wt, but in turn highly significant increase compared to XPG-
PIP (p<0.001; Mann-Whitney-U-test). The double mutant XPG-PIP-UBM behaved like the XPG-PIP 
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single mutant. The PIP mutant showed a comparable low UDS level to the FF-mutation alone (not 
significant, Mann-Whitney-U-test), designating the residue P179 to a new essential factor for 
immediate UV irradiation response (see Table 14, see chapter 4.2.1).   
The postulated PCNA-interaction defective mutant FF was additionally mutated to the FF-PIP and FF-
UBM double as well as FF-PIP-UBM triple mutants (see Figure 22b). The UDS levels of both double 
mutants showed an even more impaired repair synthesis rate compared to the FF-mutation alone 
(p<0.001; Mann-Whitney-U-test). Surprisingly, the developed triple mutant displayed synthesis 
activity on the same level of the FF mutant alone.  
The addition of PIP- and/or UBM- mutations to the E791A mutant combines an endonuclease defect 
with the disturbance of interactions between PCNA or ubiquitin and XPG, respectively (see Figure 
22c). All mutants, whether double or triple, show a highly significant (p<0.001; Mann-Whitney-U-
test) decrease of UDS in comparison to the E791A mutation alone but significantly enhanced with the 
empty vector as the control group (E791A: p<0.01, all others: p<0.001; Mann-Whitney-U-test). The 
UDS rate in dependency of E791A-UBM is slightly significant increased compared to the E791A-PIP 
mutant (p<0.05; Mann-Whitney-U-test). Both PIP- as well as the UBM-mutation containing 
endonuclease defective mutants display a low DNA synthesis on FF level (no significant difference; 
Mann-Whitney-U-test). 
A really unexpected picture was displayed using PIP- and/or UBM single- or double mutants of the 
XPG Isoform VI depicted in Figure 22d. The splice variant IsoVI (see chapter 4.2.1) was selected 
during the master thesis of Janin Lehmann under my supervision with regard to the highest XP20BE 
complementation ability using Host Cell Reactivation (also see Figure 23) (Lehmann, 2013).  
The isoform itself displays only a weak, non significant increase compared to the empty vector 
control in this figure (Mann-Whitney-U-test). However, as mentioned before a control diluted with 
empty vector displayed a significant enhancement compared to the empty vector, in contrast to IsoVI 
alone (see Figure 26).  
Both mutations PIP and UBM as well as the double mutant shift the increase of UDS rate into a 
(partly highly) significant area (IsoVI-UBM: p<0.001, all others: p<0.01; Mann-Whitney-U-test). The 
statistical comparison between IsoVI and the particular PIP- and UBM mutants displayed no 
significant difference. Hence, all IsoVI mutants display about the same rate of UDS and are able to 
facilitate a reduced but sill significant DNA synthesis after UV irradiation on the same level like the FF 
mutant.  
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Taken together these results indicate an essential role of the N-terminally located PIP-N and UBM 
boxes of XPG. Due to the fact that there is no dramatic difference between the UBM and PIP 
mutations and as cumulative reducing effect of both mutations in concert was observed, it is obvious 
that these two domains act in concert. The significant UDS increase of the UBM mutant compared to 
PIP mutant in wt-XPG and E791A proteins possibly indicated for a more important support of the 
functional main PCNA recruiting domain (C-terminal PIP box) rather by the PIP-box than by the UBM 
box. The unexpected increase of UDS due to the FF-PIP-UBM triple mutant compared to the FF-PIP 
and FF-UBM mutants will be discussed later (see chapters 4.2.4, 5). The weak but detectable 
complementation ability of IsoVI utilizing UDS was, in contrast to all other XPG species, not further 
compromised by PIP or UBM mutations. The simplest solution to explain this fact is that it behaves in 
a different fashion than the normal XPG. 
4.2.3 Host cell reactivation assessment of XPG mutants 
Utilizing the UDS (see chapter 3.5.2) assay, I was able to investigate the immediate DNA synthesis 
after irradiation in dependency of multiple XPG mutants. However, I further analyzed how these 
mutants complement the XPG deficiency in XP20BE fibroblast cells  via transient overexpression and 
performance of the host cell reactivation (HCR) assay three days after transfection (see Figure 23) 
(see chapter 3.5.1).  
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Figure 23: Host cell reactivation of XP20BE cells by XPG mutants 
The black bars indicate the relative NER capacity of an UV irradiated Firefly reportergene plasmid 
compared to the unirradiated expression level (normalized to the cotransfected Renilla luciferase, 
see chapter 3.5.1) in dependency of various XPG mutants, three days after transfection. The error 
bars are calculated using error propagation of the mean values of normalized Firefly, either irradiated 
or not, due to statistical standard techniques. Significance levels are calculated using the Student’s T-
Test (comparison of two groups). The small fat vertical lines, in the left of each significance 
comparison, mark the reference group. Abbreviations: ***=p<0.001, **=p<0.01, *=p<0.05, n.s. = not 
significant; e.v. = empty vector; WT = healthy donor; DM = double mutant).  
 
XP20BE cells transfected with the empty vector showed no complementation ability at all, whereas 
the transfection of wildtype XPG complemented this defect, measured three days after transfection. 
Wildtype cells of a healthy donor displayed an even more increased NER capacity, which is due to the 
fact that recombinant XPG in cured XP20BE cells, in contrast to endogen XPG in wt cells, first has to 
be expressed and modified etc. to a certain extent before it is able perform NER. Furthermore, the 
transient transfection approach supplies 50-60% transfection efficacy (data not shown) (see chapter 
3.3.4). 
All full-length mutants (FF, E791A, D77A and their respective double mutants) increase the repair 
rate of the XPG deficient fibroblasts excessively in a highly significant manner compared to the empty 
vector (p<0.001; Student’s T-test). The truncated Isoform VI, preselected for NER activity, confirms 
that strong enhancement compared to the empty vector control (p=0.002; Student’s T-test). In 
contrast the artificially truncated XPG version Del is not able to complement.  
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Both FF-mutation containing clones were able to complement XP20BE cells to the same extent 
compared to wildtype XPG. Furthermore the D77A endonuclease defective mutant (mutation in N-
domain) displayed also no significant difference. In contrast, the E791A mutation in the I-domain of 
XPG reduces the NER capacity compared to wt XPG, whether alone or in combination with D77A 
(E791A: p<0.01, DM_E/D: p=0.06; Student’s T-test). However, due to the relatively low sample size in 
the case of DM_E/D (p-value 0.006), significance was only achieved in the case of E791A alone. The 
fact that the DM_E791A/FF double mutant behaves like wt XPG indicates the cure of E791A-caused 
impaired NER by the lack of the C-terminally located PIP-box. This accounts possibly for another 
factor, which is favorable able to recruit PCNA and to perform endonuclease cleavage. 
The endonuclease defective mutant E791A itself in turn revealed an increased NER activity compared 
to the truncated versions Del and IsoVI (p<0.001; Student’s T-test). IsoVI represents the weakest XPG 
variant, but is significantly enhanced capable of performing NER compared to Del (p<0.05; Student’s 
T-test). 
Taken together, these results indicate a strong influence on NER capability by the essential E791 
mutation to alanine and a detectable but significantly decreased activity of Isoform VI. The next 
figure displays the HCR analysis of several XPG PIP- and UBM mutants (see Figure 24, see chapter 
4.2.1). 
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Figure 24: HCR of PIP- and UBM mutants as well as the respective double- and triple mutants 
A) XPG b) FF c) E791A and d) IsoVI were used as template for additional mutagenesis of the PIP-N and 
UBM domain of XPG (see chapter 4.2.1). The black bars indicate the relative NER capacity of an UV 
irradiated Firefly Reportergene plasmid compared to the unirradiated expression level (normalized to 
the cotransfected Renilla luciferase, see chapter 3.5.1) in dependency of various XPG mutants, three 
days after transfection. The error bars are calculated using error propagation of the mean values of 
normalized Firefly, either irradiated or not, due to statistical standard techniques. Significance levels 
are calculated using the Student’s T-Test (comparison of two groups). The small fat vertical lines, in 
the left of each significance comparison, mark the reference group. Abbreviations: ***=p<0.001, 
**=p<0.01, *=p<0.05, n.s. = not significant; e.v. = empty vector; WT = healthy donor).  
 
Both, the PIP- and UBM mutation, decrease the XP20BE complementation ability of wt XPG (see 
Figure 24a) in a significant manner (XPG-UBM: p<0.001, all other: p<0.05; Student’s T-test). The 
displayed difference of reduced significance levels of all PIP mutants compared to the UBM mutant, 
are due to the relative low sample size of HCR measurements of the PIPs compared to all others. 
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Methodical difficulties during mutagenesis of this specific region lead only to the successful creation 
at the very end of the thesis. The PIP-, UBM-, and the respective double mutants all behaved in the 
same fashion like the endonuclease defective E791A mutant (no significant difference, Student’s T-
test).  
In comparison to the PIP-box mutated FF mutant (see Figure 24b), all further PCNA interaction 
impairing mutations, PIP- and UBM, particularly decrease the complementation activity of the FF 
clone to a very significant extent in the double mutants (p<0.001; Student’s T-test). Most strikingly, 
the triple mutant FF-PIP-UBM is not able to perform NER, whereas the respective single mutants 
complement on E791A level. 
The E791A mutation was combined with PIP- and UBM mutagenesis and also analyzed utilizing HCR 
(see Figure 24c). The PIP mutation had no influence on the behavior, indicated by the E791A-PIP 
double mutant compared to E791A alone. Though the E791A-UBM mutant and the triple mutant 
E791A-UBM-PIP decrease the observed NER capability in a weak and strongly significant manner 
(E791A-UBM: p<0.05, E791A-UBM-PIP: p<0.001; Student’s T-test), respectively. However, the E791-
PIP-UBM triple mutant shows no significant difference to the E791A-UBM or FF-PIP-UBM mutants, 
and behaved like the empty vector control (Student’s T-test).  
The XPG splice variant Isoform VI was also mutated via quick change mutagenesis in order to create 
single- as well as double mutants and analyzed with the HCR assay (Figure 24d). The performed 
mutagenesis displayed no significant difference of the respective mutants compared to Isoform VI 
(Mann-Whitney-U-test). However, the PIP- and UBM single mutants still statistically complement the 
XP20BE XPG deficiency (IsoVI-PIP: p<0.01, IsoVI-UBM: p<0.001; Student’s T-test) in contrast to the 
corresponding double mutant IsoVI-PIP-UBM which is not significantly different from the empty 
vector control (Student’s T-test). 
Taken together, these results indicate that FF sites are dispensable for complementation, but not for 
immediate DNA repair synthesis (see chapter 4.2.4). The mutagenesis of PIP-N and UBM confers 
complementation deficiency to XPG on the same level like E791A mutation. The simultaneous 
mutagenesis of three sites (FF-PIP-UBM, E791A-PIP-UBM) leads to the prevention or strong 
restriction of NER activity. Additionally, the N-terminal mutations of PIP-N and UBM display a 
synergistic effect, which leads to the suggestion that they act in concert.  
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4.2.4 Short summary of the quantitative results 
Table 15:  Lineup of XPG mutants  
XPG mutants are lined up regarding their classification of NER activities during the Host cell 
reactivation assay in comparison to the Unscheduled DNA synthesis measurements. 
 
 HCR UDS consistent 
Leer ↓ ↓ yes 
XPG ↑ ↑ yes 
FF ↑ ↘ no 
Del ↓ ↘ yes 
E791A → → yes 
DM_E/FF ↑ → no 
FF-PIP → ↓ no 
FF-UBM → ↓ no 
FF-PIP-UBM ↓ ↘ no 
E791A-PIP → ↘ no 
E791A-UBM ↘ ↘ yes 
E791A-PIP-UBM ↘ ↘ yes 
IsoVI (all mutants) ↘ ↘ yes 
 
In presence of wt XPG, the empty vector, isoform VI as well as most of the endonuclease deficient 
E791A mutants (except E791A-PIP) the HCR (see chapter 4.2.3) and UDS (see chapter 4.2.2) results 
show a similar picture (see Table 15). In these cases, the complementation ability was conferred or 
not regarding both activities: the immediate start of DNA repair synthesis and the termination of NER 
(accurate TCR) using either UDS or HCR, respectively (see chapters 1.3, 3.5.2, 3.5.1). 
All FF mutants (except FF-UBM-PIP) as well as E791A-PIP mutant display an inconsistent picture with 
a good complementation ability (HCR) but a compromised immediate start of DNA repair synthesis 
(UDS) (see chapter 4.2.1). The notion, that the E791A-PIP mutant is the only endonuclease defective 
mutant with a similar result, indicates the importance of the functional XPG – PCNA interaction for 
DNA repair synthesis.  
Furthermore, there is a decreased rate of NER activity (HCR) observed with rising numbers of 
interaction impairments (number of mutations) among the FF and E791A mutants. However, due to 
the fact that the FF-PIP-UBM mutant, comprising the highest number of PCNA-interactions impairing 
mutations including an ubiquitin interaction, showed a diverse picture with high UDS and low 
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complementation ability, I raise a model which involves the obligatory ubiquitination of PCNA and 
the recruitment of translesion polymerases.  
4.2.5 Estimation of simultaneous PCNA-recruitment and UDS synthesis at DNA damage 
sites in dependency of XPG mutants 
There is a discrepancy between immediate DNA repair synthesis on the one hand (UDS) and the TCR 
complementation ability (HCR) on the other hand by the FF clone and its respective mutants (see 
Table 15) (see chapters 1.3.4.4, 3.5.2, and 3.5.1). I investigated the PCNA recruitment to DNA 
damage and UDS in that spot separately at the same time. This was performed to exclude the 
possibility of PCNA recruitment but a stalled synthesis machinery due to the XPG defect. Figure 25 
shows Triple- Immunofluorescence staining (see chapter 3.5.4), in order to clarify the responsible 
interactions for PCNA interaction and/or start of synthesis in dependency of XPG and FF. 
 
Figure 25: Triple staining (Triple-IF) of wt and XP20BE cells at different points in time after UV 
irradiation  
A) WT fibroblasts, b) XP20BE + empty vector (e.v.), c) XP20BE + XPG, d) XP20BE + FF. Triple staining 
was performed like described in the methods section (see chapter 3.5.4). Red dots indicateUV 
derived DNA damages (CPDs), the green spots are UDS and the monograph picture displays PCNA. (h 
= hours, yellow scale = 20µm) 
  
In wildtype fibroblasts (see Figure 25a) as well as XPG complemented XP20BE cells (see Figure 25c) a 
clear merge between the DNA repair synthesis derived green UDS spots with the red cyclobutane 
pyrimidine dimers (CPD) (see chapter 1.2.3) spots, indicating DNA repair synthesis until this point in 
time after UVC irradiation (at all point in time 1.5 to 4.5h). Furthermore PCNA could be seen, to a 
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certain extent, co-localized with the UV lesion and the UDS incorporation (at point in time 1.5 and 
4.5h). Three hours after irradiation a clear CPD spot, marks the existence of DNA damage, and is 
observed as well as the UDS signal, demonstrating incorporated DNA nucleotides in this time period. 
No accumulated PCNA is observed at this point in time, independent of the PIP-box status of XPG, 
maybe indicating a periodical occurrence of repair (see Figure 25c, d).  
The empty vector control (see Figure 25b) displays neither UDS nor PCNA accumulation in merge 
with a CPD spot in the observed period. This reveals a XPG dependency of the cells to perform the 
triple staining observed in Figure 25 a and c.  
Surprisingly, the FF mutant (see Figure 25d) displayed a recruitment of PCNA as well as DNA repair 
synthesis activity like wt XPG. However, the difference between the quantitative UDS results (see 
Figure 21) and the qualitative triple IF assay is debated in the discussion (see chapter 5).  
Taken together, these results indicate the independency of the C-terminally located canonical PIP-
box for both, PCNA recruitment as well as DNA repair synthesis. However, an endonuclease defective 
XPG (E791A) or a truncated XPG isoform VI were neither able to recruit PCNA nor lead to DNA repair 
synthesis (data not shown).  
4.3 Investigations of other nucleases as a backup mechanism with regard to 
XPG Isoform VI 
In order to investigate the mechanism that enables the endonuclease defective and PCNA interaction 
compromised splice variant IsoVI of XPG to complement XP20BE cells (see chapter 4.2.3), I examined 
the effects of (co-)transfected candidate genes (see chapter 1.5, Table 14) on the UDS level two 
hours after irradiation. 
Single transfection of DNA2 or Fen1 (or its endonuclease defective mutant D181A) displays no 
significant difference in comparison to the empty vector (see Figure 26a) (Mann-Whitney-U-test). 
The IsoVI+e.v. (isoform and empty vector in a ratio of 1:2) positive control, as well as the transfection 
with wt-XPG and wt fibroblast cells transfected with the empty vector, show a highly significant 
increase of UDS levels compared to the empty vector (p<0.001; Mann-Whitney-U-test).  
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Figure 26: Assessment of UDS with respect to NER capability of Fen1 and DNA2 
A) Illustrates controls, b) co-transfections of IsoVI plus Fen1 and/or DNA2. The gray bars represent 
the mean values of UDS of XP20BE nuclei (see chapter 3.5.2). The cells were transiently transfected 
with several XPG mutants (see chapter 4.2.1).  The small black horizontal lines or white box of each 
bar indicate the median value two hours after irradiation. Significance levels were correlated using 
the Mann-Whitney U-Test for abnormally distributed series of measurements (***=p<0.001, 
**=p<0.01, *=p<0.05, n.s. = not significant; e.v. = empty vector). The small fat vertical lines, in the left 
of each significance comparison, mark the reference group. 
 
Figure 26b illustrates the effect of co-transfection of two or three plasmids at once into XP20BE cells. 
The transfection of three plasmids at a single blow is routinely done and works well in the context of 
the HCR assay (see chapter 3.5.1). The double transfection of Isoform VI with Fen1 or its respective 
endonuclease defective mutant D181A displays no significant difference compared to IsoVI alone and 
complements XP20BE cells (Mann-Whitney-U-test). The co-transfection of IsoVI and DNA2 reduces 
the complementation in a significant manner but still enables IsoVI to complement the XPG defect 
(both p<0.05; Mann-Whitney-U-test). The triple transfection of IsoVI, DNA2 and either Fen1 or 
D181A exhibits the clear result that the D181A mutant disturbs the DNA synthesis and thus 
complementation. 
Taken together, these findings give a hint for the NER activity of Isoform VI in dependency of the 
endonuclease activity of Fen1. Thus, Fen1 is maybe suitable for a backup endonuclease to overcome 
a partial XPG defect. 
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5 Discussion 
The XPG protein is a key player in cell nuclei, comprising endonucleolytic as well as structural 
functions during DNA repair and transcription (see chapter 1.4). The aim of this study was to survey 
the behavior of XPG during NER by  
- first, the exploration of the Xeroderma pigmentosum patient XP172MA in order to broaden 
and expand the spectrum of physiologically occurring XPG mutations as a model for XPG 
protein functions (see chapter 4.1), 
- second, the genetic characterization of the PCNA-XPG interaction in terms of the XPG ability 
to catalyze DNA repair synthesis and facilitate NER (see chapter 1.3.2). This comprises the N-
terminal PIP-UBM box as well as the C-terminal PIP-box (see chapter 4.2), 
- third, the study of an alternative pathway during the very last steps of NER in dependency of 
the presence of a functionally constricted XPG and the involvement of Fen1 and DNA2 (see 
chapters 1.5, 4.3). 
5.1 General remarks 
XPG is essential for nuclear function. It interacts with a lot of diverse proteins and plays a role in DNA 
repair and basal transcription (see chapter 1.4.1). In line with its functional relevance, XPG patients 
are very scarce, even among the rare hereditary recessive disorder Xeroderma Pigmentosum itself. 
Patients often comprise the more severe XP/CS phenotype depending on the length of the residual 
XPG allele.   
Furthermore, very little is known about the appearance of XPG during NER, amongst other reasons, 
because of no available crystal structure. Especially the picture of the PCNA - XPG binding originates 
from studies regarding Fen1 family members (see chapter 1.5.1.1). Critical questions remain 
unanswered, e.g. how many monomers of (ubiquitinated) PCNA are bound by XPG or if there is a 
possibility for a handover between the two separated XPG PCNA-interaction domains (see chapter 
4.2.1). However, XPG is designated to bind one monomer of PCNA in the depicted model and the 
ubiquitination of PCNA was assumed to be obligatory during (stalled) NER and is part of the 
regulation of interactions (see chapters 1.3.5, 1.3.6). 
XP20BE primary fibroblasts, used as the XPG deficient host during this study, comprises only a 
residual 138AA (and 11AAs) XPG allele and displays a good cell behavior regarding proliferation and 
cell stature in the early passages (4-7), followed by a rapid decrease in cell viability in the late 
passages (8-12). Presumably, this decrease rests on the essential status of XPG for the cell 
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metabolism, because XPG is a multiplayer with many interactions and functions, e.g. during 
transcription and DNA repair (see chapter 1.4). It is remarkable that the genotype of XP20BE resulted 
in a phenotype compatible with life. However, the XP20BE patient died after 6 years displaying 
severe CS symptoms and no skin cancers (Moriwaki et al, 1996).  
General remarks concerning the functional assays used during this thesis 
Host cell reactivation 
During Host cell reactivation (HCR) assays, the cells were transiently transfected with XPG (mutants) 
and reportergene expression plasmids (e.g. firefly luciferase) at the same time. Three days after 
transfection, the Transcription coupled repair (TCR) was measured as described (see chapter 3.5.1). 
The (potentially different) influence of the respective diverse XPG variants regarding transcription 
(see Figure 7) can be excluded. The arithmetical division of the damaged plasmid with an undamaged 
co-transfected second reporter gene plasmid, carrying the same promoter like the firefly plasmid, 
should be sufficient for normalization. The used dose during this approach is very high (750 J/m2, 
applied on naked DNA) and requires NER to repair error free in sufficient amounts. However, XP20BE 
cells transfected with the empty vector did not result in a detectable reportergene expression above 
background.  
Unscheduled DNA synthesis 
The Unscheduled DNA synthesis (UDS) of genomic DNA was measured after low dose UV irradiation 
(20 J/m2) directly applied onto living cells (see chapter 3.5.2). All cells in growth phase were 
measured (see Figure 15), but just half of the cells showed XPG-dependent DNA repair synthesis. The 
reason lies in the transient transfection approach. This - like it is postulated by the manufacturer of 
the transfection reagent (Qiagen) - normally leads to a transfection efficacy of about 50-60%, with a 
trend towards a decreasing rate using higher passages of the XP20BE cells (data not shown). The 
result was a population of abnormally distributed UDS value measurements.  
To overcome that deficiency in comparison to stable transfected cell lines used by other groups, at 
least 300 nuclei derived from at least three independent transfections were estimated per XPG 
mutant and an appropriate statistical significance test was performed (Mann-Whitney-U-Test).  
Additionally, every UDS nucleus measurement was subtracted with the respective cytosolic 
background fluorescence of the cell to yield a specific UV-dependent DNA repair synthesis rate. The 
influence of S-phase dependent DNA repair synthesis was excluded by omitting these cells as 
described (see chapter 3.5.2). The UDS rates reflect the presence of DNA synthesis until this point in 
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time, with no information about termination of NER, the length of the synthesized DNA stretch, or 
NER accuracy.  
Comparison of UDS and HCR 
To compare these two assays in summary, the UDS displays short term genomic DNA repair activity 
(two hours) with no regard to the length (bp) or correctness of the synthesis, whereas HCR measures 
the long term repair capacity (three days) of correct NER in a transcriptional context (reportergene 
plasmid, requires correct protein coding). This leads to the conclusion, that if there is any UDS 
measured in dependency of a certain XPG mutant, which was not able to complement XPG deficient 
cells by HCR, DNA repair synthesis (UDS) promotes no XPG cleavage (partial synthesis) or has to be 
error prone (see Table 15, see Figure 8, see chapter 1.3.6).  
Moreover, XPG acts at the very end of the NER pathway and plays a major role in both subpathways 
of NER, in GGR and TCR. However, due to its tight association with TFIIH it is probably recruited more 
easily if attached near to TFIIH in a transcriptional context. This would simplify complementation 
during HCR assays, not during UDS assays (see chapter 1.3.4).  
Triple-fluorescence staining 
The triple-fluorescence staining (Triple-IF) was established at the very end of the thesis with regard 
to the clarification of possible kinetic differences between PCNA recruitment and DNA repair 
synthesis (see chapter 3.5.4). The assay detects the local UV-derived DNA-damage (CPD), the PCNA 
sliding clamp and UDS at the same time in one cell. However, if any UDS is seen at any point in time, 
this accounts for the presence of PCNA prior to UDS with regard of its processive role during DNA 
synthesis (see chapter 1.3.5).  
The assay was conducted qualitatively and has been performed only once prior to the completion of 
this thesis. With respect to the quantitative approach of HCR and UDS and the transientity of the 
transfection approach, the Triple-IF results should not be overrated. Additionally, in contrast to 
normal UDS (20J/m2), Triple-IF deals with a high dose of local DNA damage (150J/m2) in the 
chromosomal DNA. One reason for the strong UDS at different points in time observed can be due to 
the presence of Exo1 during NER (see chapter 1.5.1.2). 
5.2 XP172MA provides insights into XPG-TFIIH interaction  
A new disease-causing allele was identified in the very rare XP/CS complementation group G, a novel 
and unusually large deletion mutation (genomic deletion of exons 2-5) leading to a truncated but in-
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frame XPG protein with stable expression and nuclear localization, but no functional repair activity 
(Lehmann, 2013; Schubert et al, 2013). 
Fibroblast cells of respective patient XP172MA, exhibited a reduced post-UV survival as it was 
expected with regard to the phenotype and previously reported by UDS results (3% of wildtype, data 
not shown) (see Figure 17). The viability of XP172MA fibroblasts was strongly impaired even at low 
doses of UVC irradiation with a LD50 value of 4J/m
2 and LD90 of 12J/m
2. In comparison to this, the LD50 
of WT fibroblasts was estimated at 180J/m2 (data not shown) whereas cells from XPC patients exhibit 
a LD50 value of about 30J/m
2. The striking impact of the loss of XPG function is quite obvious and 
consistent with behavior of, also severely affected, other XPG/CS patient fibroblasts utilizing the MTT 
assay, reported by our group before (Schafer et al, 2013a; Schafer et al, 2013b). However, the post-
UV survival reflects the overall ability of the cells to cope with UV-derived DNA damages and involves 
several cellular mechanisms (NER, DDR, and apoptosis). The viability after UV irradiation of XP172MA 
fibroblast cells was very low and consistent with the severe XP/CS phenotype of the patient. In order 
to specifically estimate the NER capacity of these cells, Host cell reactivation was performed. 
Patient XP172MA displayed a barely detectable NER value (<0.1%) and was assigned to the XPG 
complementation group via HCR (see Figure 17). The introduction of wt-XPG into the cells restored 
NER capability to 50-60% compared to wildtype, consistent with the observed transfection efficacy 
during this transient approach and clearly demonstrating XPG deficiency. Additional experiments 
where the larger XP172MA allele (see Figure 18) was cloned out of the patient’s mRNA (cDNA) of the 
patient  into an expression vector and investigated regarding the complementation ability of the 
mutant protein in another XPG deficient cell line (XP20BE) under my supervision, revealed no 
complementation ability on empty vector level (Lehmann, 2013). This clearly suggests that the 
observed XP/CS phenotype, derived from the defective XPG protein, is independent of the genetic 
background.  
To further characterize the XPG patient mutation which is disease-causing in XP172MA, sequencing 
on genome and mRNA (cDNA) level was performed. The sequencing results showed the occurrence 
of a minor and a major variant in the patient (see Figure 18). Both variants exhibit in frame exon 
skipping from exon1 to exon6 due to a huge homozygous chromosomal deletion (6.7kbp). The longer 
variant, expressed to minor extent, showed a deletion of the respective amino acids 29-175. The 
shorter variant, expressed to the major extent, retained only 17 amino acids of exon 1. It remains 
speculative, but the low expression-level variant is possibly due to splice variation, because of the 
homozygous nature of the deletion.  
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As mentioned above, we decided to investigate the behavior of the larger variant during the master 
thesis of Janin Lehmann. It was shown in another study that a XPG splicevariant, expressed to a 
smaller extent, was able to rescue the phenotype to a certain extent (Thorel et al, 2004). Consistent 
with the severe XP/CS phenotype of the patient no NER activity of the cloned variant in cross-
complementing experiments was detected (HCR, no complementation (like empty vector),(Lehmann, 
2013)). 
There is a greatly established genotype-phenotype correlation of the severe XPG/CS phenotype with 
the deficiency of the XPG patient’s gene products in TFIIH binding (see chapter 1.4.1). With regard to 
the reduced post-UV survival and the compromised NER capacity of the living cells, I propose that the 
disease-causing mutation of this patient leads to the inability to bind TFIIH (see chapter 1.1.2). The 
interaction of the N-terminus of XPG with TFIIH (XPB, XPD) has been earlier investigated during in 
vitro studies (Iyer et al, 1996; Sarker et al, 2005).  
In conclusion, the XPG-TFIIH interaction is so far designated to the amino acids 1-85 (see chapter 
1.4.2). By genotype-phenotype correlation, this study greatly suggests to narrow down the 
functionally important XPG interaction domain to the amino-acids 30-85, which are designated to the 
endonucleolytic active N-domain. Because of the strong correlational evidence, we have already 
published these data (British Journal of Dermatology, under revision) with no need for further 
interaction studies. 
5.3 Genetic characterization of the functional XPG-PCNA interaction during 
NER 
In the following chapter, I discuss the genetic characterization of the PCNA-XPG interaction in terms 
of XPG’s ability to catalyze DNA repair synthesis and facilitate NER (see chapter 1.3.4.4). This 
comprises the N-terminal PIP-UBM box as well as the C-terminal PIP-box (see chapters 1.4.2, 4.2). 
5.3.1 The C-terminal PIP-box of XPG is required for quick DNA repair synthesis but is 
unimportant for complementation of XPG 
By comparison of the UDS and HCR results obtained during this study, I demonstrated that the C-
terminal PIP-box is required for immediate UV response but not for the functionality of XPG during 
TCR or in response to local high-dose UV irradiation. 
Both PCNA C-terminal interaction defective XPG mutants (Del, FF) used during this study were 
subcloned from plasmids provided by Prof. Ronal Gary (UNLV, USA) into the standardly used 
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pcDNA3.1(+) vector (Gary et al, 1999; Gary et al, 1997). The results of the truncated Del mutant are 
discussed later (see chapter 5.4.2).  
The FF clone is an artificially created XPG mutant optimized for defective PCNA binding in vitro. The 
same mutations of the respective Fen1 aminoacids result in ineffective PCNA binding and show the 
same effect in the respective XPG mutant, due to the highly conserved character of these residues 
(personal correspondence with Ron Gary, UNLV, USA) (see Figure 12). Furthermore, this XPG peptide 
was able to compete with p21 (PCNA inhibitor) for PCNA binding, underlining the conserved nature 
of this interaction, like it was supposed from the PCNA-interacting Peptide (PIP) sequence alignment 
(see chapter 6.2).  
Results obtained during this thesis with FF mutants 
Utilizing UDS, compared to the empty vector, FF was able to restore UV damage response slightly but 
significant. This observation indicates the ability of this in vitro PCNA interaction defective XPG full-
length mutant to facilitate DNA repair synthesis in living cells, assuming the actual model of ongoing 
DNA repair synthesis during the intermediate state of NER (see Figure 8). However, compared to wt-
XPG or endonuclease deficient E791A, the FF mutant displayed a strongly reduced UDS rate (see 
Figure 23). The corresponding double mutant, who combines endonuclease defectiveness with PCNA 
binding deficiency from the results of in vitro studies, behaved like the FF single mutant (see chapter 
4.2.1). These results indicate an impairment of immediate UV response (until two hours after 
irradiation) in dependency of the loss of PIP-box mediated PCNA binding, which was mutated in the 
FF clone.  
The in vitro E791A endonuclease defective mutant of XPG permits a higher rate of UDS compared to 
FF at an earlier point in time (two hours, UDS) (see chapter 5.4.1). The corresponding double mutant 
E/FF behaved like the FF mutant alone, underlining that the rate-limiting mutation for UDS is the one 
in the PIP-box motif. Furthermore, DM_E/FF behaved like E791A only during HCR assays, indicating 
that the respective E791A mutation is responsible the reduction of the repair capacity of this mutant. 
In order to clarify the possible divergence between PCNA recruitment and the start of DNA repair 
synthesis during NER, I decided to investigate a simultaneous triple staining of CPDs (DNA damage), 
PCNA and UDS, in dependency of XPG mutants transfected into XP20BE cells (see Figure 25). The FF 
mutant displayed a recruitment of PCNA and simultaneous UDS activity like WT. An UDS-CPD merge 
picture was observed at all points in time. However, in WT and FF, PCNA was missing after three 
hours indicating either transfection problems due to the one-try challenge (see general) or a 
periodical repair action.  
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I did not detect a discrepancy between temporal PCNA recruitment and DNA synthesis, because 
PCNA spots without UDS were not detected during triple staining. This result was unsurprising 
because of the processive nature of PCNA-dependent DNA synthesis (see chapter 1.3.5). 
Nevertheless, these results are not completely consistent with the quantitative analysis of the UDS 
rate two hours after irradiation (see Figure 23), which displays a significantly reduced rate compared 
to wildtype XPG.  
One explanation for the observed divergence between the results obtained by UDS and Triple-IF, lies 
in the competition of XPG with p21 for PCNA binding (see chapters 1.3.3, 1.4, 6.2). The occurrence of 
local high-dose UV-derived DNA damage (Triple-IF) requires much more chromatin remodeling 
activity at one spot compared to low-dose cellular damage (UDS). The C-terminal Pip-box of XPG has 
been shown to compete with p21 for binding and is abolished in presence of the FF-mutation 
resulting in an accumulation of p21. This should lead to subsequent p300 hyper-acetylation and 
Histone acetyl transferase (HAT) activation. A second explanation for the increase in DNA repair 
synthesis, in dependency of the FF-mutant during the Triple-IF assay, resembles favoritsm of the 
Exo1 pathway performing end resection under these circumstances (see chapter 1.5.1.2). The 
involvement of the p21 pathway was not investigated during this thesis. Thus, it is highly speculative 
and ignored for the illustration of the model. 
However, the Triple-IF results were approved by the complementation rate, measured three days 
after transfection of XP20BE cells with the UV-damaged reporter gene plasmid (see chapter 3.5.1). 
The FF repair value was comparable to wt-XPG. The repair rate was significantly enhanced compared 
to empty vector control as well as to endonuclease defective E791A. 
Results obtained by other research groups with the FF mutant 
In contrast to our study, Fagbemi and colleagues utilized immunofluorescence studies with the same 
FF mutation in XPG. They found out, that PCNA foci formation and 6-4PP removal of the FF mutant 
was comparable to WT, suggesting a rapid PCNA recruitment and depletion from local UV damage, 
utilizing immunofluorescence studies (Fagbemi, 2012). This is in line with our Triple-IF staining in 
dependency of the FF mutant. This accounts for a different behavior of this mutant in presence of 
high-dose local UV damage in comparison to low-dose UVC irradiation during UDS (see Figure 25).   
The HCR results of my thesis are in consistency with previous findings by Gary et al using a 
comparable reporter gene based system. They also observed only a slight reduce in the Host cell 
reactivation capacity in XPG-deficient UV135 cells by PCNA-interaction compromised mutants of XPG 
(R992A/E) (Gary et al, 1997). The HCR findings presented here are also in line with the effect on 6-
4PP removal in dependency of the XPG FF mutant in another dissertation (Fagbemi, 2012). In that 
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study, the FF mutant behaved like wt XPG with a strong reduction of 6-4PP spots within the first six 
hours after irradiation. By all means, the presence of the FF mutation alone results not in an error-
prone pathway, due to the complementation results using HCR (see model). 
Taken together, especially comparing the UDS and HCR results obtained during this study, these 
findings demonstrate that the C-terminal PIP-box is required for immediate UV response but not for 
the functionality of XPG to perform accurate NER in transiently transfected primary fibroblasts. 
5.3.2 The functional N-terminal PCNA-XPG interaction is required for optimal NER 
The data presented here indicates importance of the functional, partly ubiquitin-derived, XPG-PCNA 
interaction, mediated by the conserved N-terminal PIP-UBM domain of XPG for functional NER. 
Furthermore, it implicates the existence of an (to a certain extent) obligatory occurrence of 
ubiquitinated PCNA during stalled NER. This observation leads to the proposal of a new XPG function 
in blocking the recruitment of translesion polymerases. 
The C-terminally located highly conserved PIP-box is essential for complete DNA repair synthesis two 
hours after irradiation (UDS) but dispensable for complementation of XPG-deficiency during HCR 
assays (see Table 15). The FF mutant was shown to be PCNA binding defective in vitro. However, it 
was still able to facilitate DNA repair synthesis and NER during our experiments. The small N-terminal 
PIP-box (by length “a half” of the classical C-terminal PIP box) is located directly beside the also highly 
conserved ubiquitin binding domain (UBM) in the N-terminus of XPG. The influence of this PIP-UBM 
domain was estimated using HCR and UDS (see chapters 1.4.2, 3.5.1, 3.5.2, 4.2). 
Results obtained during this thesis with PIP-UBM mutants  
PIP mutation as well as UBM mutations (see chapter 4.2.1) were both sufficient to compromise the 
immediate repair synthesis (UDS) of the respective full-length wildtype or mutant XPGs (see Figure 
22a-c). Furthermore, the single mutation of the N-terminal PIP-box (L179A) seems to be more 
efficient in decreasing the UDS rate compared to the UBM mutations (L196A & P197A) alone (see 
Figure 22a, c). Noteworthy, the ubiquitin molecule is attached to PCNA in a flexible fashion, which   
increases its availability for binding partners (Hibbert & Sixma, 2012; Hishiki et al, 2009). One 
explanation might be that the small N-terminal PIP-box of XPG plays a crucial role in the positioning 
of the ubiquitin molecule. 
The simultaneous mutation of both domains (PIP-UBM), either using wildtype or endonuclease 
defective E791A XPG template, did not display any additive effect during UDS. Noteworthy, the PIP-
UBM double mutant showed no significant difference compared to the E791A-PIP-UBM triple 
mutant. This suggests a great importance of the N-terminal PIP-UBM box for the immediate UV 
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derived DNA damage repair and underlines the irrelevance of XPG endonuclease function for the 
start of repair synthesis.  
In case of the FF double mutants, whenever a FF mutant was mutated further at the N-terminal 
PCNA interaction domains (PIP, UBM), no mutant, neither the one with the addition of the PIP 
mutation nor the other one with mutations of the UBM domain, was sufficient to decrease the UDS 
rate of these double mutants to a level of zero (empty vector level) (see Figure 22b). However, the 
respective FF-PIP-UBM triple mutant somehow seems to compensate the strong defect of the 
respective double mutants and shows UDS at the level of the FF single mutation. This fact will be 
discussed with regard to the HCR results of these mutants, which are rather controversal.  
The HCR assay reflects the ability to deal with huge amounts of UV derived DNA damage on a 
plasmid in an error-free fashion in dependency of the used XPG mutants (see Figure 24). 
Mutagenesis of single domains, either PIP or UBM, decreased the complementation ability of XPG in 
XP20BE cells about 50%, comparable to the level of the respective triple mutant as well as to the 
single E791A mutation in an endonuclease defective XPG clone (see Figure 24a, c).  
The addition of either the single PIP mutation or the UBM domain mutations to endonuclease 
defective E791A (with the exception of E791A-PIP) or the FF mutant decreased the complementation 
ability compared to the E791A or FF mutations alone (see Figure 24b, c). The triple mutants E791A-
PIP-UBM and FF-PIP-UBM displayed an additive decrease compared to the double mutants. 
Mutations of the N-terminal PIP and UBM domains of the preselected XPG Isoform VI had no effect 
on the UDS rate (see Figure 22d). The DNA repair synthesis rate was comparable to the one FF 
catalyzed.  This suggests a different mechanism of complementation by IsoVI compared to full-length 
wt-XPG, E791A and FF. One explanation for this is the truncated nature of Isoform VI with an altered 
incision complex formation during NER.  
Results obtained by other research groups with PIP-UBM mutants 
The UBM domain of XPG was mutated by another research group in the same way as I did it and it 
was demonstrated that the mutations strongly compromise ubiquitin binding of XPG (Fagbemi, 
2012).  However, the clear proof of XPG’s binding to specifically ubiquitinated PCNA (at the Lysine 
164) is still pending, but due to the adjacent location of the N-terminal PIP-box the binding of 
ubiquitinated PCNA is highly recommended (personal communication with Prof. Orlando Schärer, 
Stony Brook university). 
My results are consistent with the observation of Fagbemi and colleagues, where no PCNA foci 
formation was observed during immunofluorescence studies in dependency of the PIP mutant and 
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the PIP-UBM double mutant.  Nevertheless, the single UBM mutant displayed a significant rate of 
PCNA foci formation, comparable to the level that is produced by E791A (Fagbemi, 2012). Assuming 
that PCNA foci formation and start of UDS are connected very tightly, and with no regard to the 
possible differences in these assays (see chapter 5.1), even the quantitative observation made by 
Fagbemi is reproduced with the UDS approach used during this study (see Figure 22a, c). 
My UDS results obtained with the FF-PIP and FF-UBM double mutants are not in line with the 
observation from the Schärer group, that the FF-UBM double mutant facilitates PCNA foci formation 
on a level comparable to wt XPG at early measuring times and E791A at the later ones (Fagbemi, 
2012). The differences between the assays are discussed elsewere and indicate a potential diverse 
back-up mechanism for XPG’s endonuclease function (see chapters 5.1, 5.4.1). 
The results of the presented HCR measurements (see Figure 24) of the PIP and UBM single mutants 
are consistent with the observation of the Schärer research group. They showed that PIP mutations 
and UBM mutations alone and the respective double mutant as well as E791A and a FF-UBM mutant 
all displayed comparable rates of 6-4PP removal around 50% compared to the wt-XPG as well as the 
FF mutation alone (personal communication with Prof. Orlando Schärer, Stony Brook University) 
(Fagbemi, 2012).  
Conclusion with respect to the functional XPG-PCNA interaction 
During this thesis, I discovered great evidence for the functional importance of XPG-PCNA interaction 
during the Nucleotide excision repair pathway. The interactions of the NER dual incision complex are 
manifold, highly organized and orchestrated.  
The number of impaired XPG functions, no matter if PCNA/ubiquitin interaction- or endonuclease-
defective, seems to have more influence on the functional NER than the type of the aminoacid 
substitution itself (see Figure 22, Figure 24). Two mutations in the XPG cDNA were sufficient to 
decrease the UDS as well as the HCR rate with a trend towards an even more decreased value with 
three mutations. I suggest that the interaction between (ubiquitinated) PCNA and XPG is multi-
layered, all contributing in part to the overall function of XPG during NER. This observation is used in 
analogy to the translesion polymerase Rev1 during the illustration of the model (see chapter 1.3.6).  
The almost negative influence of PIP and UBM single mutant variants of XPG during UDS and HCR 
(see Figure 22, Figure 24) further suggests that the N-terminal PIP and UBM domains of XPG work in 
concert in order to facilitate NER and thus can be seen as one PIP-UBM domain. When a XPG with a 
higher number of mutations is present (three, PIP-UBM plus E791A or FF), the occurrence of PIP and 
UBM mutations becomes additive regarding the decreasing NER.  
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The only exception within my results is the FF-PIP-UBM clone which leads to great new insights into 
XPG’s NER function. The UDS rate of the FF-UBM-PIP mutant was above the respective double 
mutants and comparably high to the FF mutation alone. This excludes XPG as the factor responsible 
for PCNA recruitment, because PCNA is needed for appropriate DNA synthesis (see chapter 1.3.5). 
This is in line with the observation that the clamp loader RFC is sufficient for recycling PCNA at stalled 
replication intermediates during in vitro studies. Therefore, I suggest that the clamp loader RFC is 
also able to load PCNA onto the DNA structure during stalled NER incision intermediates (see Figure 
27) (Masuda et al, 2007).  
The complementation ability during HCR was not enhanced compared to the empty vector control 
and strongly reduced to the FF mutation alone. This mutant is highly compromised in PCNA binding 
in an ubiquitin-dependent way.  
Ubiquitination of PCNA is a well established enhancer for the recruitment of translesion polymerases 
(e.g. Rev1) (see chapter 1.3.6). The binding of Rev1 to PCNA was shown to be regulated by the 
number of interactions in the mutasome, and Rev1 was still able to facilitate binding with a 
decreased number of interactions (seven to four).  
It is very plausible to explain the FF-UBM-PIP results with a proposal for a new function of XPG in the 
following fashion: it blocks the association of translesion polymerases with stalled NER intermediates 
via multiple interactions with PCNA. In the context of NER, translesion polymerases would use the 
undamaged strand as a template and perform DNA synthesis with very low accuracy (error-prone). 
The involvement of the UBM binding domain of XPG in this observation leads to the second proposal 
of obligatory ubiquitinated PCNA during NER, which is in line with former suggestions (Masuda et al, 
2010; Soria et al, 2006). That designates XPG as the factor that restricts the activation of translesion 
polymerases after UV irradiation to S-phase. 
5.4 Investigations on a backup mechanism for the XPG endonuclease function 
The third aim of my thesis was to investigate a theoretically possible alternative pathway during the 
very last steps of NER depending on the presence of a functionally constricted XPG. I investigated the 
effects of DNA2 and Fen1 regarding their endonucleolytic NER activity. 
5.4.1 Endonuclease defective XPG (E791A) is able to complement XP20BE deficient cells 
Results obtained from analyzes of the E791A mutant indicate the existence of a back-up mechanism, 
constantly present in human (skin) cells, which is somehow able to complement the endonucleolytic 
deficiency of XPG (especially HCR). Furthermore, the results of UDS support the actual “cut-patch-
cut-patch” model during dual incision (see Figure 8). 
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Results obtained during this thesis with the E791A mutants  
During this study, I investigated the activity of the endonuclease defective XPG mutants E791A and 
D77A in living cells. Utilizing Unscheduled DNA synthesis, the immediate post-UV response (two 
hours) of transiently transfected XP20BE fibroblast cells, with expression plasmids encoding these 
mutants, was measured by visualization of incorporated nucleoside analogs during genomic repair 
synthesis. Both mutants, as well as the respective double mutant, displayed a significantly reduced 
level of UDS, which is consistent with the current model drawn by Staresincic and colleagues in 2009 
(Staresincic et al, 2009). During the intermediate state of dual incision, the repair synthesis 
machinery, composed of RFC, PCNA, and Polymerase δ, is recruited after the first 5’ cut upstream of 
the lesion, performed by XPF/ERCC1, and starts synthesis along the undamaged strand prior to the 
downstream cut 3’ by XPG (see chapter 1.3.4.4).  
The UDS rate I observed within XPG complemented XP20BE cells is consistent with the estimated 
transfection efficacy of about 50-60% in comparison to the UDS rate of wildtype fibroblasts of a 
healthy donor (see Figure 26). Especially E791A displayed a decreased level of 50-60% UDS activity 
compared to wt-XPG, perfectly matching with the results of the Schärer research group, utilizing the 
classical UDS (there, incorporation of radioactive [3H-1’,2’]-thymidine was measured) (see Figure 22). 
This fact demonstrates the functionality of the assay used in this study and it supports the proposed 
“cut-patch-cut-patch” model for partial repair synthesis prior to the second XPG cleavage (see Figure 
8). However, the apparent small increase (not significant) of UDS observed with the double mutant, 
compared to the endonuclease defective single mutants, could be up to common fluctuations in the 
underlying transient transfection approach as well as to the ordinarily occurring slight variations 
observed within this kind of DNA repair assays (personal communication with Prof. Kenneth 
Kraemer, NIH). 
The Host cell reactivation of XP20BE cells by XPG mutants revealed truly unexpected results. Both 
endonuclease defective single mutants as well as the respective double mutant were able to 
complement the XPG deficiency (see Figure 23). Both XPG variants containing the corresponding 
E791A mutation, showed a significantly reduced HCR level compared to wildtype XPG as well as to 
D77A, indicating the more severe influence of the E791A amino acid substitution on both mutants. 
Again, the complementation rate of wt-XPG in comparison to fibroblasts of a healthy donor (WT, see 
Figure 23) perfectly matches the estimated transfection efficacy of XP20BE cells of about 50-60% 
(GFP plasmid based estimation of transfection efficacy analyzed using immunofluorescence 
techniques, data not shown).  
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Results obtained by other research groups with E791A XPG mutants 
Constantinou et al demonstrate that both substitutions from acidic residues to alanine (D77A, E791A) 
were not able to fully restore UV resistance in XPG-deficient cells (3H-thymidine incorporation, 
viability assay), whereas substitutions to acidic aminoacids did, suggesting a strong impairment of 
XPG function in vitro by these mutations (Constantinou et al, 1999). Indeed, both substitutions were 
definitely shown to be endonuclease defective in vitro. However, the study by Constantinou and co-
workers used stably transfected lymphoblastoid cells derived from the XPG patients XP3BR and 
XP125LO, both carrying residual full-length XPG alleles and retaining a splicevariant with intron 
retention between the XPG aa 917-962 and the in vitro endonuclease function compromising (not 
abolishing) A792V mutation, respectively (Scharer, 2008b). In comparison to the XP20BE cells used 
during my study (remaining alleles: 138 and 11 aa), the endogenous gene product of these cells used 
by Schärer et al is quite large. Hence, a rather dominant positive influence of the E791A and D77A 
mutants on the truncated endogenous patient protein was measured. Two other amino acid 
substitutions at the same position (D77E and E791D, acidic to acidic) were able to restore UV 
resistance of XP20BE cells in the same study, utilizing the same techniques (Constantinou et al, 
1999). However, the influence of E791A and D77A on XP20BE post-UV survival was not published or 
analyzed there.  
Consistent with my findings, another dissertation reports the partly complementation of XPCS1RO 
(XPG/CS) cells by stable transfection of E791A and by utilization of 6-4PP removal studies (about 30-
40% retained activity) (Fagbemi, 2012). Within the first six hours after UV irradiation E791A removed 
6-4PPs like WT. This period was followed by a barely detectable removal of DNA damage until 24 
hours. Furthermore, the occurrence of PCNA foci at sites of local DNA damage in dependency of XPG 
(mutants) was also observed during that study.  
5.4.2 XPG Isoform VI supports complementation of XPG deficient cells and requires Fen1 
endonuclease activity 
The physiologically occurring spontaneous mRNA splicevariant isoform VI, a truncated XPG variant, 
was able to perform UDS as well as HCR activity at a low level and is compromised in the presence of 
an endonuclease defective Fen1, possibly indicating the involvement of a DNA2/Fen1- dependent 
backup mechanism for the endonuclease function of XPG. 
The activity of truncated XPG versions during NER 
Two truncated XPG variants were investigated with regard to the UV damage response during this 
thesis. Isoform VI, on the one hand, cloned out of the cDNA pool of fibroblasts of healthy individuals 
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and preselected for NER activity. Del, on the other hand, was created artificially [Del: (Gary et al, 
1997), IsoVI: (Lehmann, 2013)].  
Due to the fact that truncation mutations of XPG cause the loss of TFIIH binding ability and XP/CS 
(1.1.2, 1.4), a reduced NER capacity was expected. In consistency with this assumption, both mutants 
showed a decreased level of UDS two hours after irradiation (see Figure 22).  
Noteworthy, both mutants are able to localize in the nucleus, as it was estimated by 
immunofluorescence studies using GFP fusion proteins of these mutants (Lehmann, 2013). In 
addition to the two major C-terminal NLS signals of XPG, an N-terminal nuclear localization signal 
(NLS-A) was detected two decades ago (see Figure 10) (Knauf et al, 1996). This indicates the 
sufficiency of the N-terminal NLS-site (40% activity) for nuclear transport as well as for the presence 
of Isoform VI in nuclei in vivo.  
In case of Isoform VI, the UDS rate was obviously enhanced, but did not reach a significant increase 
compared to the empty vector control. However, the dilution of IsoVI with empty vector (1:2) prior 
to transfection gained a significantly enhanced UDS rate compared to the IsoVI alone (see Figure 26). 
One reason for this observation might be a small malfunction of NER, created by the overexpression 
of a recombinant protein. The length of the IsoVI splicevariant is comparable to the allele of the 
XPCS1LV XPG/CS patient (659 aa) who suffers from a comparable phenotype like XP20BE (died at age 
of 6.5 years). IsoVI has, despite its truncated nature, the ability to configure the NER dual incision 
complex in a fashion that enables the first 5’ cleavage by ERCC1/XPF. The observed UDS rate with 
IsoVI accounts at least for the partial DNA repair, like it was observed with E791A (see chapter 
1.3.4.4). The binding affinity of a truncated XPG variant, like Isoform VI, during NER dual incision 
complexes, is expected to be lower than a full-length XPG variant. Hence, it is likely displaced more 
quickly and potentially restricts the stalling of the NER complex to a certain extent. Compared to 
E791A, isoform VI probably decreases the number of successful NER events but thereby affords the 
synthesis of a longer DNA stretch. 
The HCR results displayed a similar picture. The physiological splicevariant of XPG IsoVI increased the 
repair of the reporter gene plasmid to a small extent but in a highly significant manner (p=0.002). In 
contrast to that, the transfection of the artificially created Del mutant transferred no NER activity to 
XP20BE cells, which is consistent with previous findings utilizing a comparable luciferase reporter 
gene assay (Gary et al, 1997). Neither PCNA recruitment nor UDS was observed within the first 4.5 
hours after local UV irradiation in dependency of the Isoform VI using Triple-IF staining (data not 
shown). 
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Isoform VI is one of two physiological isoforms that, under my supervision, were preselected among 
seven isoforms (Lehmann, 2013) with the highest complementation ability in living cells using HCR. 
Due to the truncated stature of IsoVI protein, it is unable to perform the endonucleolytic cleavage 
itself and needs a helper nuclease for the termination of NER. 
The occurrence of physiological isoforms of XPG in skin cells and the NER activity underline the 
possibility of the existence of a nuclear backup mechanism for the XPG endonuclease function during 
NER. Moreover, endonuclease deficient Isoform VI itself is an evolutionary developed backup 
mechanism for the structural function of XPG during NER and uses a helper nuclease to perform the 
cleavage (see fig27). The helper nuclease in this case is the backup mechanism for the XPG 
endonuclease function. 
Investigations regarding a backup mechanism for XPG endonuclease function 
In accordance with the literature, DNA2 and Fen1 were chosen as candidates for further 
investigations. They are well known for the orchestrated action of flap primer removal during 
Okazaki fragment maturation (Burgers, 2009). An influence by Fen1 on post UV survival of higher 
eukaryotes has been proposed before (Matsumoto, 2001). Moreover, Fen1 and XPG are classified in 
the same endonuclease family, sharing a lot of homologies and comparable activities regarding the 
endonuclease and C-terminal PCNA binding domains and abilities (see chapter 1.5.1.1). Additionally, 
S. pombe Fen1 was shown to be able to cut down flaps with a length of 9-11 nts and a TT dimer 5’cap 
(Yoon et al, 1999). Under the assumption of the “cut-patch-cut-patch” model of the intermediate 
state of dual incision (see Figure 8), considering that a stalled NER reaction causes a similar structure 
as during Okazaki fragment maturation (see Figure 14), it is quite plausible to investigate the 
influence of Fen1 (in cooperation with DNA2) on the repair capacity of transfected XPG deficient 
cells. First, the unwinding of the long flap (24-32 nts, size of displaced oligonucleotide during NER) is 
performed by DNA2 followed by a cleavage adjacent (5’) to the UV lesion. Second, this leaves exactly 
the structure of a short flap with damage cap, like it was shown to be cleaved by Fen1 in vitro (Tapias 
et al, 2004) (see chapter 1.5.1.1).  
As I have mentioned before concerning the E791A mutant, it evolved to be a difficult task to 
investigate the hypothesis of a backup mechanism for XPG endonuclease function. However, due to 
the fact that during HCR assays three plasmids are transfected in an obligatory fashion, I decided to 
conduct UDS assays with XPG Isoform VI and additionally transfected DNA2 and Fen1 (or a Fen1 
endonuclease defective mutant, D181A) to measure the indirect effect of the inhibition of the NER 
reaction by the endonuclease defective Fen1.  
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Figure 26a displays the ability of Isoform VI to gain DNA repair synthesis after UVC irradiation. 
Multiple plasmid transfections, with additionally overexpressed Fen1 or D181A, displayed no 
difference compared to IsoVI diluted with the empty vector. However, addition of recombinant DNA2 
protein to the cells results in a decreased IsoVI-dependent complementation in presence of 
endonuclease defective Fen1 (D181A) (see Figure 26b). This is consistent with the observation that 
Fen1 alone has no effect, neither enhancing nor reducing, regarding the repair capability of E791A 
(personal communication with Prof. Orlando Schärer, Stony Brook University).  
All three proteins (IsoVI, Fen1, and DNA2) have a comparable size and are supposed to act as 
monomers during NER reactions (see Table 14). The addition of DNA2 alone to IsoVI reduced the 
repair ability. One explanation could be the negative influence of overexpression and the disturbance 
of the molecular ratios between the three molecules, resulting in a decreased (short-term) UDS rate. 
But indeed, these findings support a strong dependency on Fen1 during this reaction.  
The indirect proof towards the requirement for the endonuclease function of Fen1, thus meaning the 
complementation of IsoVI endonuclease deficiency, is produced with the great and highly significant 
reduction of IsoVI+DNA2+D181A in comparison to IsoVI diluted with the empty vector.  
I suggest that my Isoform VI data displays an evolutionary evolved backup mechanism for XPG’s 
function. However, further investigations are needed to clearly demonstrate a DNA2/Fen1 
involvement (see chapter 6.2).  
Conclusion with respect to a possible backup mechanism for endonuclease function during NER 
The results of the UDS analysis of the endonuclease defective XPG clones, and especially E791A, 
support the “cut-patch-cut-patch” model of a structural role of XPG to trigger XPF/ERCC1 5’ incision 
independently of XPG’s 3’ endonuclease function, like it has been demonstrated in vitro several times 
(Staresincic et al, 2009; Wakasugi et al, 1997). XPF/ERCC1 is recruited to sites of UV damage repair in 
dependency of the presence of XPG and is able to perform the 5’ cut, which leaves a structure able to 
recruit the DNA synthesis machinery (see Figure 8).  
It was rather unexpected that a truncated version of XPG is able to complement XPG deficient cells. A 
closer look at the difference between Del and Isoform VI gives a hint for the reason of this IsoVI 
complementation ability. The artificially created Del mutant is about 250 amino acids longer than 
Isoform VI. This leads to the additional lack of a part of the RPA binding domain in IsoVI and of the C-
terminal TFIIH interaction domain (four components) as well as the I-domain, which is known to be 
important for endonuclease activity (see Figure 10). Furthermore, IsoVI comprises 11 additional 
amino acids in its C-terminus, derived from intron retention due to the diverse splicing (Emmert et al, 
Discussion 
98 
2001). Overexpression studies of Del mixed with DNA2 and Fen1 displayed no enhancement of the 
UDS rate in comparison to the empty vector control or Del alone, underlining the repair 
defectiveness of Del during NER (data not shown). Taken together, the most plausible explanation for 
the inability of Del to complement during NER is the evolutionarily evolved character of XPG isoform 
VI. 
The theoretical involvement of Fen1 and/or DNA2 in the resolution of the proposed stalled 
intermediate structure in presence of E791A should be further investigated in order to clarify which 
nuclease(s) complement XPG endonuclease deficiency. The approach of knocking down Fen1 or 
DNA2 using shRNAs failed (data not shown). The knockdown was very efficient but destroyed 
proliferation of the cells because of the involvement of both proteins during Okazaki fragment 
maturation (see Figure 14). This was deleterious for the transient transfection approach during this 
study, which needs cell division for DNA delivery to nuclei. Additionally, simultaneous overexpression 
of E791A, Fen1 and DNA2 in addition to the reportergene plasmids Firefly and Renilla during HCR 
reactions (see chapter 3.5.1) failed (data not shown). Our observations point towards the 
ineffectiveness in bringing more than three plasmids to one cell at once.  
The involvement of Exo1 end resection, as it was proposed during stalled NER intermediates in yeast 
and human cells (see 1.3, 1.5.1.2), should be excluded within UDS assays. Due to the fact that Exo1 is 
known to resect the end of DNA, beginning at the free 5’ flap over a huge stretch of DNA, creating big 
gaps of ssDNA within chromosomal regions, the observed UDS levels should be expected to be much 
higher. Additionally, the Exo1- dependent pathway can be seen as the unfavorable way of resolution 
due to the deleterious character of occurrence of great (RPA covered) ssDNA stretches. This includes 
the sensitivity of DNA regarding hydrolysis and the activation of cell cycle checkpoints (see chapter 
1.3.1). However, the occurrence of the Exo1 pathway during HCR is naturally unknown. 
I propose that both pathways just exist in parallel and that there is a chance for both ways of 
resolution in one or another context. 
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6 Summary and conclusions 
I was able to narrow down the functionally important XPG interaction domain between TFIIH and 
XPG to the XPG amino-acids 30-85 by performing genotype-phenotype correlation studies of a novel 
XPG patient (XP172MA). 
Furthermore, the model depicted in 6.1. illustrates a strong hint towards a complex multifactoral 
NER intermediate state. Within this study, I clarified that 
- first, XPG is not responsible for the recruitment of PCNA, 
- second, the XPG-ubiquitin interaction is much more important during NER than XPG’s 
endonuclease function, and  
- third, IsoVI represents a physiologically relevant backup mechanism for XPG’s structural 
function that is (as least in part) depending on Fen1’s nuclease activity, one cellular backup 
mechanism for the endonuclease function of XPG. 
I propose that the XPG-ubiquitin interaction blocks the association of translesion polymerases with 
NER intermediates and restricts UV-activated TLS polymerase recruitment to S-phase. The model 
illustrated in Figure 27 is a very plausible explanation that confers consistency to the results 
presented during this thesis. 
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6.1 Model for the function of XPG during stalled NER intermediates 
 
Figure 27: Model for the function of XPG during stalled NER intermediates  
 
6.1.1 General remarks concerning the model 
The model displays four different pathways of resolution in an error-free (green boxed) or error-
prone (red boxed) fashion. Involved mutants in the pathways are named beside the arrows and the 
illustration between two boxes (green, red) indicates an involvement in both pathways.  
Due to simplification of the involved proteins, three groups were created (see Legend of Figure 27): 
- NER dual incision complex, “NER Holo complex” [TFIIH (10 subunits), RPA, XPA], 
- “helper nuclease” *either DNA2/Fen1 or Exo1+ (see chapter 1.5), and 
- translesion polymerase *TLS polymerases κ, η, ζ, ι or Rev1+.  
PCNA is seen like a molecular revolver barrel during this model, due to its circular nature and the 
presence as a trimer. Each monomer can be modified or carry a protein (“bullet”), and a simple 
turnaround of PCNA would subsequently deliver another reaction partner to (stalled) reaction 
complexes, no matter of in terms of replication or NER. 
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The translesion polymerase involved in this case is currently unknown but potentially involves the 
TLS polymerases κ, η, ζ, ι or Rev1. The latter is a translesion polymerase, beside its unique function of 
cytosine incorporation activity, it is able to recruit other translesion polymerases (see chapter 1.3.6). 
These polymerases partly share sequence homologies with XPG and are known to bind also DNA and 
(ubiquitinated) PCNA in a XPG-like fashion. Especially Rev1 was shown to have four interactions in 
the replication complex, with PCNA (2), ubiquitin (1), and DNA (1), just like it is assumed for XPG 
during this work (see Figure 9). Due to the similarities in binding, I conclude that every interaction 
with ubiquitin, PCNA and DNA plays a role in the ability of XPG to perform successful NER. In the 
context of this NER dual incision model, translesion polymerases would use the undamaged strand as 
a template and perform DNA synthesis with very low accuracy (error-prone). 
The N-terminal PCNA interaction (PIP) is important for NER. It potentially ensures the correct 
positioning of the whole machinery, in concert with the ubiquitin binding UBM box, prior to XPG’s 
cleavage. The C-terminal PIP-box (FF-mutant) is responsible for the fast track of the assembled DNA 
repair synthesis machinery, possibly preventing ubiquitination of PCNA. The third interaction is the 
one between XPG’s nuclease domains and DNA, which might also be important for positioning and a 
tight grip of XPG to the whole NER complex. Only if the complex is assembled in a sufficient position, 
this will lead to the (fast or slow) cut by XPG.  
6.1.2 Elucidation of the model 
The model of dual incision during NER, which is presented here (see Figure 27), is in great consistency 
with data presented in this study (see chapters 4.2, 4.3, especially Table 15). Furthermore, the 
current status of knowledge in the field of DNA repair and replication was taken into account. The 
result depicted in Figure 27 represents a model derived by genetic screening and is designated to be 
proofed in further biochemical experiments, which is discussed in the last chapter (see chapter 6.2). 
The upper box of Figure 27, which is outlined black, depicts the status of NER during normal dual 
incision. A legend for the naming of the factors, depicted in the black and blue box, is illustrated at 
the lower end of the figure in a grey box. General assumptions are found in the respective section 
(see chapter 6.1.1).  
A) The NER dual incision complex is completely recruited as well as both endonucleases 
XPF/ERCC1 and XPG (see chapter 1.3.4.4). The DNA displays a bubble structure and the 
complex is arranged in a correct fashion to perform the first ssDNA cut of the damaged 
strand 5’ of the lesion. XPF-ERCC1 performs the first cleavage depending on the presence of 
a XPG, which is able to fulfill its structural function in order to sufficiently stabilize the NER 
incision complex. 
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B) After the cleavage by XPF/ERCC1, the endonuclease is displaced by the DNA repair synthesis 
machinery consisting of PCNA, RFC and Pol δ. The simple occurrence of a dsDNA-ssDNA 
junction with free 3’ OH is sufficient for the recruitment of the clamp loader RFC, subsequent 
recruitment of the processivity factor PCNA and the polymerase (Masuda et al, 2007). RFC 
transfers the processivity to this machinery, especially to PCNA, whereas the polymerase 
itself displays a rather distributive character.   
C) The actual model proposes the start of DNA repair synthesis prior to the performance of the 
second cut by XPG 3’ of the lesion (see chapter 1.3.4.4). The clash of the polymerase δ and 
XPG (no direct interaction published) should be sufficient to displace the polymerase as well 
as RPA from the undamaged strand. This might be the trigger for the cleavage of XPG. 
However, the disruption of processivity of the polymerase in this situation leaves a stalled 
NER reaction, which involves the same core factors like a replication event (PCNA, RFC, and 
Pol δ).  
D) A stalled complex in the first instance creates time for molecular reactions to occur (blue 
outline). The presence of RPA, whether bound to the ssDNA of the bubble structure or after 
displacement at the ssDNA flap, is sufficient to recruit the Rad6/Rad18 ubiquitin ligase, which 
is known to ubiquitinate PCNA monomers at the conserved K164 residue (see chapters 1.3.5, 
1.3.6). The excised oligonucleotides after NER reactions were found to be coated with RPA, 
which leads to the conclusion that RPA is present in NER reactions until the second 3’ (XPG) 
cut has been performed. Hence, RPA74 will be able to recruit Rad6/Rad18 (Sale et al, 2012). A 
possibility is that the same displaced RPA from the undamaged strand subsequently binds 
the damaged ssDNA flap. 
Furthermore, my results in this thesis reveal a strong influence of the N-terminally located 
ubiquitin-mediated PCNA interaction domain of XPG regarding the DNA repair activity 
measured by two different assays in living cells. Mutations in these domains decreased the 
NER capacity of XPG, at least to an extent of an essentially compromised endonuclease 
deficient XPG. 
I propose a model that involves obligatory ubiquitination of PCNA during NER, at least due to 
the high potential of leaving enough time for secondary modifications. Not every NER event 
necessarily involves ubiquitination of PCNA but the number of these events is in a 
physiologically relevant area and an ubiquitin molecule is most probably bound by the N-
terminally located PIP-UBM box of XPG. This leads to faster or slower NER reactions, but in 
turn results in the cleavage by XPG. In presence of the FF XPG mutant (C-terminal PIP box) 
the stalling is prolonged, compared to the WT XPG, and the transition to E) is slower, 
indicated by the blue dotted arrow. This can increase the probability of PCNA ubiquitination.  
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The blue outlined, stalled dual incision reaction, was chosen as an origin to reconsider the different 
XPG cases regarding the reactions at a NER bubble. The big blue box in Figure 27 illustrates the 
proposal of an error-prone (red box) as well as two error-free (green box) pathways of resolution of a 
stalled NER reaction in dependency of diverse XPG mutants (or an isoform).  
6.1.2.1 Error-free pathways of resolution 
Intermediate resolution pathway one (wt-XPG, FF, PIP-UBM): 
E) After the 3’ endonucleolytic cleavage performed by XPG, the NER dual incision complex as 
well as XPG are displaced together with the excised damage containing oligonucleotide. The 
highly conserved canonical PIP-box in the C-terminus (which was mutated using the FF 
mutant during this thesis) promotes an ubiquitination-free immediate repair synthesis in an 
error-free fashion. A XPG variant with mutations in the PIP-UBM box is still capable of 
performing the fast track resolution of the stalled intermediates by using the C-terminal PIP-
box. Polymerase δ is recruited again as well as a ligase for nick sealing. The latter by another 
monomer of PCNA. Error-free repair synthesis is completed.  
Intermediate resolution pathway two (E791A, IsoVI, DM_E/FF): 
F) The presence of an endonuclease defective full-length XPG (E791A) is able to assemble the 
NER incision complex correctly. Due to its complete (ubiquitin-)PCNA binding ability (three 
interactions), it should be able to protect the reaction from the recruitment of translesion 
polymerases during the stalling of the reaction, which is supposed to be longer due to the 
requirement for the recruitment of the helper endonuclease, most probably by PCNA’s free 
third monomer. However, the suggested pathway of resolution is error-free. The addition of 
the FF-mutation to E791A has an increasing effect on the complementation rate (HCR) 
compared to E791A alone, whereas the UDS rate is decreased, with the same level of DNA 
repair synthesis like the FF. This underlines the depicted model in Figure 27. The addition of 
the FF mutation apparently enables E791A the performance of an error-free pathway more 
easily by making it easier for the helper nuclease to be recruited.  
In presence of the XPG splicevariant IsoVI, a physiologically relevant truncated version of 
XPG, the NER reaction complex is assembled correctly but in a decreased frequency and less 
stable compared to full-length XPG. However, the NER complex is formed if IsoVI is present. 
It is very likely that the stalling of the complex is sufficient enough for ubiquitination of PCNA 
and/or direct recruitment of the helper endonuclease by the DNA structure and a 
subsequent displacement of IsoVI as well as the NER Holo complex. 
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G) The recruitment of a helper nuclease (Fen1/DNA2 or Exo1) should in turn trigger the release 
of the endonuclease deficient XPG (E791A) because the DNA structure has to become 
available somehow. Probably the release of XPG is accompanied by the recruitment of the 
DNA polymerase δ and the displacement of the NER dual incision complex.  
The XPG isoform VI also enables this error-free pathway of resolution, due to its ubiquitin 
binding ability. This pathway is accompanied by the rapid displacement of IsoVI, the NER 
Holo complex as well as the helper endonuclease, and the dual incision product. However, 
the further mutagenesis of IsoVI in the PIP-UBM domain did not result in a decrease rate of 
UDS or HCR repair, indicating the unimportance of this interaction domain regarding the 
binding of ubiquitinated PCNA. This is potentially due to the lack of TFIIH interaction of the C-
terminus as well as to the loss of RPA binding activity and DNA binding with the I-Domain 
(see chapter 1.4.2). One explanation might be that IsoVI presence somehow favors the direct 
recruitment of helper nucleases. In comparison, the artificially truncated mutant Del is not 
able to complement at all (see chapter 4.3). This raises the possibility of an evolutionarily 
developed backup mechanism for the XPG function during NER by Isoform VI. However, the 
reduced binding ability and the low complementation rate (HCR) of IsoVI also account for the 
error-prone resolution pathway three (see chapter 3.5.1). Within this apparent discrepancy 
lies the potential of an evolutionarily developed mechanism to fine-tune the rate of 
mutations in the genome. 
H) The cleavage is performed. The oligonucleotide containing the lesion is displaced as well as 
the involved factors. One monomer of PCNA is free and probably able to recruit ligase I/III, 
setting everything up for the nick sealing after the termination of DNA repair synthesis.  
6.1.2.2 Error-prone pathways of resolution 
Intermediate resolution pathway three (IsoVI, FF-PIP-UBM, E791A-PIP-UBM): 
In the presence of PCNA binding deficient XPG in living cells (FF-PIP-UBM) the incision complex is 
stably built due to sufficient interactions with the NER Holo complex. Moreover, the possibility of a 
triggered XPG incision would be plausible if the clash with polymerase δ would lead to the 
subsequent XPG cleavage.  
I) If the clash between Pol δ and XPG is not sufficient for the activation of the XPG 3’ 
endonuclease activity and further PCNA interaction is needed, the FF-UBM-PIP is hardly 
compromised to perform the cleavage. In that case XPG is displaced, together with or 
without the NER Holo complex, and a helper nuclease is recruited via their interaction with 
PCNA, probably bound to another PCNA monomer. The recruitment of the translesion 
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polymerase should be sufficient to displace XPG and also probably the NER dual incision 
complex.  
The helper endonuclease is recruited to the DNA structure and cuts specifically (DNA2/Fen1) 
or resects the end of a damaged strand over long stretch (Exo1). Beside its observed role 
during local high-dose UV repair, in contrast to Fen1, I did not find any hint in the literature 
for the ability of Exo1 to digest NER intermediate structures in vitro. However, in terms of 
avoidance of deleterious long stretches of (RPA coated) ssDNA in presence of DNA damage 
(possible problems: hydrolysis, recombination, activation of cellular checkpoints), the 
genome integrity would possibly favor a Fen1/DNA2 based mechanism. 
J) The error-prone action of TLS polymerases on the undamaged template, which incorporates 
a wrong nucleotide every 30 bases (see chapter 1.3.6), is sufficient to create mutations. 
However, the lesion-containing oligonucleotide is displaced as well as the NER Holo complex 
and the helper nuclease.  
The proposed involvement of IsoVI in this error-prone pathway displays an evolutionarily developed 
backup mechanism for XPG which is able to fine-tune the mutation frequency of cells in order to gain 
new functional changes in terms of genetic adaption.  
The addition of the E791A mutation to a PIP-UBM mutant is supposed to act in this pathway. The lack 
of ubiquitin binding and the inability to cleave DNA results in a highly error-prone DNA synthesis, 
displayed by comparison of the UDS and HCR results, with a moderate post-UV DNA synthesis and a 
very low reporter gene expression, respectively. 
Intermediate resolution pathway four (FF-PIP-UBM, PIP-UBM): 
K) If XPG cleavage is performed in presence of ubiquitin binding defective mutants (PIP-UBMs), 
after the clash with the polymerase, the subsequent displacement of the NER dual incision 
complex, XPG, and of the excised oligo enables the recruitment of error-prone translesion 
polymerases, stimulated by the unbound ubiquitinated PCNA. I conclude, because of the 
data presented during this study, that XPG blocks the recruitment of TLS polymerases via its 
interaction with ubiquitinated PCNA. In case of the artificially created FF-UBM-PIP triple 
mutant, XPG’s mechanism of action provides a small but significant amount of error-prone 
TLS synthesis (see Table 15). However, the strikingly decreasing effect by mutations of the N-
terminal PIP domain alone leaves the possibility that the proposed direct interaction 
between PCNA and the N-terminally located PIP of XPG is highly important for the 
positioning of the complex in order to bind ubiquitin, because the ubiquitin molecule was 
found to be attached to PCNA in a flexible fashion. The PIP-UBM double mutant is still able to 
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perform the error-free pathway using the C-terminal PIP domain during the quick proceeding 
of the stalling (see chapter 6.1.2.1). This mutant complements during NER with about 50% 
repair activity compared to wildtype (HCR, UDS) which reflects probably a 50-50 chance for 
both pathways. 
6.2 Future perspectives 
The first clear evidence that has to be produced is the direct interaction of XPG with ubiquitinated 
PCNA. This can involve Co-IP studies using protein cell extracts of XPG-variant transfected cells or 
direct in vitro interaction studies with purified recombinant proteins. There are in vitro methods 
available to even control the ubiquitination status of each monomer. This can solve the question 
about the number of bound PCNA monomers of XPG. Furthermore, such studies would provide more 
evidence regarding the question which mechanism triggers cleavage by XPG during dual incision 
(Figure 8). 
Additionally, the involvement of several translesion polymerases in dependency of the XPG mutants 
has to be studied.  Especially Rev1 is a great candidate. This can be conducted by recruitment kinetics 
using immunofluorescence techniques or by in vitro NER reactions. The latter would be similarly well 
suited to clarify if the FF-PIP-UBM XPG mutant is able to perform an incision during NER. The 
establishment of stable transfected cell lines would be a big advantage for immunofluorescence 
studies. However, the immortalization of the XP20BE cells, the basis for these types of experiments, 
is currently under preparation.  
The ongoing debate about the existence of a second backup mechanism involving DNA2/Fen1 could 
also be solved in vitro. The control of the composition of the reaction factors is able to reproduce a 
mechanism involving either Exo1 or DNA2 and Fen1. It is quite essential to clarify the occurrence or 
non-occurrence of Exo1 at NER reaction bubbles, e.g. in G1-phase (measured in UDS). The ongoing 
translesion synthesis as well as the processive end resection by Exo1 both would be able to increase 
the UDS rate. However, the effect of Exo1 would be much bigger compared to normal or translesion 
synthesis and is probably excluded by the avoidance of grain nuclei measurements for UDS ratios. To 
set up an in vitro experiment which is able to track NER synthesis from single events should also be 
able to solve this problem.  
Additional analysis of a quadruple mutant (E791A-FF-PIP-UBM) with the same techniques as well as 
analysis of several other mutants in the triple IF stainings could be useful for the Exo1 debate on the 
one hand and on the other hand for confirmation or disproval of the model presented here (see 
Figure 27). 
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XPG splicevariants are an ongoing field of research in our lab. The establishment of specific qRT-PCRs 
for each isoform and the measurement of respective expression levels in different individuals and 
tissues are temporarily under investigation. Splicevariants are a highly suitable protein species for 
the investigation as cancer biomarkers, as has been reported before (Brinkman, 2004; Zhang et al, 
2013b). Further research in this field is highly recommended and can lead to a new prognostic value 
of XPG regarding chemotherapeutic response (Hu et al, 2014). Furthermore, the possible influence of 
the isoform VI as a backup mechanism for several other XPG functions (see chapter 1.4) can be 
tested.  
I was not able to detect PCNA without UDS during Triple-IF studies. However, the assay theoretically 
enables also the detection of other proteins than PCNA and can be a new strong tool for the 
clarification of molecular interplay at NER intermediates. 
In general, the transient transfection approach of primary fibroblasts is very useful for the relatively 
fast screening of many mutants regarding the NER activity in living cells. However, for statistically 
better quantitative results with UDS and recruitment kinetics, additional work with stable transfected 
cell lines is highly recommended. Nevertheless, the screening for genetic functions, like it was 
executed during this thesis, is much more feasible with the used “high-throughput” transient 
transfection approach. 
Beside other factors, XPG is also involved in chromatin remodeling in the context of UV damage 
repair (see chapter 1.3.3). The PCNA-XPG-p21-p300 signal transduction is potentially an additional 
layer of regulation of NER activity. XPG is acetylated in vitro in a p300-dependent fashion. This 
attachment is inhibited by PCNA and is in turn dependent on the interaction between p21 and PCNA 
(Tillhon et al, 2012). XPG is further known to inhibit p21 binding to PCNA (see chapters 1.3.5, 1.4), 
most probably via the conserved PIP-box in the C-terminus of XPG, mutated in the FF mutant (see 
chapter 1.4.2) (Gary et al, 1997). P21 was also shown to transfer Histone acetyl transferase (HAT) 
activity to p300 which is required for the chromatin remodeling in response to UV irradiation.  
Secondary modifications were excluded from the model, as well as the functional p21 involvement 
(see chapter 1.5.1.1). Like Fen1 (see chapter 1.5.1.1), XPG comprises a lot of theoretical 
phosphorylation sites and, so far, nothing is known about their functionalities 
(http://www.phosphosite.org). Due to its close relationship to Fen1, especially the phosphorylation 
of XPG is most probably functionally relevant and nothing about it is published, making it extremely 
time-consuming to investigate.  
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I already successfully applied for a post-doc start-up grant from the DFG. Furthermore, a large 
research application for the investigation of splicevariants of NER protein at Deutsche Krebshilfe e.V. 
has already been submitted and involves the plan to conduct biochemical in vitro assays as 
mentioned above.  
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